Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Ишемический инсульт и транзиторная ишемическая атака у взрослых

Список литературы

  1. Неврология: национальное руководство. Под ред. Е. И. Гусева, А. Н. Коновалова, В. И. Скворцовой. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа 2018; 1: 880.
  2. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee JM, Moseley ME, Peterson ED, Turan TN, Valder- rama AL, Vinters HV; American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epi- demiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabo- lism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Jul;44(7):2064-89. doi: 10.1161/STR.0b013e318296aeca
  3. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, John- ston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL; American Heart Association; American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Interdisciplinary Council on Peripheral Vascular Disease. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/Amer- ican Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009 Jun;40(6):2276-93. doi: 10.1161/STROKEAHA.108.192218
  4. Гусев Е.И., Скворцова В.И. Ишемия головного мозга, М.: Медицина, 2001. – 328 с.
  5. Инсульт: руководство для врачей. Под ред. Л.В. Стаховской, С.В. Котова. 2-е изд., доп. и перераб. М.: Медицинское информационное агентство 2018; 488.
  6. Caplan, L. (Ed.). (2016). Caplan's Stroke: A Clinical Approach (5th ed.). Cambridge: Cambridge University Press. doi:10.1017/CBO9781316095805 7. Campbell BCV, Khatri P. Stroke. Lancet. 2020 Jul 11;396(10244):129-142. doi: 10.1016/S0140- 6736(20)31179-X
  7. Barrett KM, Brott TG. Stroke Caused by Extracranial Disease. Circ Res. 2017 Feb 3;120(3):496-501. doi: 10.1161/CIRCRESAHA.117.310138
  8. Banerjee C, Chimowitz MI. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res. 2017 Feb 3;120(3):502-513. doi: 10.1161/CIRCRESAHA.116.308441
  9. Regenhardt RW, Das AS, Lo EH, Caplan LR. Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review. JAMA Neurol. 2018 Oct 1;75(10):1273-1281. doi: 10.1001/jamaneurol.2018.1073
  10. Ekker M.S., Boot E.M., Singhal A.B. et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018;17(9):790-801. doi: 10.1016/S1474-4422(18)30233-3
  11. Cucchiara, Brett & Kasner, Scott. Treatment of “Other” Stroke Etiologies. 2022. doi: 10.1016/B978-0-323- 69424-7.00058-2
  12. Latchaw RE, Yonas H, Hunter GJ, Yuh WT, Ueda T, Sorensen AG, Sunshine JL, Biller J, Wechsler L, Hi- gashida R, Hademenos G; Council on Cardiovascular Radiology of the American Heart Association. Guidelines and rec- ommendations for perfusion imaging in cerebral ischemia: A scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke. 2003 Apr;34(4):1084-104. doi: 10.1161/01.STR.0000064840.99271.9E
  13. Paciaroni M, Caso V, Agnelli G. The concept of ischemic penumbra in acute stroke and therapeutic opportu- nities. Eur Neurol. 2009;61(6):321-30. doi: 10.1159/000210544
  14. Chamorro Á, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke: targeting excitotoxicity, oxida- tive and nitrosative stress, and inflammation. Lancet Neurol. 2016 Jul;15(8):869-881. doi: 10.1016/S1474-4422(16)00114- 9
  15. Khoshnam SE, Winlow W, Farzaneh M, Farbood Y, Moghaddam HF. Pathogenic mechanisms following is- chemic stroke. Neurol Sci. 2017 Jul;38(7):1167-1186. doi: 10.1007/s10072-017-2938-1
  16. Zerna C, Thomalla G, Campbell BCV, Rha JH, Hill MD. Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke. Lancet. 2018 Oct 6;392(10154):1247-1256
  17. Liebeskind DS, Jüttler E, Shapovalov Y, Yegin A, Landen J, Jauch EC. Cerebral Edema Associated With Large Hemispheric Infarction. Stroke. 2019 Sep;50(9):2619-2625. doi: 10.1161/STROKEAHA.118.024766
  18. Lu G, He Q, Shen Y, Cao F. Potential biomarkers for predicting hemorrhagic transformation of ischemic stroke. Int J Neurosci. 2018 Jan;128(1):79-89. doi: 10.1080/00207454.2017.1349766
  19. Liebeskind DS, Jüttler E, Shapovalov Y, Yegin A, Landen J, Jauch EC. Cerebral Edema Associated With Large Hemispheric Infarction. Stroke. 2019 Sep;50(9):2619-2625. doi: 10.1161/STROKEAHA.118.024766
  20. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY; American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Asso- ciation/American Stroke Association. Stroke. 2011 Apr;42(4):1158-92. doi: 10.1161/STR.0b013e31820a8364
  21. Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019 Aug 23;19(10):74. doi: 10.1007/s11910-019-0988-x
  22. Green M, Styles T, Russell T, Sada C, Jallow E, Stewart J, Lazariashvili O, Lubomirova I, Cotlarciuc I, Sharma S, Han TS, Sharma P. Non-genetic and genetic risk factors for adult cerebral venous thrombosis. Thromb Res. 2018 Sep;169:15-22. doi: 10.1016/j.thromres.2018.07.005
  23. Afifi K, Bellanger G, Buyck PJ, Zuurbier SM, Esperon CG, Barboza MA, Costa P, Escudero I, Renard D, Lemmens R, Hinteregger N, Fazekas F, Conde JJ, Giralt-Steinhauer E, Hiltunen S, Arauz A, Pezzini A, Montaner J, Putaala J, Weimar C, Schlamann M, Gattringer T, Tatlisumak T, Coutinho JM, Demaerel P, Thijs V. Features of intracranial hemorrhage in cerebral venous thrombosis. J Neurol. 2020 Nov;267(11):3292-3298. doi: 10.1007/s00415-020-10008-0
  24. GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):439-458. doi: 10.1016/S1474- 4422(19)30034-1
  25. Здравоохранение в России. 2019: Стат.сб. Росстат. М. 2019; 170.
  26. Медико-демографические показатели Российской Федерации в 2012 году` 2013: стат. справочник. Минздрав России. М. 2013; 180.
  27. Стаховская Л.В., Ключихина О.А., Богатырева М.Д., Коваленко В.В. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009-2010). Журнал неврологии и психиатрии 2013; 5: 4-10.
  28. Стаховская Л.В., Клочихина О.А., Богатырева М.Д., Чугунова С.А. Анализ эпидемиологических показателей повторных инсультов в регионах Российской Федерации (по итогам территориально-популяционного регистра 2009–2014 гг.). Consilium Medicum. 2016; 18 (9): 8-11
  29. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, Sacco RL, Connolly SJ; Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014 Apr;13(4):429-38. doi: 10.1016/S1474-4422(13)70310-7
  30. Béjot Y., Bailly H., Durier J., Giroud M. Epidemiology of stroke in Europe and trends for the 21st century. Presse Med 2016; 45: 391-98.
  31. Bejot Y., Daubail B., Jacquin A. et al. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry. J Neurol Neurosurg Psychiatry 2014; 85: 509-13
  32. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sec- tional study. Stroke. 2012;43(12):3375-7.
  33. Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016; 47 (9): 2180-2.
  34. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-367
  35. Неврология: национальное руководство. Под ред. Е. И. Гусева, А. Н. Коновалова, В. И. Скворцовой. 2- е изд., перераб. и доп. М.: ГЭОТАР-Медиа 2018; 1: 880.
  36. Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, Ayata C, Towfighi A, Smith EE, Chong JY, Koroshetz WJ, Sorensen AG. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Clas- sification of Stroke System. Stroke. 2007 Nov;38(11):2979-84. doi: 10.1161/STROKEAHA.107.490896
  37. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 May 24:STR0000000000000375. doi: 10.1161/STR.0000000000000375
  38. Barrett KM, Brott TG. Stroke Caused by Extracranial Disease. Circ Res. 2017 Feb 3;120(3):496-501. doi: 10.1161/CIRCRESAHA.117.310138.
  39. anerjee C, Chimowitz MI. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res. 2017 Feb 3;120(3):502-513. doi: 10.1161/CIRCRESAHA.116.308441
  40. Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, Ayata C, Towfighi A, Smith EE, Chong JY, Koroshetz WJ, Sorensen AG. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Clas- sification of Stroke System. Stroke. 2007 Nov;38(11):2979-84. doi: 10.1161/STROKEAHA.107.490896
  41. Kamel H, Healey JS. Cardioembolic Stroke. Circ Res. 2017 Feb 3;120(3):514-526. doi: 10.1161/CIRCRESAHA.116.308407.
  42. Sacchetti DC, Furie KL, Yaghi S. Cardioembolic Stroke: Mechanisms and Therapeutics. Semin Neurol. 2017 Jun;37(3):326-338. doi: 10.1055/s-0037-1603465
  43. Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, Ayata C, Towfighi A, Smith EE, Chong JY, Koroshetz WJ, Sorensen AG. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Clas- sification of Stroke System. Stroke. 2007 Nov;38(11):2979-84. doi: 10.1161/STROKEAHA.107.490896
  44. Kim JS, Caplan LR. Clinical Stroke Syndromes. Front Neurol Neurosci. 2016;40:72-92. doi: 10.1159/000448303.
  45. He L, Xu R, Wang J, Zhang L, Zhang L, Zhou F, Dong W. Capsular warning syndrome: clinical analysis and treatment. BMC Neurol. 2019 Nov 13;19(1):285. doi: 10.1186/s12883-019-1522-0.
  46. Regenhardt RW, Das AS, Lo EH, Caplan LR. Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review. JAMA Neurol. 2018 Oct 1;75(10):1273-1281. doi: 10.1001/jamaneurol.2018.1073
  47. Wardlaw JM, Smith EE, Biessels GJ et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach. Lancet Neurol. 2013;12:822–38. https://doi.org/10.1016/S1474-4422(13)70124-8/
  48. ESO Guideline on covert cerebral small vessel disease. / Wardlaw, Joanna M.; Debette, Stephanie; Jokinen, Hanna; De Leeuw, Frank Erik; Pantoni, Leonardo; Chabriat, Hugues; Staals, Julie; Doubal, Fergus; Rudilosso, Salvatore; Eppinger, Sebastian; Schilling, Sabrina; Ornello, Raffaele; Enzinger, Christian; Cordonnier, Charlotte; Taylor-Rowan, Martin; Lindgren, Arne G. In: European Stroke Journal 2021; 24.
  49. Кулеш А.А., Емелин А.Ю., Боголепова А.Н., Доронина О.Б., Захаров В.В., Колоколов О.В., Котов С.В., Корсунская Л.Л., Кутлубаев М.А., Ласков В.Б., Левин О.С., Парфенов В.А. Клинические проявления и вопросы диагностики хронического цереброваскулярного заболевания (хронической ишемии головного мозга) на ранней (додементной) стадии. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):4-12. https://doi.org/10.14412/2074-2711-2021-1-4-12
  50. Cucchiara, Brett & Kasner, Scott. Treatment of “Other” Stroke Etiologies. 2022. Doi: 10.1016/B978-0-323- 69424-7.00058-2
  51. Ekker M.S., Boot E.M., Singhal A.B. et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018;17(9):790-801
  52. Debette S., Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol- ogy. 2009; 8: 668-78. Doi: 10.1016/S1474-4422(09)70084-5
  53. Debette S., Compter A., Labeyrie M.A., Uyttenboogaart M., Metso T.M., Majersik J.J., et al. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurology. 2015;14:640-54. doi: 10.1016/S1474-4422(15)00009-5
  54. Калашникова Л.А, Добрынина Л.А, Чечеткин А.О., Древаль М.В., Кротенкова М.В., Захаркина М.В. Нарушения мозгового кровообращения при диссекции внутренней сонной и позвоночной артерий. Алгоритм диагностики. Нервные болезни. 2016;2:10-17
  55. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Wolf ME, Hennerici MG. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis. 2013;36(1):1-5. doi: 10.1159/000352050
  56. Kim JS, Caplan LR. Clinical Stroke Syndromes. Front Neurol Neurosci. 2016;40:72-92. doi: 10.1159/000448303
  57. Leigh R, Knutsson L, Zhou J, van Zijl PC. Imaging the physiological evolution of the ischemic penumbra in acute ischemic stroke. J Cereb Blood Flow Metab. 2018 Sep;38(9):1500-1516. doi: 10.1177/0271678X17700913
  58. Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update. Curr Neurol Neurosci Rep. 2019;19(10):74.
  59. Mehta A, Danesh J, Kuruvilla D. Cerebral Venous Thrombosis Headache. Curr Pain Headache Rep. 2019 May 30;23(7):47. doi: 10.1007/s11916-019-0786-9
  60. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356–367
  61. Duman T, Uluduz D, Midi I, Bektas H, Kablan Y, Goksel BK, Milanlioglu A, Necioglu Orken D, Aluclu U; VENOST Study Group. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1848-1857. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.020.
  62. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Profes- sionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-e418. doi: 10.1161/STR.0000000000000211
  63. Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, de la Ossa NP, Strbian D, Tsivgoulis G, Turc G. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021 Mar;6(1):I-LXII. doi: 10.1177/2396987321989865
  64. Kim YJ, Kim BJ, Kwon SU, Kim JS, Kang DW. Unclear-onset stroke: Daytime-unwitnessed stroke vs. wake- up stroke. Int J Stroke. 2016 Feb;11(2):212-20. doi: 10.1177/1747493015616513.
  65. Dufouil C, Beiser A, McLure LA, et al. Revised Framingham Stroke Risk Profile to Reflect Temporal Trends. Circulation. 2017;135(12):1145-1159. doi: 10.1161/CIRCULATIONAHA.115.021275.
  66. Maas MB, Singhal AB. Unwitnessed stroke: impact of different onset times on eligibility into stroke trials. J Stroke Cerebrovasc Dis. 2013 Apr;22(3):241-3. doi: 10.1016/j.jstrokecerebrovasdis.2011.08.004
  67. O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, et al; INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016 Aug 20;388(10046):761-75. doi: 10.1016/S0140-6736(16)30506-2.
  68. Wafa HA, Wolfe CDA, Rudd A, Wang Y. Long-term trends in incidence and risk factors for ischaemic stroke subtypes: Prospective population study of the South London Stroke Register. PLoS Med. 2018 Oct 5;15(10): e1002669. doi: 10.1371/journal.pmed.1002669.
  69. Tan BYQ, Tan JTC, Cheah D, Zheng H, Pek PP, et al. Long-Term Trends in Ischemic Stroke Incidence and Risk Factors: Perspectives from an Asian Stroke Registry. J Stroke. 2020 Sep;22(3):396-399. doi: 10.5853/jos.2020.00878
  70. Bock BF. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke: Re- sponse System for Patients Presenting With Acute Stroke. Available at: http://www.ninds.nih.gov/news_and_events/pro- ceedings/ stroke_proceedings/bock.htm. Accessed August 23, 2011.
  71. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardi- ology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947. doi: 10.1161/STR.0b013e318284056a. Epub 2013 Jan 31
  72. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6
  73. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006 Jul;5(7):603-12. doi: 10.1016/S1474-4422(06)70495-1.
  74. Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treat- ment (TOAST). Neurology. 1999 Jul 13;53(1):126-31. doi: 10.1212/wnl.53.1.126.
  75. Fonarow GC, Saver JL, Smith EE, Broderick JP, Kleindorfer DO, Sacco RL, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH. Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke. J Am Heart Assoc. 2012 Feb;1(1):42-50. doi: 10.1161/JAHA.111.000034
  76. Пирадов М.А., Супонева Н.А., Рябинкина Ю.В., и др. Шкала подробной оценки состояния ареактивных пациентов (Full Outline of UnResponsiveness, FOUR): перевод и лингвокультурная адаптация русскоязычной версии // Анналы клинической и экспериментальной неврологии. 2019; 13 (3): 47-54. doi: 10.25692/ACEN.2019.3.7.
  77. Белкин А.А., Бочкарев П.Ю., Левит А.Л., Заболотских И.Б. Оценка нарушения сознания: шкала FOUR или шкала Glasgow? Вестник интенсивной терапии имени А.И. Салтанова. 2019;3:46–51
  78. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diag- nosis, and pulmonary complications. Stroke 2005; 36:2756-63.
  79. Feng MC, Lin YC, Chang YH, Chen CH, Chiang HC, Huang LC, Yang YH, Hung CH. The Mortality and the Risk of Aspiration Pneumonia Related with Dysphagia in Stroke Patients. J Stroke Cerebrovasc Dis. 2019 May;28(5):1381- 1387. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.011
  80. Joundi RA, Martino R, Saposnik G, Giannakeas V, Fang J, Kapral MK. Predictors and Outcomes of Dysphagia Screening After Acute Ischemic Stroke. Stroke. 2017 Apr;48(4):900-906. doi: 10.1161/STROKEAHA.116.015332.
  81. Chen PC, Chuang CH, Leong CP, Guo SE, Hsin YJ. Systematic review and meta-analysis of the diagnostic accuracy of the water swallow test for screening aspiration in stroke patients. J Adv Nurs. 2016 Nov;72(11):2575-2586. doi: 10.1111/jan.13013. Epub 2016 May 29
  82. Диагностика и лечение дисфагии при заболеваниях центральной нервной системы. Клинические рекомендации. Вестник восстановительной медицины 2014; 4: 99–115.
  83. Wondergem R, Pisters MF, Wouters EJ, Olthof N, de Bie RA, Visser-Meily JM, Veenhof C. The Course of Activities in Daily Living: Who Is at Risk for Decline after First Ever Stroke? Cerebrovasc Dis. 2017;43(1-2):1-8. doi: 10.1159/000451034. Epub 2016 Oct 18. PMID: 27750246
  84. Hebert D, Lindsay MP, McIntyre A, Kirton A, Rumney PG, Bagg S, Bayley M, Dowlatshahi D, Dukelow S, Garnhum M, Glasser E, Halabi ML, Kang E, MacKay-Lyons M, Martino R, Rochette A, Rowe S, Salbach N, Semenko B, Stack B, Swinton L, Weber V, Mayer M, Verrilli S, DeVeber G, Andersen J, Barlow K, Cassidy C, Dilenge ME, Fehlings D, Hung R, Iruthayarajah J, Lenz L, Majnemer A, Purtzki J, Rafay M, Sonnenberg LK, Townley A, Janzen S, Foley N, Teasell R. Canadian stroke best practice recommendations: Stroke rehabilitation practice guidelines, update 2015. Int J Stroke. 2016 Jun;11(4):459-84. doi: 10.1177/1747493016643553. Epub 2016 Apr 14. PMID: 27079654
  85. Mundiyanapurath S, Hees K, Ahmed N, et al.. Predictors of symptomatic intracranial haemorrhage in off-label thrombolysis: an analysis of the safe implementation of treatments in stroke registry. Eur J Neurol 2018; 25: e340–e311.
  86. Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, Lanari A, Micheli S, Bertolani L, Venti M, Palmerini F, Billeci AM, Comi G, Previdi P, Silvestrelli G. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis. 2009; 28 (2): 119-23. doi: 10.1159/000223436
  87. Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I-LXII. doi:10.1177/2396987321989865
  88. Rost NS, Masrur S, Pervez MA, Viswanathan A, Schwamm LH. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology. 2009;73(23):1957-1962. doi:10.1212/WNL.0b013e3181c5b46
  89. Хеннерици М.Г., Богуславски Ж., Сакко Р.Л.; перевод с английского; под общей редакцией чл.-корр. РАМ Скворцовой В.И. Инсульт: клиническое руководство. 2-е изд. М.: МЕДпресс-инфо 2008; 224.
  90. Инсульт. Руководство для врачей. Под редакцией Л.В. Стаховской, С.В. Котова. М.: Издательство МИА 2014; 400.
  91. Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC, Nogueira RG, Dem- chuk AM, Tomasello A, et al; HERMES Collaborators. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316:1279–1288. doi: 10.1001/jama.2016.13647
  92. Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, et al; on behalf of the Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373–2379. doi: 10.1161/STROKEAHA.116.013644
  93. Aghaebrahim A, Streib C, Rangaraju S, Kenmuir CL, Giurgiutiu DV, Horev A, Saeed Y, Callaway CW, Guyette FX, Martin-Gill C, et al. Streamlining door to recanalization processes in endovascular stroke therapy. J Neuroin- terv Surg. 2017;9:340–345. doi: 10.1136/neurintsurg-2016-012324
  94. Messe SR, Khatri P, Reeves MJ, Smith EE, Saver JL, Bhatt DL, Grau-Sepulveda MV, Cox M, Peterson ED, Fonarow GC, et al. Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry. Neurol- ogy. 2016;87:1565–1574
  95. Zaidi SF, Shawver J, Espinosa Morales A, Salahuddin H, Tietjen G, Lindstrom D, Parquette B, Adams A, Korsnack A, Jumaa MA. Stroke care: initial data from a county-based bypass protocol for patients with acute stroke. J Neurointerv Surg. 2017;9:631–635. doi: 10.1136/ neurintsurg-2016-012476
  96. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, et al; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21. doi: 10.1056/NEJMoa1706442
  97. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, et al; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–718. doi: 10.1056/NEJMoa1713973
  98. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030. doi: 10.1056/NEJMoa1414905
  99. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Román L, Serena J, Abilleira S, Ribó M, et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–2306. doi: 10.1056/NEJMoa1503780
  100. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, et al; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372: 2285-2295. doi: 10.1056/NEJMoa1415061
  101. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, et al; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009-1018. doi: 10.1056/NEJMoa1414792
  102. Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, Guillemin F; THRACE Investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016; 15: 1138-1147. doi: 10.1016/S1474-4422(16)30177-6
  103. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute is- chemic stroke. N Engl J Med. 2015; 372: 11-20. doi: 10.1056/NEJMoa1411587
  104. Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, et al; DEFUSE 2, IMS III, STAR, and SWIFT Trialists; DEFUSE 2 IMS III STAR and SWIFT Trialists. Effect of endovascular reperfusion in relation to site of arterial occlusion. Neurology. 2016; 86: 762-770. doi: 10.1212/WNL.0000000000002399
  105. Yoo AJ, Simonsen CZ, Prabhakaran S, Chaudhry ZA, Issa MA, Fugate JE, Linfante I, Liebeskind DS, Khatri P, Jovin TG, et al; for the Cerebral Angiographic Revascularization Grading Collaborators. Refining angiographic bi- omarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke. 2013; 44: 2509-2512. doi: 10.1161/STROKEAHA.113.001990
  106. Marks MP, Lansberg MG, Mlynash M, Kemp S, McTaggart R, Zaharchuk G, Bammer R, Albers GW; DE- FUSE 2 Investigators. Correlation of AOL recanalization, TIMI reperfusion and TICI reperfusion with infarct growth and clinical outcome. J Neurointerv Surg. 2014; 6: 724-728. doi: 10.1136/neurintsurg-2013-010973
  107. Muir KW, Ford GA, Messow CM, Ford I, Murray A, Clifton A, Brown MM, Madigan J, Lenthall R, Robertson F, et al; PISTE Investigators. Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial. J Neurol Neurosurg Psychiatry. 2017; 88: 38-44. doi: 10.1136/jnnp-2016- 314117
  108. Mocco J, Zaidat OO, von Kummer R, Yoo AJ, Gupta R, Lopes D, Frei D, Shownkeen H, Budzik R, Ajani ZA, et al; THERAPY Trial Investigators. Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke. 2016; 47: 2331-2338. doi: 10.1161/STROKEAHA.116.013372
  109. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013; 368: 893-903. doi: 10.1056/NEJMoa1214300
  110. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, Boccardi E; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013; 368: 904-913. doi: 10.1056/NEJMoa1213701
  111. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013; 368: 914-923. doi: 10.1056/NEJMoa1212793
  112. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, Liebeskind DS, Smith WS; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012; 380: 1231-1240. doi: 10.1016/S0140-6736(12)61299-9
  113. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO; SWIFT Trialists. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012; 380: 1241-1249. doi: 10.1016/S0140-6736(12)61384-1
  114. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T; for the MELT Japan Study Group. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke. 2007; 38: 2633- 2639. doi: 10.1161/STROKEAHA.107.488551
  115. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282: 2003-2011. doi: 10.1001/jama.282.21.2003
  116. Тул Дж.Ф., Гусев Е.И., Сосудистые заболевания головного мозга: руководство для врачей. Пер. с англ. Под ред акад. РАМН Е.И. Гусева, проф. А.Б. Гехт. 6 изд. М.: ГЭОТАР-Медиа 2007; 608.
  117. Рекомендации по ведению больных с ишемическими инсультами и транзиторными ишемическими атаками Европейского общества по борьбе с инсультами (ESO), 2008 Cerebrovasc Dis 2008; 25: 457-507. Available at: http//nsicu.ru/uploads/attachment/file/61/ StrokeGuidelinesRussian.pdf (рус. яз.) http://www.karger.com/Article/Pdf/131083
  118. Рекомендации по ведению больных с острым нарушением мозгового кровообращения Американской ассоциации сердца (АНА) и Американской ассоциации по борьбе с инсультами (АSA) 2005 Stroke 2005; 36; 916-923. Available at: http://stroke.ahajournals.ord/con- tent/36/4/916.e[tract]
  119. Van Wijngaarden JD, Dirks M, Huijsman R, Niessen LW, Fabbricotti IN, Dippel DW; Promoting Acute Thrombolysis for Ischaemic Stroke (PRACTISE) Investigators. Hospital rates of thrombolysis for acute ischemic stroke: the influence of organizational culture. Stroke. 2009 Oct; 40 (10): 3390-2.
  120. Jauch EC, Saver JL, Adams HP Jr., Bruno A, Connors JJ, Demaerschalk B, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardi- ology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44: 870-947.
  121. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2015; 46: 000-000
  122. Ois A, Cuadrado-Godia E, Rodríguez-Campello A, Jimenez-Conde J, Roquer J. High risk of early neurolog- ical recurrence in symptomatic carotid stenosis. Stroke. 2009; 40: 2727-2731. doi: 10.1161/STROKEAHA. 109.548032
  123. De Rango P, Brown MM, Chaturvedi S, Howard VJ, Jovin T, Mazya MV, Paciaroni M, Manzone A, Far- chioni L, Caso V. Summary of evidence on early carotid intervention for recently symptomatic stenosis based on meta- analysis of current risks. Stroke. 2015; 46: 3423-3436. doi: 10.1161/STROKEAHA.115.010764
  124. Marnane M, Ni Chroinin D, Callaly E, Sheehan OC, Merwick A, Hannon N, Horgan G, Kyne L, Moroney J, McCormack PM, et al. Stroke recurrence within the time window recommended for carotid endarterectomy. Neurology. 2011; 77: 738-743. doi: 10.1212/WNL.0b013e31822b00cf
  125. Ohansson EP, Arnerlöv C, Wester P. Risk of recurrent stroke before carotid endarterectomy: the AN- SYSCAP study. Int J Stroke. 2013; 8: 220-227. doi: 10.1111/j.1747-4949.2012.00790.x
  126. Strömberg S, Nordanstig A, Bentzel T, Österberg K, Bergström GM. Risk of early recurrent stroke in symp- tomatic carotid stenosis. Eur J Vasc Endovasc Surg. 2015; 49: 137-144. doi: 10.1016/j.ejvs.2014.11.004
  127. Kazandjian C, Kretz B, Lemogne B, Aboa Eboulé C, Béjot Y, Steinmetz E. Influence of the type of cerebral infarct and timing of intervention in the early outcomes after carotid endarterectomy for symptomatic stenosis. J Vasc Surg. 2016; 63: 1256-1261. doi: 10.1016/j.jvs.2015.10.097
  128. Azzini C, Gentile M, De Vito A, Traina L, Sette E, Fainardi E, Mascoli F, Casetta I. Very early carotid endarterectomy after intravenous thrombolysis. Eur J Vasc Endovasc Surg. 2016; 51: 482-486. doi: 10.1016/j.ejvs.2015.11.006
  129. Dachi K, Sadato A, Hayakawa M, Maeda S, Hirose Y. Acute carotid artery stenting in symptomatic high- grade cervical carotid artery stenosis. Neurosurg Rev. 2017; 40: 45-51. doi: 10.1007/s10143-016-0737-4

  1. Vasconcelos V, Cassola N, da Silva EM, Baptista-Silva JC. Immediate versus delayed treatment for recently symptomatic carotid artery stenosis. Cochrane Database Syst Rev. 2016; 9: CD011401. doi: 10.1002/14651858.CD011401.pub2
  2. Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC, Taylor DW, Haynes RB, Finan JW, Hachinski VC, et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke. 1999; 30: 1751-1758. doi: 10.1161/01.str.30.9.1751
  3. Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC, Nogueira RG, Demchuk AM, Tomasello A, et al; HERMES Collaborators. Time to treatment with endovascular thrombectomy and out- comes from ischemic stroke: a meta-analysis. JAMA. 2016; 316: 1279-1288. doi: 10.1001/jama.2016.13647
  4. Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, et al; on behalf of the Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016; 47: 2373-2379. doi: 10.1161/STROKEAHA.116.013644
  5. Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC, Nogueira RG, Demchuk AM, Tomasello A, et al; HERMES Collaborators. Time to treatment with endovascular thrombectomy and out- comes from ischemic stroke: a meta-analysis. JAMA. 2016; 316: 1279-1288. doi: 10.1001/jama.2016.13647
  6. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, et al; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018; 378: 11-21. doi: 10.1056/NEJMoa1706442
  7. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, et al; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018; 378: 708-718. doi: 10.1056/NEJMoa1713973
  8. R. Souillard-Scemama, M. Tisserand, D. Calvet, D. Jumadilova, S. Lion, G. Turc, M. Edjlali, C. Mellerio, C. Lamy, O. Naggara, J.-F. Meder, C. Oppenheim, An update on brain imaging in transient ischemic attack, Journal of Neuroradiology 2015; 42 (1): 3-11.
  9. Wardlaw J, Brazzelli M, Miranda H, et al. An assessment of the cost-effectiveness of magnetic resonance, includ- ing diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation. Health Technology Assessment, Southampton (UK): NIHR Journals Library; 2014 Apr.; 18 (27).
  10. Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, Guillemin F; THRACE Investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016; 15: 1138-1147. doi: 10.1016/S1474-4422(16)30177-6
  11. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute is- chemic stroke. N Engl J Med. 2015; 372: 11-20. doi: 10.1056/NEJMoa1411587
  12. Ehrlich ME, Turner HL, Currie LJ, Wintermark M, Worrall BB, Southerland AM. Safety of computed tomo- graphic angiography in the evaluation of patients with acute stroke: a single-center experience. Stroke. 2016; 47: 2045- 2050. doi: 10.1161/STROKEAHA.116.013973
  13. Aulicky P, Mikulík R, Goldemund D, Reif M, Dufek M, Kubelka T. Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis. J Neurol Neurosurg Psychiatry. 2010; 81: 783-787. doi: 10.1136/jnnp.2009.184002
  14. Lima FO, Lev MH, Levy RA, Silva GS, Ebril M, de Camargo EC, Pomerantz S, Singhal AB, Greer DM, Ay H, et al. Functional contrastenhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast- induced nephropathy. AJNR Am J Neuroradiol. 2010; 31: 817-821. doi: 10.3174/ajnr.A1927
  15. Hopyan JJ, Gladstone DJ, Mallia G, Schiff J, Fox AJ, Symons SP, Buck BH, Black SE, Aviv RI. Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke. AJNR Am J Neuroradiol. 2008; 29: 1826-1830. doi: 10.3174/ajnr.A1257
  16. Krol AL, Dzialowski I, Roy J, Puetz V, Subramaniam S, Coutts SB, Demchuk AM. Incidence of radiocon- trast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke. 2007; 38: 2364-2366. doi: 10.1161/STROKEAHA.107.482778
  17. Josephson SA, Dillon WP, Smith WS. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology. 2005; 64: 1805-1806. doi: 10.1212/01.WNL.0000161845.69114.62
  18. Ehrlich ME, Turner HL, Currie LJ, Wintermark M, Worrall BB, Southerland AM. Safety of computed tomo- graphic angiography in the evaluation of patients with acute stroke: a single-center experience. Stroke. 2016; 47: 2045- 2050. doi: 10.1161/STROKEAHA.116.013973
  19. Aulicky P, Mikulík R, Goldemund D, Reif M, Dufek M, Kubelka T. Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis. J Neurol Neurosurg Psychiatry. 2010; 81: 783-787. doi: 10.1136/jnnp.2009.184002
  20. Lima FO, Lev MH, Levy RA, Silva GS, Ebril M, de Camargo EC, Pomerantz S, Singhal AB, Greer DM, Ay H, et al. Functional contrastenhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast- induced nephropathy. AJNR Am J Neuroradiol. 2010; 31: 817-821. doi: 10.3174/ajnr.A1927
  21. Hopyan JJ, Gladstone DJ, Mallia G, Schiff J, Fox AJ, Symons SP, Buck BH, Black SE, Aviv RI. Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke. AJNR Am J Neuroradiol. 2008; 29: 1826-1830. doi: 10.3174/ajnr.A1257
  22. Krol AL, Dzialowski I, Roy J, Puetz V, Subramaniam S, Coutts SB, Demchuk AM. Incidence of radiocon- trast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke. 2007; 38: 2364-2366. doi: 10.1161/STROKEAHA.107.482778
  23. Josephson SA, Dillon WP, Smith WS. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology. 2005; 64: 1805-1806. doi: 10.1212/01.WNL.0000161845.69114.62
  24. Yaghi S., Willey J.Z., Cucchiara B. et al. Treatment and outcome of hemorrhagic transformation after intra- venous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2017; 48: e343-e361. DOI: 10.1161/ STR.0000000000000152. PMID: 29097489
  25. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen ac- tivator for acute ischemic stroke. N Engl J Med. 1995; 333: 1581-1587.
  26. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359: 1317-1329. doi: 10.1056/NEJMoa0804656
  27. Trouillas P, von Kummer R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke. 2006; 37: 556-561. doi: 10.1161/ 01.STR.0000196942.84707.71.
  28. von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD, Treurniet KM, Majoie CB, Marquering HA, Mazya MV, San Román L, Saver JL, Strbian D, Whiteley W, Hacke W. The Heidelberg Bleeding Clas- sification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke. 2015; 46: 2981-2986. doi: 10.1161/STROKEAHA.115.010049
  29. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators: Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998; 29: 4-11.
  30. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Dávalos A, Erilä T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Köhr- mann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G; for the SITS-MOST Investigators. Multivar- iable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke. 2008; 39: 3316-3322. doi: 10.1161/STROKEAHA.107.510768
  31. Trouillas P, von Kummer R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke. 2006; 37: 556-561. doi: 10.1161/01.STR.0000196942.84707.71.
  32. Ekundayo OJ, Saver JL, Fonarow GC, Schwamm LH, Xian Y, Zhao X, Hernandez AF, Peterson ED, Cheng EM. Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With The Guidelines–Stroke. Circ Cardiovasc Qual Outcomes. 2013; 6: 262-269. doi: 10.1161/CIRCOUTCOMES.113.000089
  33. Никитин А.С., Крылов В.В., Буров С.А., Петриков С.С., Асратян С.А., Камчатнов П.Р., Кемеж Ю.В., Белков М.В., Завалишин Е.Е. Дислокационный синдром у больных со злокачественным течением массивного ишемического инсульта. Журнал неврологии и психиатрии имени С.С.Корсакова 2015; 3 (Спецвып. «Инсульт»): 20- 26.
  34. Aghaebrahim A, Streib C, Rangaraju S, Kenmuir CL, Giurgiutiu DV, Horev A, Saeed Y, Callaway CW, Guyette FX, Martin-Gill C, et al. Streamlining door to recanalization processes in endovascular stroke therapy. J Neurointerv Surg. 2017; 9: 340-345. doi: 10.1136/neurintsurg-2016-012324
  35. Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, Halperin JL, Hlatky MA, Jacobs AK, Mark DB, et al. ACC/ AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. Circulation. 2014; 129: 2329-2345. doi: 10.1161/CIR.0000000000000042
  36. Wardlaw JM, Seymour J, Cairns J, Keir S, Lewis S, Sandercock P. Immediate computed tomography scan- ning of acute stroke is cost-effective and improves quality of life. Stroke. 2004; 35: 2477-2483. doi: 10.1161/01.STR.0000143453.78005.44
  37. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007; 369: 293-298. doi: 10.1016/S0140-6736(07)60151-2
  38. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, Tomanek A, Frayne R, Buchan AM; ASPECTS Study Group. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry. 2005; 76: 1528-1533. doi: 10.1136/jnnp.2004.059261
  39. Wardlaw JM, Seymour J, Cairns J, Keir S, Lewis S, Sandercock P. Immediate computed tomography scan- ning of acute stroke is cost-effective and improves quality of life. Stroke. 2004; 35: 2477-2483. doi: 10.1161/01.STR.0000143453.78005.44
  40. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007; 369: 293-298. doi: 10.1016/S0140-6736(07)60151-2
  41. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, Tomanek A, Frayne R, Buchan AM; ASPECTS Study Group. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry. 2005; 76: 1528-1533. doi: 10.1136/jnnp.2004.059261
  42. Goldstein LB. Stroke code chest radiographs are not useful. Cerebrovasc Dis. 2007; 24 (5): 460-2. doi: 10.1159/000108437.
  43. Saber H, Silver B, Santillan A, Azarpazhooh MR, Misra V, Behrouz R. Role of emergent chest radiography in evaluation of hyperacute stroke. Neurology. 2016; 87: 782-785. doi: 10.1212/WNL.0000000000002964
  44. Thijs V. Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke. Stroke. 2017 Oct; 48 (10): 2671-2677. doi: 10.1161/STROKEAHA.117.017083.
  45. Maciel R, Palma R, Sousa P, Ferreira F, Nzwalo H. Acute stroke with concomitant acute myocardial infarc- tion: will you thrombolyse? J Stroke. 2015 Jan; 17 (1): 84-6. doi: 10.5853/jos.2015.17.1.84.
  46. Battaglini D, Robba C, Lopes da Silva A, Dos Santos Samary C, Leme Silva P, Dal Pizzol F, Pelosi P, Rocco PRM. Brain-heart interaction after acute ischemic stroke. Crit Care. 2020 Apr 21; 24 (1): 163. doi: 10.1186/s13054-020- 02885-8
  47. Kallmünzer B, Breuer L, Kahl N, Bobinger T, Raaz-Schrauder D, Huttner HB, Schwab S, Köhrmann M. Serious cardiac arrhythmias after stroke: incidence, time course, and predictors--a systematic, prospective analysis. Stroke. 2012 Nov; 43 (11): 2892-7. doi: 10.1161/STROKEAHA.112.664318
  48. Fernández-Menéndez S, García-Santiago R, Vega-Primo A, González Nafría N, Lara-Lezama LB, Redondo- Robles L, Montes-Montes M, Riveira-Rodríguez MC, Tejada-García J. Cardiac arrhythmias in stroke unit patients. Eval- uation of the cardiac monitoring data. Neurologia. 2016 Jun; 31 (5): 289-95. English, Spanish. doi: 10.1016/j.nrl.2015.03.013
  49. Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, Reinhardt R, Hepp T, Kirchhof P, Aleynichenko E, Ringleb P, Hacke W, Veltkamp R. Continuous stroke unit electrocardiographic monitoring versus 24- hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012 Oct; 43 (10): 2689- 94. doi: 10.1161/STROKEAHA.112.654954
  50. Tsivgoulis G, Katsanos AH, Köhrmann M, Caso V, Perren F, Palaiodimou L, Deftereos S, Giannopoulos S, Ellul J, Krogias C, Mavridis D, Triantafyllou S, Alexandrov AW, Schellinger PD, Alexandrov AV. Duration of Implantable Cardiac Monitoring and Detection of Atrial Fibrillation in Ischemic Stroke Patients: A Systematic Review and Meta-Anal- ysis. J Stroke. 2019 Sep; 21 (3): 302-311. doi: 10.5853/jos.2019.01067
  51. Grond M, Jauss M, Hamann G, Stark E, Veltkamp R, Nabavi D, Horn M, Weimar C, Köhrmann M, Wachter R, Rosin L, Kirchhof P. Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Stroke. 2013 Dec; 44 (12): 3357-64. doi: 10.1161/STROKEAHA.113.001884
  52. Rubio Campal JM, García Torres MA, Sánchez Borque P, Navas Vinagre I, Zamarbide Capdepón I, Miracle Blanco Á, Bravo Calero L, Sáez Pinel R, Tuñón Fernández J, Serratosa Fernández JM. Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (from the DAF-ESUS registry). Am J Cardiol. 2020 Feb 1; 125 (3): 409-414. doi: 10.1016/j.amjcard.2019.10.050.
  53. Kitsiou A, Rogalewski A, Kalyani M, Deelawar S, Tribunyan S, Greeve I, Minnerup J, Israel C, Schäbitz WR. Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source during 3 Years of Prolonged Monitoring with an Implantable Loop Recorder. Thromb Haemost. 2021 Jun; 121(6): 826-833. doi: 10.1055/a-1346-2899.
  54. Triantafyllou S, Katsanos AH, Dilaveris P, Giannopoulos G, Kossyvakis C, Adreanides E, Liantinioti C, Tympas K, Zompola C, Theodorou A, Palaiodimou L, Flevari P, Kosmidou M, Voumvourakis K, Parissis J, Deftereos S, Tsivgoulis G. Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke. Ann Neurol. 2020 Nov; 88(5): 946-955. doi: 10.1002/ana.25886.
  55. Schnabel RB, Haeusler KG, Healey JS, Freedman B, Boriani G, Brachmann J, Brandes A, Bustamante A, Casadei B, Crijns HJGM, Doehner W, Engström G, Fauchier L, Friberg L, Gladstone DJ, Glotzer TV, Goto S, Hankey GJ, Harbison JA, Hobbs FDR, Johnson LSB, Kamel H, Kirchhof P, Korompoki E, Krieger DW, Lip GYH, Løchen ML, Mair- esse GH, Montaner J, Neubeck L, Ntaios G, Piccini JP, Potpara TS, Quinn TJ, Reiffel JA, Ribeiro ALP, Rienstra M, Rosenqvist M, Themistoclakis S, Sinner MF, Svendsen JH, Van Gelder IC, Wachter R, Wijeratne T, Yan B. Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. Circulation. 2019 Nov 26; 140 (22): 1834-1850. doi: 10.1161/CIRCULATIONAHA.119.040267
  56. Poli S, Diedler J, Härtig F, Götz N, Bauer A, Sachse T, Müller K, Müller I, Stimpfle F, Duckheim M, Steeg M, Eick C, Schreieck J, Gawaz M, Ziemann U, Zuern CS. Insertable cardiac monitors after cryptogenic stroke--a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol. 2016 Feb; 23(2): 375-81. doi: 10.1111/ene.12843
  57. Ntaios G. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Jan 28; 75(3): 333-340. doi: 10.1016/j.jacc.2019.11.024
  58. Schnabel RB, Haeusler KG, Healey JS, Freedman B, Boriani G, Brachmann J, Brandes A, Bustamante A, Casadei B, Crijns HJGM, Doehner W, Engström G, Fauchier L, Friberg L, Gladstone DJ, Glotzer TV, Goto S, Hankey GJ, Harbison JA, Hobbs FDR, Johnson LSB, Kamel H, Kirchhof P, Korompoki E, Krieger DW, Lip GYH, Løchen ML, Mair- esse GH, Montaner J, Neubeck L, Ntaios G, Piccini JP, Potpara TS, Quinn TJ, Reiffel JA, Ribeiro ALP, Rienstra M, Rosenqvist M, Themistoclakis S, Sinner MF, Svendsen JH, Van Gelder IC, Wachter R, Wijeratne T, Yan B. Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. Circulation. 2019 Nov 26; 140 (22): 1834-1850. doi: 10.1161/CIRCULATIONAHA.119.040267
  59. Poli S, Diedler J, Härtig F, Götz N, Bauer A, Sachse T, Müller K, Müller I, Stimpfle F, Duckheim M, Steeg M, Eick C, Schreieck J, Gawaz M, Ziemann U, Zuern CS. Insertable cardiac monitors after cryptogenic stroke--a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol. 2016 Feb; 23(2): 375-81. doi: 10.1111/ene.12843
  60. Li YG, Pastori D, Farcomeni A, et al. A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects. Chest. 2019; 155(3): 510-518.
  61. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Associa- tion for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1; 42(5): 373-498. doi: 10.1093/eurheartj/ehaa612
  62. Ntaios G, Perlepe K, Lambrou D, Sirimarco G, Strambo D, Eskandari A, Karagkiozi E, Vemmou A, Korompoki E, Manios E, Makaritsis K, Vemmos K, Michel P. Identification of patients with embolic stroke of undeter- mined source and low risk of new incident atrial fibrillation: The AF-ESUS score. Int J Stroke. 2021 Jan; 16(1): 29-38. doi: 10.1177/1747493020925281
  63. Pagola J, Pagola C, Juega J, González-Alujas T, Alvarez-Sabin J, Molina CA. The Role of Echocardiography Screening at the Stroke Unit. Front Neurol. 2020 Sep 11; 11:1003. doi: 10.3389/fneur.2020.01003
  64. Zhang L, Harrison JK, Goldstein LB. Echocardiography for the detection of cardiac sources of embolism in patients with stroke or transient ischemic attack. J Stroke Cerebrovasc Dis. 2012 Oct; 21(7): 577-82. doi: 10.1016/j.jstroke- cerebrovasdis.2011.01.005.
  65. Fralick M, Goldberg N, Rohailla S, Guo Y, Burke MJ, Lapointe-Shaw L, Kwan JL, Weinerman AS, Rawal S, Tang T, Razak F, Verma AA. Value of routine echocardiography in the management of stroke. CMAJ. 2019 Aug 6; 191(31): E853-E859. doi: 10.1503/cmaj.190111.
  66. ordan K, Yaghi S, Poppas A, Chang AD, Mac Grory B, Cutting S, Burton T, Jayaraman M, Tsivgoulis G, Sabeh MK, Merkler AE, Kamel H, Elkind MSV, Furie K, Song C. Left Atrial Volume Index Is Associated With Cardio- embolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source. Stroke. 2019 Aug; 50(8): 1997-2001. doi: 10.1161/STROKEAHA.119.025384.
  67. Stewart MH, Gilliland Y. Role of Transesophageal Echocardiography in Patients with Ischemic Stroke. Prog Cardiovasc Dis. 2018 Nov-Dec; 61 (5-6): 456-467. doi: 10.1016/j.pcad.2018.11.007
  68. Katsanos AH, Giannopoulos S, Frogoudaki A, Vrettou AR, Ikonomidis I, Paraskevaidis I, Zompola C, Va- dikolias K, Boviatsis E, Parissis J, Voumvourakis K, Kyritsis AP, Tsivgoulis G. The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a meta-analysis. Eur J Neurol. 2016 Mar; 23(3): 569- 79. doi: 10.1111/ene.12897
  69. Schnabel RB, Camen S, Knebel F, Hagendorff A, Bavendiek U, Böhm M, Doehner W, Endres M, Gröschel K, Goette A, Huttner HB, Jensen C, Kirchhof P, Korosoglou G, Laufs U, Liman J, Morbach C, Nabavi DG, Neumann- Haefelin T, Pfeilschifter W, Poli S, Rizos T, Rolf A, Röther J, Schäbitz WR, Steiner T, Thomalla G, Wachter R, Haeusler KG. Expert opinion paper on cardiac imaging after ischemic stroke. Clin Res Cardiol. 2021 Jul; 110(7): 938-958. doi: 10.1007/s00392-021-01834-x
  70. Katsanos AH, Giannopoulos S, Frogoudaki A, Vrettou AR, Ikonomidis I, Paraskevaidis I, Zompola C, Vadikolias K, Boviatsis E, Parissis J, Voumvourakis K, Kyritsis AP, Tsivgoulis G. The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a meta-analysis. Eur J Neurol. 2016 Mar; 23(3): 569-79. doi: 10.1111/ene.12897
  71. Mahmoud AN, Elgendy IY, Agarwal N et al. Identification and quantification of patent foramen ovale me- diated shunts: echocardiography and transcranial Doppler. Interv Cardiol Clin. 2017; 6: 495-504.
  72. Droste DW, Lakemeier S, Wichter T et al. Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke. 2002; 33: 2211-2216.
  73. Serena J, Segura T, Perez-Ayuso MJ et al. The need to quantify right-to-left shunt in acute ischemic stroke: A case-control study. Stroke 1998; 29: 1322-1328
  74. Mojadidi MK, Winoker JS, Roberts SC, Msaouel P, Zaman MO, Gevorgyan R, Tobis JM. Accuracy of conventional transthoracic echocardiography for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of pro- spective studies. Echocardiography. 2014 Oct; 31(9): 1036-48. doi: 10.1111/echo.12583
  75. Hakimi R, Sivakumar S. Imaging of Carotid Dissection. Curr Pain Headache Rep. 2019 Jan 19; 23(1): 2. doi: 10.1007/s11916-019-0741-9
  76. Калашникова Л.А., Добрынина Л.А., Чечеткин А.О., Древаль М.В., Кротенкова М.В., Захаркина М.В. Нарушения мозгового кровообращения при диссекции внутренней сонной и позвоночной артерий. Алгоритм диагностики. Нервные болезни 2016; 2:10-15.
  77. Ahmed N, Steiner T, Caso V, Wahlgren N; ESO-KSU session participants. Recommendations from the ESO- Karolinska Stroke Update Conference, Stockholm 13-15 November 2016. Eur Stroke J. 2017 Jun; 2(2): 95-102. doi: 10.1177/2396987317699144.
  78. Buyck PJ, de Keyzer F, Vanneste D, Wilms G, Thijs V, Demaerel D. CT density measurement and H:H ratio are useful in diagnosing acute cerebral venous sinus thrombosis. AJNR Am J Neuroradiol. 2013; 34: 1568-72.
  79. van Dam LF, van Walderveen MAA, Kroft LJM, Kruyt ND, Wermer MJH, van Osch MJP, Huisman MV, Klok FA. Current imaging modalities for diagnosing cerebral vein thrombosis - A critical review. Thromb Res. 2020 May; 189: 132-139.
  80. Pongmoragot J, Saposnik G. Intracerebral hemorrhage from cerebral venous thrombosis. Curr Atheroscler Rep. 2012; 14(4): 382-389.
  81. Buyck PJ, de Keyzer F, Vanneste D, Wilms G, Thijs V, Demaerel D. CT density measurement and H:H ratio are useful in diagnosing acute cerebral venous sinus thrombosis. AJNR Am J Neuroradiol. 2013; 34: 1568-72.
  82. Canedo-Antelo M, Baleato-González S, Mosqueira AJ, et al. Radiologic Clues to Cerebral Venous Throm- bosis. Radiographics. 2019; 39(6): 1611-1628.
  83. Wasay M, Azeemuddin M. Neuroimaging of cerebral venous thrombosis. J Neuroimaging. 2005; 15: 118- 28.
  84. Rollins N, Ison C, Reyes T, Chia J. Cerebral MR venography in children: comparison of 2D time-of-flight and gadoliniumenhanced 3D gradient-echo techniques. Radiology. 2005; 235(3): 1011-7.
  85. Conforto AB, Nader SN, Puglia Junior P, Yamamoto FI, Gonçalves MR, Vasconcelos FR, et al. Dural arte- riovenous fistula and cerebral venous thrombosis. Arq Neuropsiquiatr. 2015; 73: 548.
  86. George M.G. Risk Factors for Ischemic Stroke in Younger Adults: A Focused Update. Stroke. 2020; 51(3): 729-735
  87. Omran S.S., Lerario M.P., Gialdini G. et al. Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2019; 28(4): 882-88
  88. Tan RY, Markus HS. Monogenic causes of stroke: now and the future. J Neurol. 2015 Dec; 262(12): 2601- 16. doi: 10.1007/s00415-015-7794-4
  89. Adams HP Jr. Cerebral vasculitis. Handb Clin Neurol. 2014; 119: 475-94. doi: 10.1016/B978-0-7020-4086- 3.00031-X
  90. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke (Cochrane re- view). In: The Cochrane Library. Oxford, UK: Update Software CD000213 2003; 1.
  91. Cavallini A, Micieli G, Marcheselli S, Quaglini S. Role of monitoring in management of acute ischemic stroke patients.Stroke. 2003 Nov; 34(11): 2599-603.
  92. Langhorne P, Pollock A: What are the components of effective stroke unit care? Age Ageing 2002; 31: 365- 371.
  93. Borsellino B, Schultz MJ, Gama de Abreu M, Robba C, Bilotta F. Mechanical ventilation in neurocritical care patients: a systematic literature review. Expert Rev Respir Med. 2016; 10: 1123-32
  94. Rajajee V, Riggs B, Seder DB. Emergency neurological life support: airway, ventilation, and sedation. Neu- rocrit Care. 2017; 27(Suppl 1): 4-28.
  95. Robba, C., Bonatti, G., Battaglini, D. et al. Mechanical ventilation in patients with acute ischaemic stroke: from pathophysiology to clinical practice. Crit Care 2019; 23: 388. doi:10.1186/s13054-019-2662-8
  96. Jauch EC, Cucchiara B, Adeoye O, Meurer W, Brice J, Chan YY, Gentile N, Hazinski MF. Part 11: adult stroke: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care [published correction appears in Circulation. 2011;124:e404]. Circulation. 2010; 122(suppl 3): S818-S828
  97. Ding J, Zhou D, Sui M, Meng R, Chandra A, Han J, Ding Y, Ji X. The effect of normobaric oxygen in patients with acute stroke: a systematic review and meta-analysis. Neurol Res. 2018; 40(6): 433-44.
  98. Araujo de Franca S, Tavares WM, Salinet ASM, Paiva WS, Teixeira MJ. Early tracheostomy in stroke pa- tients: A meta-analysis and comparison with late tracheostomy. Clin Neurol Neurosurg. 2021 Apr; 203: 106554. doi: 10.1016/j.clineuro.2021.106554. Epub 2021 Feb 10. PMID: 33607581
  99. Bennett MH, Weibel S, Wasiak J, Schnabel A, French C, Kranke P. Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014:CD004954
  100. Heyboer M 3rd, Sharma D, Santiago W, McCulloch N. Hyperbaric oxygen therapy: side effects defined and quantified. Adv Wound Care (New Rochelle). 2017; 6: 210-224.
  101. Bath, PM, Krishnan, K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Da- tabase Syst Rev 2014; 10: CD000039.
  102. Appiah, KO, Minhas, JS, Robinson, TG. Managing high blood pressure during acute ischemic stroke and intracerebral hemorrhage. Curr Opin Neurol 2018; 31: 8-13.
  103. Lee M, Ovbiagele B, Hong KS, Wu YL, Lee JE, Rao NM, Feng W, Saver JL. Effect of blood pressure lowering in early ischemic stroke: meta-analysis. Stroke. 2015; 46: 1883-1889. doi: 10.1161/STROKEAHA.115.009552
  104. Stead LG, Gilmore RM, Vedula KC, Weaver AL, Decker WW, Brown RD Jr. Impact of acute blood pressure variability on ischemic stroke outcome. Neurology. 2006; 66: 1878-1881. doi: 10.1212/01.wnl.0000219628 78513.b5
  105. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, Jagger C. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009; 8: 48-56. doi: 10.1016/S1474- 4422(08)70263-1
  106. He J, ZhangY, XuT, ZhaoQ, WangD, ChenCS, TongW, LiuC, XuT, JuZ, PengY, PengH, LiQ, GengD, ZhangJ, LiD, ZhangF, GuoL, SunY, WangX, CuiY, LiY, MaD, YangG, GaoY, YuanX, BazzanoLA, ChenJ; CATIS In- vestigators. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA. 2014; 311: 479-489. doi: 10.1001/jama.2013.282543
  107. Sandset, EC, Bath, PM, Boysen, G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011; 377: 741-750.
  108. Bath, PM, Woodhouse, L, Scutt, P, et al. ENOS trial investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015; 385: 617-628.
  109. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. European Stroke Journal 2021; 6(2): X48-L89.
  110. Visvanathan A, Dennis M, Whiteley W. Parenteral fluid regimens for improving functional outcome in peo- ple with acute stroke. Cochrane Database Syst Rev. 2015:CD011138.
  111. Wohlfahrt P, Krajcoviechova A, Jozifova M, Mayer O, Vanek J, Filipovsky J, Cifkova R. Low blood pres- sure during the acute period of ischemic stroke is associated with decreased survival.J Hypertens. 2015; 33: 339-345. doi: 10.1097/HJH.0000000000000414
  112. Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CD, Rudd AG: Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke 2000; 31: 2043-2048.
  113. Butcher K, Christensen S, Parsons M, De Silva DA, Ebinger M, Levi C, Jeerakathil T, Campbell BC, Barber PA, Bladin C, Fink J, Tress B, Donnan GA, Davis SM; for the EPITHET Investigators. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010; 41: 72-77.
  114. Perini F, De Boni A, Marcon M, Bolgan I, Pellizzari M, Dionisio LD. Systolic blood pressure contributes to intracerebral haemorrhage after thrombolysis for ischemic stroke. J Neurol Sci. 2010; 10.
  115. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, Wahlgren N, Ahmed N; for the SITS Investi- gators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012; 43: 1524-1531.
  116. Waltimo T, Haapaniemi E, Surakka IL, Melkas S, Sairanen T, Sibolt G, Tatlisumak T, Strbian D. Post- thrombolytic blood pressure and symptomatic intracerebral hemorrhage. Eur J Neurol. 2016; 23: 1757-1762.
  117. Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG; ENCHANTED Investigators and Coordinators.Intensive blood pres- sure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, ran- domised, open-label, blinded-endpoint, phase 3 trial. Lancet. 2019 Mar 2; 393(10174): 877-888.
  118. Liu K, Yan S, Zhang S, Guo Y, Lou M. Systolic blood pressure variability is associated with severe hemor- rhagic transformation in the early stage after thrombolysis. Transl Stroke Res. 2016; 7: 186-191.
  119. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jan- kowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018 Jan 4; 378(1): 11-21.
  120. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Roman L, Serena J, Abilleira S, Ribo M, Millan M, Urra X, Cardona P, Lopez-Cancio E, Tomasello A, Castano C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Perez M, Goyal M, Demchuk AM, von Kummer R, Gallofre M, Davalos A; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015; 372: 2296- 2306.
  121. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Baxter BW, Devlin TG, Lopes DK, Reddy VK, du Mesnilde Rochemont R, Singer OC, Jahan R; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372: 2285-2295.
  122. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 372: 1009-1018.
  123. Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, Guillemin F; THRACE Investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016; 15: 1138-1147.
  124. Berkhemer OA, Fransen PS, Beumer D, vanden Berg LA, Lingsma HF,Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama a Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, deBruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van Rooij WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, SchreuderTH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg- Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, JenniskensSF, BeenenLF, vandenBergR, KoudstaalPJ, vanZwamWH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW; MRCLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015; 372: 11-20.
  125. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019-1030.
  126. Bath PM, Krishnan K, Appleton JP. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase in- hibitors for acute stroke. Cochrane Database Syst Rev. 2017 Apr 21; 4: CD000398;
  127. Bath PM, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Data- base Syst Rev. 2014 Oct 28; (10): CD000039
  128. Bath PM. Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. Cochrane Data- base Syst Rev. 2004; (3): CD000211.
  129. Zhang J, Liu J, Li D, Zhang C, Liu M. Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev. 2019 Feb 13; 2: CD001928.
  130. Visvanathan A, Dennis M, Whiteley W. Parenteral fluid regimens for improving functional outcome in peo- ple with acute stroke. Cochrane Database Syst Rev. 2015:CD011138.
  131. Mullen MT, Parthasarathy AB, Zandieh A, Baker WB, Mesquita RC, Loomis C, Torres J, Guo W, Favilla CG, Messé SR, Yodh AG, Detre JA, Kasner SE. Cerebral Blood Flow Response During Bolus Normal Saline Infusion After Ischemic Stroke. J Stroke Cerebrovasc Dis. 2019 Nov; 28(11): 104294.
  132. Bhalla A, Wolfe CD, Rudd AG. Management of acute physiological parameters after stroke. QJM. 2001 Mar; 94(3): 167-72.
  133. Dharmasaroja PA. Fluid Intake Related to Brain Edema in Acute Middle Cerebral Artery Infarction. Transl Stroke Res. 2016 Feb; 7(1): 49-53.
  134. Shackford SR, Zhuang J, Schmoker J. Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg. 1992; 76(1): 91-8.
  135. Visvanathan A, Dennis M, Whiteley W. Parenteral fluid regimens for improving functional outcome in people with acute stroke. Cochrane Database Syst Rev. 2015: CD011138.
  136. van der Jagt, M. Fluid management of the neurological patient: a concise review. Crit Care 2016; 20: 126. Doi: 10.1186/s13054-016-1309-2
  137. Chang TS, Jensen MB. Haemodilution for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2014; 8: CD000103. DOI:10.1002/14651858.CD000103.pub2.
  138. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. The New England Journal of Medicine 2004; 350: 2247-56.
  139. Middleton, S, McElduff, P, Ward, J. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): A cluster randomised controlled trial. Lancet 2011; 378: 1699-706.
  140. Middleton, S, Drury, P, Levi, CR. What processes of clinical care are associated with 90-day survival and independence? Results from the quality in acute stroke care QASC trial. Int J Stroke 2012; 7: 25.
  141. Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome : a metaanalysis of studies in patients. Stroke. 2000 Feb; 31(2): 410-4.
  142. Prasad K, Krishnan PR. Fever is associated with doubling of odds of short-term mortality in ischemic stroke: an updated meta-analysis.Acta Neurol Scand 2010; 122: 404-8.
  143. Azzimondi G, Bassein L, Nonino F et al. Fever in acute stroke worsens prognosis. A prospective study. Stroke 1995; 26: 2040-3.
  144. Saxena M, Young P, Pilcher D, Bailey M, Harrison D, Bellomo R, Finfer S, Beasley R, Hyam J, Menon D, Rowan K, Myburgh J. Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection. Intensive Care Med. 2015; 41: 823-832.
  145. Drury P, Levi C,McInnes E et al.Management of fever, hyperglycemia, and swallowing dysfunction follow- ing hospital admission for acute stroke in New South Wales, Australia. Int J Stroke 2014; 9: 23-3.
  146. Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998; 29: 2455-60.
  147. Middleton, S, McElduff, P, Ward, J. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): A cluster randomised controlled trial. Lancet 2011; 378: 1699-706.
  148. Saxena M, Young P, Pilcher D, Bailey M, Harrison D, Bellomo R, Finfer S, Beasley R, Hyam J, Menon D, Rowan K, Myburgh J. Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection. Intensive Care Med. 2015; 41: 823-832.
  149. Rincon F, Hunter K, Schorr C, Dellinger RP, Zanotti-Cavazzoni S. The epidemiology of spontaneous fever and hypothermia on admission of brain injury patients to intensive care units: a multicenter cohort study. J Neurosurg. 2014 Oct; 121(4): 950-60.
  150. Niven DJ, Laupland KB. Pyrexia: aetiology in the ICU. Crit Care. 2016 Sep 1; 20: 247.
  151. Westendorp WF, Vermeij JD, Zock E, Hooijenga IJ, Kruyt ND, Bosboom HJ, Kwa VI, Weisfelt M, Rem- mers MJ, ten Houten R, Schreuder AH, Vermeer SE, van Dijk EJ, Dippel DW, Dijkgraaf MG, Spanjaard L, Vermeulen M, van der Poll T, Prins JM, Vermeij FH, Roos YB, Kleyweg RP, Kerkhoff H, Brouwer MC, Zwinderman AH, van de Beek D, Nederkoorn PJ; PASS investigators. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet. 2015 Apr 18;385(9977):1519-26.
  152. Vermeij JD, Westendorp WF, Dippel DW, van de Beek D, Nederkoorn PJ. Antibiotic therapy for preventing infections in people with acute stroke. Cochrane Database Syst Rev. 2018 Jan 22;1:CD008530.
  153. Liu L, Xiong XY, Zhang Q, Fan XT, Yang QW. The Efficacy of Prophylactic Antibiotics on Post-Stroke Infections: An Updated Systematic Review and Meta-Analysis. Sci Rep. 2016 Nov 14;6:36656 .
  154. Lyden P, Hemmen T, Grotta J, Rapp K, Ernstrom K, Rzesiewicz T, Parker S, Concha M, Hussain S, Agarwal S, Meyer B, Jurf J, Altafullah I, Raman R. Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke. 2016;47:2888-2895.
  155. Geurts M, Petersson J, Brizzi M, Olsson-Hau S, Luijckx GJ, Algra A, Dippel DW, Kappelle LJ, van der Worp HB. COOLIST (Cooling for Ischemic Stroke Trial): a multicenter, open, randomized, phase II, clinical trial. Stroke. 2017;48:219-221.
  156. van der Worp, H. B., Macleod, M. R., Bath, P. M., Bathula, R., Christensen, H., Colam, B., Schwab, S. (2019). Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial. European Stroke Journal, 4(3), 254-262
  157. Piironen K, Putaala J, Rosso C, et al. Glucose and acute stroke: evidence for an interlude. Stroke 2012; 43:898-902.
  158. Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission hyperglycemia and clinical outcome in cerebral venous thrombosis. Stroke 2016; 47: 390-396;
  159. Fuentes, B., Ntaios, G., Putaala, J., Thomas, B., Turc, G., & Dez-Tejedor, E. European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke. European Stroke Journal 2018; 3 (1): 5-21.
  160. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med. 2006; 13: 174-180.
  161. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003; 34: 2208-2214.
  162. Ntaios G, Egli M, Faouzi M, Michel P. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke. 2010 Oct; 41(10): 2366-70.
  163. Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission hyperglycemia and clinical outcome in cerebral venous thrombosis. Stroke 2016; 47: 390-396.
  164. Johnston KC, Bruno A, Barrett K, et al. Stroke hyperglycemia insulin net- work effort (SHINE) trial primary results. International Stroke Conference 2019. Available at: https:// nett.umich.edu/sites /defau lt/files /docs/shine _isc_2019.final .pdf. Accessed 16 Apr 2019.
  165. Fuentes, B., Ntaios, G., Putaala, J., Thomas, B., Turc, G., & D^ez-Tejedor, E. (2018). European Stroke Or- ganisation (ESO) guidelines on glycaemia management in acute stroke. European Stroke Journal 2018; 3(1): 5-21.
  166. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49: e46-e110.
  167. Kim JT, Liebeskind DS, Jahan R, Menon BK, Goyal M, Nogueira RG, юereira VM, Gralla J, Saver JL. Impact of hyperglycemia according to the collateral status on outcomes in mechanical thrombectomy. Stroke 2018; 49: 2706-271.
  168. Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Oczkowski S, Szczeklik W, Bischoff SC. ESPEN guideline on clinical nutri- tion in the intensive care unit. Clin Nutr. 2019 Feb; 38(1): 48-79. doi: 10.1016/j.clnu.2018.08.037. Epub 2018 Sep 29.
  169. Dennis M, Lewis S, Cranswick G, Forbes J; FOOD Trial Collaboration. FOOD: a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke. Health Technol Assess. 2006;10:iii- iv, ix.
  170. Geeganage C, Beavan J, Ellender S, Bath PM. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev. 2012; 10: CD000323.
  171. Zusman O, Bendavid I, Kagan I, Theilla M, Cohen J, Singer P. Early administration of protein in critically ill patients: a large retrospective cohort study. Ann Intensive Care 2018. submitted for publication.
  172. KoekkoekWACK, van Setten CCH, Olthof LE, Kars JCN, van Zanten ARH. Timing of PROTein INtake and clinical outcomes of adult critically ill patients on prolonged mechanical VENTilation: the PROTINVENT ret- rospective study. Clin Nutr 2018. doi: 10.1016/j.clnu.2018.02.012
  173. Elke G, van Zanten ARH, Lemieux M, McCall M, Jeejeebhoy KN, Kott M, et al. Enteral versus parenteral nutrition in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials. Crit Care 2016; 20: 117.
  174. Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Oczkowski S, Szczeklik W, Bischoff SC. ESPEN guideline on clinical nutri- tion in the intensive care unit. Clin Nutr. 2019 Feb; 38(1): 48-79. doi: 10.1016/j.clnu.2018.08.037. Epub 2018 Sep 29.
  175. Middleton S, Mc Elduff P, Ward J et al. Implementation of evidence based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): A cluster randomized controlled trial. Lancet 2011; 378: 1699-706.
  176. Miles A, Zeng IS, McLauchlan H, Huckabee ML. Cough reflex testing in dysphagia following stroke: a randomized controlled trial. J Clin Med Res. 2013; 5: 222-233.
  177. Joundi RA, Martino R, Saposnik G, Giannakeas V, Fang J, Kapral MK. Predictors and outcomes of dyspha- gia screening after acute ischemic stroke. Stroke. 2017; 48: 900-906
  178. Geeganage C, Beavan J, Ellender S, Bath PM. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev. 2012; 10: CD000323.
  179. Sorensen RT, Rasmussen RS, Overgaard K, Lerche A, Johansen AM, Lindhardt T. Dysphagia screening and intensified oral hygiene reduce pneumonia after stroke. J Neurosci Nurs. 2013; 45: 139-146.
  180. Brady M, Furlanetto D, Hunter RV, Lewis S, Milne V. Staff-led interventions for improving oral hygiene in patients following stroke. Cochrane Database Syst Rev. 2006: CD003864.
  181. Wagner C, Marchina S, Deveau JA, Frayne C, Sulmonte K, Kumar S. Risk of stroke-associated pneumonia and oral hygiene. Cerebrovasc Dis. 2016; 41: 35-39.
  182. Sandercock PA, Leong TS. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev. 2017 Apr 4; 4(4): CD000119.
  183. CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration, Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013 Aug 10; 382 (9891): 516-24.
  184. Dennis M, Caso V, Kappelle LJ, Pavlovic A, Sandercock P; European Stroke Organisation. European Stroke Organisation (ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke. Eur Stroke J. 2016 Mar; 1(1): 6-19. doi: 10.1177/2396987316628384
  185. Dennis M, Mardi N, Graham C, et al. for the CLOTS, trials collaboration. The timing, extent, progression and regression of DVT in immobile stroke patients: observational data from the CLOTS randomized trials. J Thromb Haem 2011; 9: 2193-2200.
  186. Kelly J, Rudd A, Lewis RR, et al. Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 2004; 35: 2320-2325.
  187. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke 2001; 32: 262.
  188. Dennis M, Sandercock PA, Reid J, Graham C, Murray G, Venables G, Rudd A, Bowler G. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009 Jun 6; 373(9679): 1958-65.
  189. Decousus H, Tapson VF, et al. Factors at admission associated with bleeding risk in medical patients: find- ings from the IMPROVE investigators. Chest. 2011; 139: 69-79.
  190. Rosenberg DJ, Press A, et al. External validation of the IMPROVE Bleeding Risk Assessment Model in medical patients. Thromb Haemost. 2016; 116: 530-6
  191. Muscari A, Faccioli L, Lega MV, Lorusso A, Masetti M, Pastore Trossello M, Puddu GM, Spinardi L, Zoli M. Predicting hemorrhagic transformation and its timing from maximum cerebral lesion diameter in nonlacunar ischemic strokes. Brain Behav. 2020 Jan; 10(1): e01497.
  192. Best JG, Ambler G, Wilson D, Lee KJ, Lim JS et al.; Microbleeds International Collaborative Network. Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. Lancet Neurol. 2021 Apr; 20(4): 294-303.
  193. Muscari A, Faccioli L, Lega MV, Lorusso A, Masetti M, Pastore Trossello M, Puddu GM, Spinardi L, Zoli M. Predicting hemorrhagic transformation and its timing from maximum cerebral lesion diameter in nonlacunar ischemic strokes. Brain Behav. 2020 Jan; 10(1): e01497.
  194. Li L, Poon MTC, Samarasekera NE, Perry LA, Moullaali TJ, Rodrigues MA, Loan JJM, Stephen J, Ler- piniere C, Tuna MA, Gutnikov SA, Kuker W, Silver LE, Al-Shahi Salman R, Rothwell PM. Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies. Lancet Neurol. 2021 Jun; 20(6): 437-447.
  195. Prasad BK, Banerjee AK, Howard H. Incidence of deep vein thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegics. Age Ageing. 1982 Feb; 11(1): 42-4.
  196. Spinelli M, Corea F, Bignamini V, et al. Early vital and functional outcome of acute ischaemic stroke pa- tients: influence of deep vein thrombosis prevention with pneumatic compression devices. J Neurol 2006; 253: 135.
  197. Sandercock PA, Leong TS. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev 2017; 4:CD000119.
  198. Shorr AF, Jackson WL, Sherner JH, Moores LK. Differences between low-molecular- weight and unfrac- tionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis. Chest 2008; 133: 149.
  199. Paciaroni M, Agnelli G, Venti M, et al. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a metaanalysis of controlled studies. J Thromb Haemost 2011; 9: 893.
  200. Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PAG. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD001922.
  201. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Profes- sionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec; 50(12): e344-e418. doi: 10.1161/STR.0000000000000211
  202. Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM. 2000 Jun; 93(6): 359-64. doi: 10.1093/qjmed/93.6.359
  203. Нейрогенная дисфункция нижних мочевыводящих путей: клинические рекомендации. М. 2020.
  204. Нейрогенная дисфункция нижних мочевыводящих путей: рекомендации Европейской ассоциации урологов (EAU). М. 2011; 67.
  205. Европейско-азиатские рекомендации по ведению пациентов с инфекциями, связанными с уретральными катетерами, и по профилактике катетер-ассоциированных инфекций. М. 2008; 83-91.
  206. Рекомендации Европейской ассоциации урологов (EAU), Урологической ассоциации Азии (UAA) //Клиническая микробиология и антимикробная химиотерапия. М. 2008; 10 (3).
  207. Pressure Ulcer Prevention and Treatment Protocol: Health Care Protocol. Bloomington, MN; Institute for Clinical Systems Improvement (ICSI): 3rd edition. 2012 January.
  208. van der Worp HB, Hofmeijer J, Jüttler E, Lal A, Michel P, Santalucia P, Schönenberger S, Steiner T, Tho- malla G. European Stroke Organisation (ESO) guidelines on the management of space-occupying brain infarction. Eur Stroke J. 2021 Jun; 6(2): XC-CX. doi: 10.1177/23969873211014112.
  209. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996; 53: 309-315.
  210. Ropper AH, Shafran B. Brain edema after stroke: clinical syndrome and intracranial pressure. Arch Neurol. 1984; 41: 26-29.
  211. Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998; 73: 829-836.
  212. Malm J, Bergenheim AT, Enblad P, Hardemark HG, Koskinen LO, Naredi S, Nordstrom CH, Norrving B, Uhlin J, Lindgren A. The Swedish Malignant Middle Cerebral Artery Infarction Study: long-term results from a prospective study of hemicraniectomy combined with standardized neurointensive care. Acta Neurol Scand. 2006; 113: 25-30.
  213. Bardutzky J, Schwab S. Antiedema therapy in ischemic stroke. Stroke. 2007; 38: 3084-3094.
  214. Schizodimos, Theodoros et al. An overview of management of intracranial hypertension in the intensive care unit. Journal of anesthesia 2020; 34(5): 741-757.
  215. Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998; 29: 1888-1893.
  216. Reinink, H, Jüttler, E, Hacke, W, et al. Surgical decompression for space-occupying hemispheric infarction: a systematic review and individual patient Meta-analysis of randomized clinical trials. JAMA Neurol 2021; 78: 208-216.
  217. Vahedi, K, Hofmeijer, J, Juettler, E, et al. Early decompressive surgery in malignant Middle cerebral artery infarction: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6: 215-222.
  218. Diringer MN, Scalfani MT, Zazulia AR, Videen TO, Dhar R. Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke.Neurocrit Care. 2011; 14: 11-17.
  219. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998; 29: 1550-1555.
  220. Holden DN, Yung FH, Entezami P. Hypertonic saline buffered with sodium acetate for intracranial pressure management. Clin Neurol Neurosurg. 2021 Feb; 201: 106435. doi: 10.1016/j.clineuro.2020.106435. Epub 2020 Dec 15. PMID: 33373834;
  221. Chen H, Song Z, Dennis JA. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury. Cochrane Database Syst Rev. 2020 Jan 17; 1(1): CD010904. doi: 10.1002/14651858.CD010904.pub3. PMID: 31978260; PMCID: PMC6984412.
  222. Badenes R, Hutton B, Citerio G, Robba C, Aguilar G, Alonso-Arroyo A, Taccone FS, Tornero C, Catalá- López F. Hyperosmolar therapy for acute brain injury: study protocol for an umbrella review of meta-analyses and an evidence mapping. BMJ Open. 2020 Feb 6; 10(2): e033913. doi: 10.1136/bmjopen-2019-033913.
  223. Curley G, Kavanagh BP, Laffey JG. Hypocapnia and the injured brain: more harm than benefit. Crit Care Med. 2010; 38: 1348-1359.
  224. Muizelaar, JP, Marmarou, A, Ward, JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg 1991; 75: 731.
  225. Wan YH, Nie C, Wang HL, Huang CY. Therapeutic hypothermia (different depths, durations, and rewarming speeds) for acute ischemic stroke: a meta-analysis. J Stroke Cerebrovasc Dis. 2014; 23: 2736-2747.
  226. Quizilbash N, Lewington SL, Lopez-arietta J. Corticosteroids for acute ischemic stroke. Cochrane library. Oxford (United Kingdom): Update software 2001; 1.
  227. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012 Jun 23; 379(9834): 2364-72.
  228. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Data- base Syst Rev. 2014: CD000213.
  229. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rtPA stroke trials. Lancet. 2004; 363: 768–774. doi: 10.1016/S0140-6736(04)15692-4
  230. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intrave- nous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29; 384 (9958): 1929-35. doi: 10.1016/S0140-6736(14)60584-5
  231. Campbell BCV, Ma H, Ringleb PA, Parsons MW, Churilov L, Bendszus M, Levi CR, Hsu C, Kleinig TJ, Fatar M, Leys D, Molina C, Wijeratne T, Curtze S, Dewey HM, Barber PA, Butcher KS, De Silva DA, Bladin CF, Yassi N, Pfaff JAR, Sharma G, Bivard A, Desmond PM, Schwab S, Schellinger PD, Yan B, Mitchell PJ, Serena J, Toni D, Thijs V, Hacke W, Davis SM, Donnan GA; EXTEND, ECASS-4, and EPITHET Investigators. Extending thrombolysis to 4·5- 9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet. 2019 Jul 13; 394 (10193): 139-147.
  232. Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, Kleinig TJ, Wijeratne T, Curtze S, Dewey HM, Miteff F, Tsai CH, Lee JT, Phan TG, Mahant N, Sun MC, Krause M, Sturm J, Grimley R, Chen CH, Hu CJ, Wong AA, Field D, Sun Y, Barber PA, Sabet A, Jannes J, Jeng JS, Clissold B, Markus R, Lin CH, Lien LM, Bladin CF, Chris- tensen S, Yassi N, Sharma G, Bivard A, Desmond PM, Yan B, Mitchell PJ, Thijs V, Carey L, Meretoja A, Davis SM, Donnan GA; EXTEND Investigators. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. N Engl J Med. 2019 May 9; 380 (19): 1795-1803.
  233. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29; 384(9958): 1929-35.
  234. Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials. Stroke. 2016 Sep;47(9):2373-9.
  235. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Data- base Syst Rev. 2014 Jul 29; 2014(7): CD000213.
  236. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012 Jun 23; 379(9834): 2352-63.
  237. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke. 2000 Apr; 31(4): 811-6.
  238. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999 Dec 1;282(21):2019-26.
  239. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Ma- hagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995 Oct 4; 274(13): 1017-25.
  240. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study In- vestigators. Lancet. 1998 Oct 17; 352(9136): 1245-51.
  241. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM; EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombo- lytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008 Apr; 7(4): 299-309.
  242. Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of Alteplase for Acute Stroke on the Distri- bution of Functional Outcomes: A Pooled Analysis of 9 Trials. Stroke. 2016 Sep; 47(9): 2373-9.
  243. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29; 384(9958): 1929-35.
  244. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014 Jul 29; 2014(7): CD000213.
  245. Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B, Cheripelli B, Cho TH, Fazekas F, Fiehler J, Ford I, Galinovic I, Gellissen S, Golsari A, Gregori J, Günther M, Guibernau J, Häusler KG, Hennerici M, Kemmling A, Marstrand J, Modrau B, Neeb L, Perez de la Ossa N, Puig J, Ringleb P, Roy P, Scheel E, Schonewille W, Serena J, Sunaert S, Villringer K, Wouters A, Thijs V, Ebinger M, Endres M, Fiebach JB, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Gerloff C; WAKE-UP Investigators. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. N Engl J Med. 2018 Aug 16; 379(7): 611-622.
  246. Thomalla G, Boutitie F, Ma H, Koga M, Ringleb P, Schwamm LH, Wu O, Bendszus M, Bladin CF, Campbell BCV, Cheng B, Churilov L, Ebinger M, Endres M, Fiebach JB, Fukuda-Doi M, Inoue M, Kleinig TJ, Latour LL, Lemmens R, Levi CR, Leys D, Miwa K, Molina CA, Muir KW, Nighoghossian N, Parsons MW, Pedraza S, Schellinger PD, Schwab S, Simonsen CZ, Song SS, Thijs V, Toni D, Hsu CY, Wahlgren N, Yamamoto H, Yassi N, Yoshimura S, Warach S, Hacke W, Toyoda K, Donnan GA, Davis SM, Gerloff C; Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investi- gators. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data. Lancet. 2020 Nov 14; 396(10262): 1574-1584.
  247. Thomalla G, Cheng B, Ebinger M, Hao Q, Tourdias T, Wu O, Kim JS, Breuer L, Singer OC, Warach S, Christensen S, Treszl A, Forkert ND, Galinovic I, Rosenkranz M, Engelhorn T, Köhrmann M, Endres M, Kang DW, Dousset V, Sorensen AG, Liebeskind DS, Fiebach JB, Fiehler J, Gerloff C; STIR and VISTA Imaging Investigators. DWI- FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE- FLAIR): a multicentre observational study. Lancet Neurol. 2011 Nov; 10(11): 978-86.
  248. Koga M, Yamamoto H, Inoue M, Asakura K, Aoki J, Hamasaki T, Kanzawa T, Kondo R, Ohtaki M, Itabashi R, Kamiyama K, Iwama T, Nakase T, Yakushiji Y, Igarashi S, Nagakane Y, Takizawa S, Okada Y, Doijiri R, Tsujino A, Ito Y, Ohnishi H, Inoue T, Takagi Y, Hasegawa Y, Shiokawa Y, Sakai N, Osaki M, Uesaka Y, Yoshimura S, Urabe T, Ueda T, Ihara M, Kitazono T, Sasaki M, Oita A, Yoshimura S, Fukuda-Doi M, Miwa K, Kimura K, Minematsu K, Toyoda K; THAWS Trial Investigators. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial. Stroke. 2020 May; 51(5): 1530-1538.
  249. Ringleb P, Bendszus M, Bluhmki E, Donnan G, Eschenfelder C, Fatar M, Kessler C, Molina C, Leys D, Muddegowda G, Poli S, Schellinger P, Schwab S, Serena J, Toni D, Wahlgren N, Hacke W; ECASS-4 study group. Ex- tending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection. Int J Stroke. 2019 Jul; 14(5): 483-490.
  250. Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, Kleinig TJ, Wijeratne T, Curtze S, Dewey HM, Miteff F, Tsai CH, Lee JT, Phan TG, Mahant N, Sun MC, Krause M, Sturm J, Grimley R, Chen CH, Hu CJ, Wong AA, Field D, Sun Y, Barber PA, Sabet A, Jannes J, Jeng JS, Clissold B, Markus R, Lin CH, Lien LM, Bladin CF, Chris- tensen S, Yassi N, Sharma G, Bivard A, Desmond PM, Yan B, Mitchell PJ, Thijs V, Carey L, Meretoja A, Davis SM, Donnan GA; EXTEND Investigators. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. N Engl J Med. 2019 May 9; 380(19): 1795-1803. doi: 10.1056/NEJMoa1813046.
  251. Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH, Broderick JP, Chen X, Chen G, Sharma VK, Kim JS, Thang NH, Cao Y, Parsons MW, Levi C, Huang Y, Olavarría VV, Demchuk AM, Bath PM, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Ricci S, Roffe C, Pandian J, Billot L, Woodward M, Li Q, Wang X, Wang J, Chalmers J; ENCHANTED Investigators and Coordinators. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. N Engl J Med. 2016 Jun 16; 374(24): 2313-23.
  252. Wang X, Robinson TG, Lee TH, Li Q, Arima H, Bath PM, Billot L, Broderick J, Demchuk AM, Donnan G, Kim JS, Lavados P, Lindley RI, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sharma VK, Thang NH, Wang JG, Woodward M, Anderson CS, Chalmers J; Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) Investigators. Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial. JAMA Neurol. 2017 Nov 1; 74(11): 1328- 1335.
  253. Carr SJ, Wang X, Olavarria VV, Lavados PM, Rodriguez JA, Kim JS, Lee TH, Lindley RI, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Woodward M, Chalmers J, Anderson CS, Robinson TG; ENCHANTED Investigators. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis. Stroke. 2017 Sep; 48(9): 2605-2609.
  254. Chen G, Wang X, Robinson TG, Pikkemaat M, Lindley RI, Zhou S, Ping L, Liu W, Liu L, Chalmers J, Anderson CS; ENCHANTED Investigators. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial. J Neurol Sci. 2018 Apr 15; 387: 1-5.
  255. Jeong HG, Kim BJ, Yang MH, Han MK, Bae HJ, Lee SH. Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment. Neurology. 2016;87:996–1002
  256. Lindley RI, Wardlaw JM, Whiteley WN, Cohen G, Blackwell L, Murray GD, Sandercock PA; IST-3 Col- laborative Group. Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third Interna- tional Stroke Trial. Stroke. 2015 Mar; 46(3): 746-56.
  257. Chellinger PD, Tsivgoulis G. Another Enchantment From ENCHANTED (Enhanced Control of Hyperten- sion and Thrombolysis Stroke Study): Are Savings and Safety More Salutary Than Efficacy? Stroke. 2017 Jul; 48(7): 1720- 1722.
  258. Pan X, Zhu Y, Zheng D, Liu Y, Yu F, Yang J. Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials. Int J Stroke. 2015 Apr; 10(3): 317-23.
  259. Luo S, Zhuang M, Zeng W, Tao J. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiv- ing Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies. J Am Heart Assoc. 2016 May 20; 5(5): e003242.
  260. Tsivgoulis G, Katsanos AH, Zand R, Sharma VK, Köhrmann M, Giannopoulos S, Dardiotis E, Alexandrov AW, Mitsias PD, Schellinger PD, Alexandrov AV. Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis. J Neurol. 2017 Jun; 264(6): 1227-1235.
  261. Malhotra K, Katsanos AH, Goyal N, Ahmed N, Strbian D, Palaiodimou L, Karapanayiotides T, Alexandrov AW, Grotta JC, Alexandrov AV, Tsivgoulis G. Safety and efficacy of dual antiplatelet pretreatment in patients with is- chemic stroke treated with IV thrombolysis: A systematic review and meta-analysis. Neurology. 2020 Feb 18; 94(7): e657- e666.
  262. Hacke W, Lichy C. Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial? Nat Clin Pract Neurol. 2008 Sep; 4(9): 474-5.
  263. Robinson TG, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Demchuk AM, Donnan GA, Kim JS, Lavados PM, Lee TH, Lindley RI, Martins SCO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Nguyen TH, Wang JG, Woodward M, Chalmers J, Anderson CS; ENCHANTED Investigators. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study). Stroke. 2017 Jul; 48(7): 1877-1883.
  264. Schellinger PD, Tsivgoulis G. Another Enchantment From ENCHANTED (Enhanced Control of Hyperten- sion and Thrombolysis Stroke Study): Are Savings and Safety More Salutary Than Efficacy? Stroke. 2017 Jul; 48(7): 1720- 1722.
  265. Hankey GJ, Norrving B, Hacke W, Steiner T. Management of acute stroke in patients taking novel oral anticoagulants. Int J Stroke. 2014 Jul; 9(5): 627-32.
  266. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Vanassche T, Potpara T, Camm AJ, Heidbüchel H; External reviewers. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace. 2021 Oct 9; 23(10): 1612-1676.
  267. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P; European Heart Rhythm Association. European Heart Rhythm Association Practical Guide on the use of new oral antico- agulants in patients with non-valvular atrial fibrillation. Europace. 2013 May; 15(5): 625-51.
  268. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Profes- sionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec; 50(12): e344-e418.
  269. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Vanassche T, Potpara T, Camm AJ, Heidbüchel H; External reviewers. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace. 2021 Oct 9; 23(10): 1612-1676.
  270. Steiner T, Köhrmann M, Schellinger PD, Tsivgoulis G. Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes. J Stroke. 2018 Sep; 20(3): 292-301.
  271. Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Abraham A, Althaus K, Becks G, Berrouschot J, Berthel J, Bode FJ, Burghaus L, Cangür H, Daffertshofer M, Edelbusch S, Eggers J, Gerlach R, Gröschel K, Große- Dresselhaus F, Günther A, Haase CG, Haensch CA, Harloff A, Heckmann JG, Held V, Hieber M, Kauert A, Kern R, Kerz T, Köhrmann M, Kraft P, Kühnlein P, Latta J, Leinisch E, Lenz A, Leithner C, Neumann-Haefelin T, Mäurer M, Müllges W, Nolte CH, Obermann M, Partowi S, Patzschke P, Poli S, Pulkowski U, Purrucker J, Rehfeldt T, Ringleb PA, Röther J, Rossi R, El-Sabassy H, Sauer O, Schackert G, Schäfer N, Schellinger PD, Schneider A, Schuppner R, Schwab S, Schwarte O, Seitz RJ, Senger S, Shah YP, Sindern E, Sparenberg P, Steiner T, Szabo K, Urbanek C, Sarnowksi BV, Weissenborn K, Wienecke P, Witt K, Wruck R, Wunderlich S. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases. Int J Stroke. 2020 Aug; 15(6): 609-618.
  272. Frol S, Sagris D, Pretnar Oblak J, Šabovič M, Ntaios G. Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature. Front Neurol. 2021 Jun 3; 12: 666086.
  273. Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med. 2017 Aug 3; 377(5): 431- 441.
  274. Reilly PA, van Ryn J, Grottke O, Glund S, Stangier J. Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects. Am J Med. 2016 Nov; 129(11S): S64-S72.
  275. Frol S, Sagris D, Pretnar Oblak J, Šabovič M, Ntaios G. Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature. Front Neurol. 2021 Jun 3; 12: 666086.
  276. Hankey GJ, Norrving B, Hacke W, Steiner T. Management of acute stroke in patients taking novel oral anticoagulants. Int J Stroke. 2014 Jul; 9(5): 627-32.
  277. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Vanassche T, Potpara T, Camm AJ, Heidbüchel H; External reviewers. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace. 2021 Oct 9; 23(10): 1612-1676.
  278. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29; 384(9958): 1929-35.
  279. Bluhmki E, Danays T, Biegert G, Hacke W, Lees KR. Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data. Stroke. 2020 Aug; 51(8): 2322-2331.
  280. Khatri P, Conaway MR, Johnston KC; Acute Stroke Accurate Prediction Study (ASAP) Investigators. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke. 2012 Feb; 43(2): 560-2.
  281. Khatri P, Kleindorfer DO, Devlin T, Sawyer RN Jr, Starr M, Mejilla J, Broderick J, Chatterjee A, Jauch EC, Levine SR, Romano JG, Saver JL, Vagal A, Purdon B, Devenport J, Pavlov A, Yeatts SD; PRISMS Investigators. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neuro- logic Deficits: The PRISMS Randomized Clinical Trial. JAMA. 2018 Jul 10; 320(2): 156-166.
  282. Tsivgoulis G, Goyal N, Katsanos AH, Malhotra K, Ishfaq MF, Pandhi A, Frohler MT, Spiotta AM, Anadani M, Psychogios M, Maus V, Siddiqui A, Waqas M, Schellinger PD, Groen M, Krogias C, Richter D, Saqqur M, Garcia- Bermejo P, Mokin M, Leker R, Cohen JE, Magoufis G, Psychogios K, Lioutas VA, Van Nostrand M, Sharma VK, Pa- ciaroni M, Rentzos A, Shoirah H, Mocco J, Nickele C, Mitsias PD, Inoa V, Hoit D, Elijovich L, Arthur AS, Alexandrov AV. Intravenous thrombolysis for large vessel or distal occlusions presenting with mild stroke severity. Eur J Neurol. 2020 Jun; 27(6): 1039-1047.
  283. Seners P, Perrin C, Lapergue B, Henon H, Debiais S, Sablot D, Girard Buttaz I, Tamazyan R, Preterre C, Laksiri N, Mione G, Arquizan C, Lucas L, Baron JC, Turc G; MINOR-STROKE Collaborators. Bridging Therapy or IV Thrombolysis in Minor Stroke with Large Vessel Occlusion. Ann Neurol. 2020 Jul; 88(1): 160-169.
  284. Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occur- ring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry. 2015 Jan; 86(1): 87-94.
  285. Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of Alteplase for Acute Stroke on the Distri- bution of Functional Outcomes: A Pooled Analysis of 9 Trials. Stroke. 2016 Sep; 47(9): 2373-9.
  286. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012 Jun 23; 379 (9834): 2352-63.
  287. Eugene I Gusev, Mikhail Yu Martynov, Alexey A Nikonov, Nikolay A Shamalov, Michail P Semenov, Eugene A Gerasimets, Elena B Yarovaya, Andrey M Semenov, Alexander I Archakov, Sergey S Markin, and the FRIDA Study Group* Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial. Lancet Neurol 2021; 20: 721–28.
  288. Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG; ENCHANTED Investigators and Coordinators. Intensive blood pres- sure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, ran- domised, open-label, blinded-endpoint, phase 3 trial. Lancet. 2019 Mar 2; 393(10174): 877-888.
  289. Berge E, Cohen G, Lindley RI, Sandercock P, Wardlaw JM, Sandset EC, Whiteley W. Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke. Stroke. 2015 Dec; 46(12): 3362-9.
  290. Tsivgoulis G, Katsanos AH, Mavridis D, Lambadiari V, Roffe C, Macleod MJ, Sevcik P, Cappellari M, Nevšímalová M, Toni D, Ahmed N. Association of Baseline Hyperglycemia With Outcomes of Patients With and Without Diabetes With Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Propensity Score-Matched Analysis From the SITS-ISTR Registry. Diabetes. 2019 Sep; 68(9): 1861-1869.
  291. Maciel R, Palma R, Sousa P, Ferreira F, Nzwalo H. Acute stroke with concomitant acute myocardial infarc- tion: will you thrombolyse? J Stroke. 2015 Jan; 17(1): 84-6.
  292. Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, Tihan T. Cardiac rupture after intrave- nous t-PA administration in acute ischemic stroke. Neurocrit Care. 2010 Oct; 13(2): 261-2.
  293. Kasner SE, Villar-Cordova CE, Tong D, Grotta JC. Hemopericardium and cardiac tamponade after throm- bolysis for acute ischemic stroke. Neurology. 1998 Jun; 50(6): 1857-9.
  294. Marto JP, Kauppila LA, Jorge C, Calado S, Viana-Baptista M, Pinho-E-Melo T, Fonseca AC. Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction: Case Series and Systematic Review. Stroke. 2019 Oct; 50(10): 2813-2818.
  295. Asaithambi G, Adil MM, Qureshi AI. Thrombolysis for ischemic stroke associated with infective endocar- ditis: results from the nationwide inpatient sample. Stroke. 2013 Oct; 44(10): 2917-9.
  296. Ong E, Mechtouff L, Bernard E, Cho TH, Diallo LL, Nighoghossian N, Derex L. Thrombolysis for stroke caused by infective endocarditis: an illustrative case and review of the literature. J Neurol. 2013 May; 260(5): 1339-42.
  297. Bhuva P, Kuo SH, Claude Hemphill J, Lopez GA. Intracranial hemorrhage following thrombolytic use for stroke caused by infective endocarditis. Neurocrit Care. 2010 Feb; 12(1): 79-82.
  298. Pruitt AA. Neurologic complications of infective endocarditis. Curr Treat Options Neurol 2013; 15: 465- 476.
  299. LeCouffe NE, Kappelhof M, Treurniet KM, Rinkel LA, Bruggeman AE, Berkhemer OA, Wolff L, van Voorst H, Tolhuisen ML, Dippel DWJ, van der Lugt A, van Es ACGM, Boiten J, Lycklama À Nijeholt GJ, Keizer K, Gons RAR, Yo LSF, van Oostenbrugge RJ, van Zwam WH, Roozenbeek B, van der Worp HB, Lo RTH, van den Wijngaard IR, de Ridder IR, Costalat V, Arquizan C, Lemmens R, Demeestere J, Hofmeijer J, Martens JM, Schonewille WJ, Vos JA, Uyttenboogaart M, Bokkers RPH, van Tuijl JH, Kortman H, Schreuder FHBM, Boogaarts HD, de Laat KF, van Dijk LC, den Hertog HM, van Hasselt BAAM, Brouwers PJAM, Bulut T, Remmers MJM, van Norden A, Imani F, Rozeman AD, Elgersma OEH, Desfontaines P, Brisbois D, Samson Y, Clarençon F, Krietemeijer GM, Postma AA, van Doormaal PJ, van den Berg R, van der Hoorn A, Beenen LFM, Nieboer D, Lingsma HF, Emmer BJ, Coutinho JM, Majoie CBLM, Roos YBWEM; MR CLEAN–NO IV Investigators. A Randomized Trial of Intravenous Alteplase before Endovascular Treat- ment for Stroke. N Engl J Med. 2021 Nov 11; 385(20): 1833-1844. doi: 10.1056/NEJMoa2107727
  300. Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T, Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K, Fujimoto S, Higashida T, Iwasaki M, Aoki J, Nishiyama Y, Otsuka T, Kimura K; SKIP Study Investigators. Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial. JAMA. 2021 Jan 19; 325(3): 244-253. doi: 10.1001/jama.2020.23522. Erratum in: JAMA. 2021 May 4; 325(17): 1795.
  301. Zi W, Qiu Z, Li F, Sang H, Wu D, Luo W, Liu S, Yuan J, Song J, Shi Z, Huang W, Zhang M, Liu W, Guo Z, Qiu T, Shi Q, Zhou P, Wang L, Fu X, Liu S, Yang S, Zhang S, Zhou Z, Huang X, Wang Y, Luo J, Bai Y, Zhang M, Wu Y, Zeng G, Wan Y, Wen C, Wen H, Ling W, Chen Z, Peng M, Ai Z, Guo F, Li H, Guo J, Guan H, Wang Z, Liu Y, Pu J, Wang Z, Liu H, Chen L, Huang J, Yang G, Gong Z, Shuai J, Nogueira RG, Yang Q; DEVT Trial Investigators. Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Pa- tients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial. JAMA. 2021 Jan 19; 325(3): 234-243. doi: 10.1001/jama.2020.23523.
  302. Maier IL, Leha A, Badr M, Allam I, Bähr M, Jamous A, Hesse A, Psychogios MN, Behme D, Liman J. Inhouse Bridging Thrombolysis Is Associated With Improved Functional Outcome in Patients With Large Vessel Occlu- sion Stroke: Findings From the German Stroke Registry. Front Neurol. 2021 Jun 10; 12: 649108. doi: 10.3389/fneur.2021.649108.
  303. Jian Y, Zhao L, Jia B, Tong X, Li T, Wu Y, Wang X, Gao Z, Gong Y, Zhang X, Wang H, Zhang R, Zhang L, Miao Z, Zhang G; ANGEL-ACT Study Group. Direct versus Bridging Mechanical Thrombectomy in Elderly Patients with Acute Large Vessel Occlusion: A Multicenter Cohort Study. Clin Interv Aging. 2021 Jul 5; 16: 1265-1274. doi: 10.2147/CIA.S313171
  304. Bourcier R, Goyal M, Liebeskind DS, Muir KW, Desal H, Siddiqui AH, Dippel DWJ, Majoie CB, van Zwam WH, Jovin TG, Levy EI, Mitchell PJ, Berkhemer OA, Davis SM, Derraz I, Donnan GA, Demchuk AM, van Oostenbrugge RJ, Kelly M, Roos YB, Jahan R, van der Lugt A, Sprengers M, Velasco S, Lycklama À Nijeholt GJ, Ben Hassen W, Burns P, Brown S, Chabert E, Krings T, Choe H, Weimar C, Campbell BCV, Ford GA, Ribo M, White P, Cloud GC, San Roman L, Davalos A, Naggara O, Hill MD, Bracard S; HERMES Trialists Collaboration. Association of Time From Stroke Onset to Groin Puncture With Quality of Reperfusion After Mechanical Thrombectomy: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials. JAMA Neurol. 2019 Apr 1; 76(4): 405-411. doi: 10.1001/jamaneurol.2018.4510
  305. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular throm- bectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr 23; 387(10029): 1723-31. doi: 10.1016/S0140-6736(16)00163-X
  306. Primiani CT, Vicente AC, Brannick MT, Turk AS, Mocco J, Levy EI, Siddiqui AH, Mokin M. Direct Aspi- ration versus Stent Retriever Thrombectomy for Acute Stroke: A Systematic Review and Meta-Analysis in 9127 Patients. J Stroke Cerebrovasc Dis. 2019 May; 28(5): 1329-1337. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.034
  307. Touma L, Filion KB, Sterling LH, Atallah R, Windle SB, Eisenberg MJ. Stent Retrievers for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Neurol. 2016 Mar; 73(3): 275-81. doi: 10.1001/jamaneurol.2015.4441.
  308. Barral M, Boudour S, Viprey M, Giroudon C, Aulagner G, Schott AM, Turjman F, Armoiry X, Gory B. Stent retriever thrombectomy for acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials, including THRACE. Rev Neurol (Paris). 2018 May; 174(5): 319-326. doi: 10.1016/j.neurol.2017.09.009
  309. Lapergue B, Blanc R, Costalat V, Desal H, Saleme S, Spelle L, Marnat G, Shotar E, Eugene F, Mazighi M, Houdart E, Consoli A, Rodesch G, Bourcier R, Bracard S, Duhamel A, Ben Maacha M, Lopez D, Renaud N, Labreuche J, Gory B, Piotin M; ASTER2 Trial Investigators. Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlu- sion: The ASTER2 Randomized Clinical Trial. JAMA. 2021 Sep 28; 326(12): 1158-1169. doi: 10.1001/jama.2021.13827
  310. Kang DH, Jung C, Yoon W, Kim SK, Baek BH, Kim JT, Park MS, Kim YW, Hwang YH, Kim YS, Kim BJ, Han MK, Bae HJ. Endovascular Thrombectomy for Acute Basilar Artery Occlusion: A Multicenter Retrospective Obser- vational Study. J Am Heart Assoc. 2018 Jul 7; 7(14): e009419. doi: 10.1161/JAHA.118.009419.
  311. Sheng K, Tong M. Therapy for acute basilar artery occlusion: a systematic review and meta-analysis. F1000Res. 2019 Feb 7; 8: 165. doi: 10.12688/f1000research.18042.1
  312. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular throm- bectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr 23; 387(10029): 1723-31. doi: 10.1016/S0140-6736(16)00163-X.
  313. Badhiwala JH, Nassiri F, Alhazzani W, Selim MH, Farrokhyar F, Spears J, Kulkarni AV, Singh S, Alqahtani A, Rochwerg B, Alshahrani M, Murty NK, Alhazzani A, Yarascavitch B, Reddy K, Zaidat OO, Almenawer SA. Endovas- cular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. JAMA. 2015 Nov 3; 314(17): 1832-43. doi: 10.1001/jama.2015.13767.
  314. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular throm- bectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr 23; 387(10029): 1723-31. doi: 10.1016/S0140-6736(16)00163-X.
  315. Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC, Nogueira RG, Demchuk AM, Tomasello A, Cardona P, Devlin TG, Frei DF, du Mesnil de Rochemont R, Berkhemer OA, Jovin TG, Siddiqui AH, van Zwam WH, Davis SM, Castaño C, Sapkota BL, Fransen PS, Molina C, van Oostenbrugge RJ, Chamorro Á, Lingsma H, Silver FL, Donnan GA, Shuaib A, Brown S, Stouch B, Mitchell PJ, Davalos A, Roos YB, Hill MD; HER- MES Collaborators. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta- analysis. JAMA. 2016 Sep 27; 316(12): 1279-88. doi: 10.1001/jama.2016.13647.
  316. Touma L, Filion KB, Sterling LH, Atallah R, Windle SB, Eisenberg MJ. Stent Retrievers for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta- analysis of Randomized Clinical Trials. JAMA Neurol. 2016 Mar; 73(3): 275-81. doi: 10.1001/jamaneurol.2015.4441
  317. Menon BK, Hill MD, Davalos A, Roos YBWEM, Campbell BCV, Dippel DWJ, Guillemin F, Saver JL, van der Lugt A, Demchuk AM, Muir K, Brown S, Jovin T, Mitchell P, White P, Bracard S, Goyal M. Efficacy of endovascular throm- bectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES Collaboration. J Neurointerv Surg. 2019 Nov; 11(11): 1065-1069. doi: 10.1136/neurintsurg-2018-014678
  318. Román LS, Menon BK, Blasco J, Hernández-Pérez M, Dávalos A, Majoie CBLM, Campbell BCV, Guille- min F, Lingsma H, Anxionnat R, Epstein J, Saver JL, Marquering H, Wong JH, Lopes D, Reimann G, Desal H, Dippel DWJ, Coutts S, du Mesnil de Rochemont R, Yavagal D, Ferre JC, Roos YBWEM, Liebeskind DS, Lenthall R, Molina C, Al Ajlan FS, Reddy V, Dowlatshahi D, Sourour NA, Oppenheim C, Mitha AP, Davis SM, Weimar C, van Oostenbrugge RJ, Cobo E, Kleinig TJ, Donnan GA, van der Lugt A, Demchuk AM, Berkhemer OA, Boers AMM, Ford GA, Muir KW, Brown BS, Jovin T, van Zwam WH, Mitchell PJ, Hill MD, White P, Bracard S, Goyal M; HERMES collaborators. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol. 2018 Oct; 17(10): 895-904. doi: 10.1016/S1474-4422(18)30242-4.
  319. Yoshimura S, Sakai N, Yamagami H, Uchida K, Beppu M, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Takeuchi M, Yazawa Y, Kimura N, Shigeta K, Imamura H, Suzuki I, Enomoto Y, Tokunaga S, Morita K, Sakakibara F, Kinjo N, Saito T, Ishikura R, Inoue M, Morimoto T. Endovascular Therapy for Acute Stroke with a Large Ischemic Region. N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMoa2118191
  320. Yoshimura S, Sakai N, Yamagami H, Uchida K, Beppu M, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Takeuchi M, Yazawa Y, Kimura N, Shigeta K, Imamura H, Suzuki I, Enomoto Y, Tokunaga S, Morita K, Sakakibara F, Kinjo N, Saito T, Ishikura R, Inoue M, Morimoto T. Endovascular Therapy for Acute Stroke with a Large Ischemic Region. N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMoa2118191
  321. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018 Feb 22; 378(8): 708-718. doi: 10.1056/NEJMoa1713973
  322. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jan- kowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018 Jan 4; 378(1): 11-21. doi: 10.1056/NEJMoa1706442
  323. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular throm- bectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr 23; 387(10029): 1723-31. doi: 10.1016/S0140-6736(16)00163-X
  324. Goyal N, Tsivgoulis G, Malhotra K, Ishfaq MF, Pandhi A, Frohler MT, Spiotta AM, Anadani M, Psychogios M, Maus V, Siddiqui A, Waqas M, Schellinger PD, Groen M, Krogias C, Richter D, Saqqur M, Garcia-Bermejo P, Mokin M, Leker R, Cohen JE, Katsanos AH, Magoufis G, Psychogios K, Lioutas V, VanNostrand M, Sharma VK, Paciaroni M, Rentzos A, Shoirah H, Mocco J, Nickele C, Inoa V, Hoit D, Elijovich L, Alexandrov AV, Arthur AS. Medical Management vs Mechanical Thrombectomy for Mild Strokes: An International Multicenter Study and Systematic Review and Meta- analysis. JAMA Neurol. 2020 Jan 1; 77(1): 16-24. doi: 10.1001/jamaneurol.2019.3112
  325. Xiong YJ, Gong JM, Zhang YC, Zhao XL, Xu SB, Pan DJ, Qu WS, Tian DS. Endovascular thrombectomy versus medical treatment for large vessel occlusion stroke with mild symptoms: A meta-analysis. PLoS One. 2018 Aug 23; 13(8): e0203066. doi: 10.1371/journal.pone.0203066
  326. Zhu F, Bracard S, Anxionnat R, et al. Impact of Emergent Cervical Carotid Stenting in Tandem Occlusion Strokes Treated by Thrombectomy: A Review of the TITAN Collaboration. Front Neurol. 2019; 10: 206. Published 2019 Mar 11. doi: 10.3389/fneur.2019.00206
  327. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular throm- bectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr 23; 387(10029): 1723-31. doi: 10.1016/S0140-6736(16)00163-X
  328. Pires Coelho A, Lobo M, Gouveia R, Silveira D, Campos J, Augusto R, Coelho N, Canedo A. Overview of evidence on emergency carotid stenting in patients with acute ischemic stroke due to tandem occlusions: a systematic review and meta-analysis. J Cardiovasc Surg (Torino). 2019 Dec; 60(6): 693-702. doi: 10.23736/S0021-9509.18.10312-0
  329. Bücke P, Aguilar Pérez M, AlMatter M, Hellstern V, Bäzner H, Henkes H. Functional Outcome and Safety of Intracranial Thrombectomy After Emergent Extracranial Stenting in Acute Ischemic Stroke Due to Tandem Occlusions. Front Neurol. 2018; 9: 940. Published 2018 Nov 20. doi:10.3389/fneur.2018.00940
  330. Zhu F, Bracard S, Anxionnat R, Derelle AL, Tonnelet R, Liao L, Mione G, Humbertjean L, Lacour JC, Hossu G, Anadani M, Richard S, Gory B. Impact of Emergent Cervical Carotid Stenting in Tandem Occlusion Strokes Treated by Thrombectomy: A Review of the TITAN Collaboration. Front Neurol. 2019 Mar 11; 10: 206. doi: 10.3389/fneur.2019.00206
  331. Zhu F, Bracard S, Anxionnat R, Derelle AL, Tonnelet R, Liao L, Mione G, Humbertjean L, Lacour JC, Hossu G, Anadani M, Richard S, Gory B. Impact of Emergent Cervical Carotid Stenting in Tandem Occlusion Strokes Treated by Thrombectomy: A Review of the TITAN Collaboration. Front Neurol. 2019 Mar 11; 10: 206. doi: 10.3389/fneur.2019.00206.
  332. Anadani M, Spiotta AM, Alawieh A, Turjman F, Piotin M, Haussen DC, Nogueira RG, Papanagiotou P, Siddiqui AH, Lapergue B, Dorn F, Cognard C, Ribo M, Psychogios MN, Labeyrie MA, Mazighi M, Biondi A, Anxionnat R, Bracard S, Richard S, Gory B; TITAN (Thrombectomy In TANdem Lesions) Investigators. Emergent Carotid Stenting Plus Thrombectomy After Thrombolysis in Tandem Strokes: Analysis of the TITAN Registry. Stroke. 2019 Aug; 50(8): 2250–2252. doi: 10.1161/STROKEAHA.118.024733
  333. Gory B, Haussen DC, Piotin M, Steglich-Arnholm H, Holtmannspötter M, Labreuche J, Kyheng M, Taschner C, Eiden S, Nogueira RG, Papanagiotou P, Boutchakova M, Siddiqui AH, Lapergue B, Dorn F, Cognard C, Killer M, Mangiafico S, Ribo M, Psychogios MN, Spiotta AM, Labeyrie MA, Biondi A, Mazighi M, Turjman F; Thrombectomy In TANdem lesions (TITAN) investigators. Impact of intravenous thrombolysis and emergent carotid stenting on reperfu- sion and clinical outcomes in patients with acute stroke with tandem lesion treated with thrombectomy: a collaborative pooled analysis. Eur J Neurol. 2018 Sep; 25(9): 1115-1120. doi: 10.1111/ene.13633
  334. Writing Group for the BASILAR Group, Zi W, Qiu Z, Wu D, Li F, Liu H, Liu W, Huang W, Shi Z, Bai Y, Liu Z, Wang L, Yang S, Pu J, Wen C, Wang S, Zhu Q, Chen W, Yin C, Lin M, Qi L, Zhong Y, Wang Z, Wu W, Chen H, Yao X, Xiong F, Zeng G, Zhou Z, Wu Z, Wan Y, Peng H, Li B, Hu X, Wen H, Zhong W, Wang L, Jin P, Guo F, Han J, Fu X, Ai Z, Tian X, Feng X, Sun B, Huang Z, Li W, Zhou P, Tu M, Sun X, Li H, He W, Qiu T, Yuan Z, Yue C, Yang J, Luo W, Gong Z, Shuai J, Nogueira RG, Yang Q. Assessment of Endovascular Treatment for Acute Basilar Artery Occlu- sion via a Nationwide Prospective Registry. JAMA Neurol. 2020 May 1; 77(5): 561-573. doi: 10.1001/jamaneurol.2020.0156
  335. Kang DH, Jung C, Yoon W, Kim SK, Baek BH, Kim JT, Park MS, Kim YW, Hwang YH, Kim YS, Kim BJ, Han MK, Bae HJ. Endovascular Thrombectomy for Acute Basilar Artery Occlusion: A Multicenter Retrospective Observational Study. J Am Heart Assoc. 2018 Jul 7; 7(14): e009419. doi: 10.1161/JAHA.118.009419.
  336. 462. Gory B, Mazighi M, Blanc R, Labreuche J, Piotin M, Turjman F, Lapergue B. Mechanical throm- bectomy in basilar artery occlusion: influence of reperfusion on clinical outcome and impact of the first-line strategy (ADAPT vs stent retriever). J Neurosurg. 2018 Dec 1; 129(6): 1482-1491. doi: 10.3171/2017.7.JNS171043
  337. Sheng K, Tong M. Therapy for acute basilar artery occlusion: a systematic review and meta-analysis. F1000Res. 2019 Feb 7; 8: 165. doi: 10.12688/f1000research.18042.1
  338. Writing Group for the BASILAR Group, Zi W, Qiu Z, Wu D, Li F, Liu H, Liu W, Huang W, Shi Z, Bai Y, Liu Z, Wang L, Yang S, Pu J, Wen C, Wang S, Zhu Q, Chen W, Yin C, Lin M, Qi L, Zhong Y, Wang Z, Wu W, Chen H, Yao X, Xiong F, Zeng G, Zhou Z, Wu Z, Wan Y, Peng H, Li B, Hu X, Wen H, Zhong W, Wang L, Jin P, Guo F, Han J, Fu X, Ai Z, Tian X, Feng X, Sun B, Huang Z, Li W, Zhou P, Tu M, Sun X, Li H, He W, Qiu T, Yuan Z, Yue C, Yang J, Luo W, Gong Z, Shuai J, Nogueira RG, Yang Q. Assessment of Endovascular Treatment for Acute Basilar Artery Occlu- sion via a Nationwide Prospective Registry. JAMA Neurol. 2020 May 1; 77(5): 561-573. doi: 10.1001/jamaneurol.2020.0156
  339. Brouwer J, Ergezen S, Mulder MJHL, Lycklama A Nijeholt GJ, van Es ACGM, van der Lugt A, Dippel DWJ, Majoie CBLM, Roos YBWEM, Coutinho JM, Emmer BJ; MR CLEAN Registry investigators. Endovascular treat- ment for isolated posterior cerebral artery occlusion stroke in the MR CLEAN registry. J Neurointerv Surg. 2022 Mar 15: neurintsurg-2021-018505. doi: 10.1136/neurintsurg-2021-018505
  340. Strambo D, Bartolini B, Beaud V, Marto JP, Sirimarco G, Dunet V, Saliou G, Nannoni S, Michel P. Throm- bectomy and Thrombolysis of Isolated Posterior Cerebral Artery Occlusion: Cognitive, Visual, and Disability Outcomes. Stroke. 2020 Jan; 51(1): 254-261. doi: 10.1161/STROKEAHA.119.026907.
  341. Memon MZ, Kushnirsky M, Brunet MC, Saini V, Koch S, Yavagal DR. Mechanical thrombectomy in iso- lated large vessel posterior cerebral artery occlusions. Neuroradiology. 2021 Jan; 63(1): 111-116. doi: 10.1007/s00234- 020-02505-w.
  342. Meyer L, Papanagiotou P, Politi M, Kastrup A, Kraemer C, Hanning U, Kniep H, Broocks G, Pilgram- Pastor SM, Wallocha M, Chapot R, Fiehler J, Stracke CP, Leischner H. Feasibility and safety of thrombectomy for isolated occlusions of the posterior cerebral artery: a multicenter experience and systematic literature review. J Neurointerv Surg. 2021 Mar; 13(3): 217-220. doi: 10.1136/neurintsurg-2020-016059.
  343. Brouwer J, Ergezen S, Mulder MJHL, Lycklama A Nijeholt GJ, van Es ACGM, van der Lugt A, Dippel DWJ, Majoie CBLM, Roos YBWEM, Coutinho JM, Emmer BJ; MR CLEAN Registry investigators. Endovascular treat- ment for isolated posterior cerebral artery occlusion stroke in the MR CLEAN registry. J Neurointerv Surg. 2022 Mar 15:neurintsurg-2021-018505. doi: 10.1136/neurintsurg-2021-018505
  344. Li H, Zhang Y, Zhang L, Li Z, Xing P, Zhang Y, Hong B, Yang P, Liu J. Endovascular Treatment of Acute Ischemic Stroke Due to Intracranial Atherosclerotic Large Vessel Occlusion: A Systematic Review. Clin Neuroradiol. 2020 Dec; 30(4): 777-787. doi: 10.1007/s00062-019-00839-4
  345. Forbrig R, Lockau H, Flottmann F, Boeckh-Behrens T, Kabbasch C, Patzig M, Mpotsaris A, Fiehler J, Liebig T, Thomalla G, Onur OA, Wunderlich S, Kreiser K, Herzberg M, Wollenweber FA, Prothmann S, Dorn F. Intra- cranial Rescue Stent Angioplasty After Stent-Retriever Thrombectomy: Multicenter Experience. Clin Neuroradiol. 2019 Sep; 29(3): 445-457. doi: 10.1007/s00062-018-0690-4
  346. Li H, Zhang Y, Zhang L, Li Z, Xing P, Zhang Y, Hong B, Yang P, Liu J. Endovascular Treatment of Acute Ischemic Stroke Due to Intracranial Atherosclerotic Large Vessel Occlusion: A Systematic Review. Clin Neuroradiol. 2020 Dec; 30(4): 777-787. doi: 10.1007/s00062-019-00839-4
  347. Stracke CP, Fiehler J, Meyer L, Thomalla G, Krause LU, Lowens S, Rothaupt J, Kim BM, Heo JH, Yeo LLL, Andersson T, Kabbasch C, Dorn F, Chapot R, Hanning U. Emergency Intracranial Stenting in Acute Stroke: Predic- tors for Poor Outcome and for Complications. J Am Heart Assoc. 2020 Mar 3; 9(5): e012795. doi: 10.1161/JAHA.119.012795
  348. Li H, Zhang Y, Zhang L, Li Z, Xing P, Zhang Y, Hong B, Yang P, Liu J. Endovascular Treatment of Acute Ischemic Stroke Due to Intracranial Atherosclerotic Large Vessel Occlusion : A Systematic Review. Clin Neuroradiol. 2020 Dec; 30(4): 777-787. doi: 10.1007/s00062-019-00839-4
  349. Luo G, Gao F, Zhang X, Jia B, Huo X, Liu R, Chi MS, Ma G, Peng G, Zhang J, Qi Z, Guo X, Han B, Tong X, Wang B, Song L, Liu L, He Z, Mo D, Ma N, Sun X, Yang M, Miao Z. Intracranial Stenting as Rescue Therapy After Failure of Mechanical Thrombectomy for Basilar Artery Occlusion: Data From the ANGEL-ACT Registry. Front Neurol. 2021 Sep 30; 12: 739213. doi: 10.3389/fneur.2021.739213. PMID: 34659098; PMCID: PMC8514631
  350. Bulwa Z, Del Brutto VJ, Loggini A, Ammar FE, Martinez RC, Christoforidis G, Brorson JR, Ardelt AA, Goldenberg FD. Mechanical Thrombectomy for Patients with In-Hospital Ischemic Stroke: A Case-Control Study. J Stroke Cerebrovasc Dis. 2020 May; 29(5): 104692. doi: 10.1016/j.jstrokecerebrovasdis.2020.104692
  351. Albano S, Bacani MG, Omuro A. A Case Report Examining a Contraindication for Mechanical Throm- bectomy in the Setting of a Large Vessel Occlusion and a Concurrent Contralateral Intracranial Hemorrhage. Cureus. 2021 Mar 17;13(3):e13956. doi: 10.7759/cureus.13956
  352. Salwi S, Cutting S, Salgado AD, Espaillat K, Fusco MR, Froehler MT, Chitale RV, Kirshner H, Schrag M, Jasne A, Burton T, MacGrory B, Saad A, Jayaraman MV, Madsen TE, Dakay K, McTaggart R, Yaghi S, Khatri P, Mistry AM, Mistry EA. Mechanical Thrombectomy in Patients With Ischemic Stroke With Prestroke Disability. Stroke. 2020 May; 51(5): 1539-1545. doi: 10.1161/STROKEAHA.119.028246
  353. Meinel TR, Kniepert JU, Seiffge DJ, Gralla J, Jung S, Auer E, Frey S, Goeldlin M, Mordasini P, Mosimann PJ, Nogueira RG, Haussen DC, Rodrigues GM, Uphaus T, L'Allinec V, Krajíčková D, Alonso A, Costalat V, Hajdu SD, Olivé-Gadea M, Maegerlein C, Pierot L, Schaafsma J, Suzuki K, Arnold M, Heldner MR, Fischer U, Kaesmacher J. Endo- vascular Stroke Treatment and Risk of Intracranial Hemorrhage in Anticoagulated Patients. Stroke. 2020 Mar; 51(3): 892- 898. doi: 10.1161/STROKEAHA.119.026606
  354. Koge J, Tanaka K, Yamagami H, Yoshimoto T, Uchida K, Morimoto T, Toyoda K, Sakai N, Yoshimura S. Mechanical thrombectomy for stroke patients anticoagulated with direct oral anticoagulants versus warfarin. J Neurol Sci. 2021 Aug 15; 427: 117545. doi: 10.1016/j.jns.2021.117545
  355. Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant treatment in acute cardio- embolic stroke: a meta-analysis of randomized controlled trials. Stroke. 2007; 38: 423–430
  356. Guekht A, Skoog I, Edmundson S, Zakharov V, Korczyn AD. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment. Stroke. 2017 May; 48(5): 1262-1270. doi: 10.1161/STROKEAHA.116.014321. PMID: 28432265; PMCID: PMC5404405
  357. Guekht A, Skoog I, Edmundson S, Zakharov V, Korczyn AD. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment. Stroke. 2017 May; 48(5): 1262-1270. doi: 10.1161/STROKEAHA.116.014321. PMID: 28432265; PMCID: PMC5404405.
  358. Bereczki D, Fekete I. Vinpocetine for acute ischaemic stroke. Cochrane Database Syst Rev. 2008 Jan 23; 2008(1): CD000480. doi: 10.1002/14651858.CD000480.pub2. PMID: 18253980; PMCID: PMC7034523
  359. Zhang YS, Li JD, Yan C. An update on vinpocetine: New discoveries and clinical implications. Eur J Phar- macol. 2018 Jan 15; 819: 30-34. doi: 10.1016/j.ejphar.2017.11.041. Epub 2017 Nov 26. PMID: 29183836; PMCID: PMC5766389
  360. Bönöczk P, Panczel G, Nagy Z. Vinpocetine increases cerebral blood flow and oxygenation in stroke pa- tients: a near infrared spectroscopy and transcranial Doppler study. Eur J Ultrasound. 2002 Jun; 15(1-2): 85-91. doi: 10.1016/s0929-8266(02)00006-x. PMID: 12044859.
  361. Zhang W, Huang Y, Li Y, Tan L, Nao J, Hu H, Zhang J, Li C, Kong Y, Song Y. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial. Clin Drug Investig. 2016 Sep; 36(9): 697-704. doi: 10.1007/s40261-016-0415-x. PMID: 27283947
  362. Vas A, Gulyás B, Szabó Z, Bönöczk P, Csiba L, Kiss B, Kárpáti E, Pánczél G, Nagy Z. Clinical and non- clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences. J Neurol Sci. 2002 Nov 15; 203-204: 259-62. doi: 10.1016/s0022-510x(02)00301-5. PMID: 12417394.
  363. Szilágyi G, Nagy Z, Balkay L, Boros I, Emri M, Lehel S, Márián T, Molnár T, Szakáll S, Trón L, Bereczki D, Csiba L, Fekete I, Kerényi L, Galuska L, Varga J, Bönöczk P, Vas A, Gulyás B. Effects of vinpocetine on the redistri- bution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study. J Neurol Sci. 2005 Mar 15; 229-230: 275-84. doi: 10.1016/j.jns.2004.11.053. Epub 2005 Jan 8. PMID: 15760651
  364. Zhang F, Yan C, Wei C, Yao Y, Ma X, Gong Z, Liu S, Zang D, Chen J, Shi FD, Hao J. Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients. Transl Stroke Res. 2018 Apr; 9(2): 174-184. doi: 10.1007/s12975-017-0549-z. Epub 2017 Jul 9. PMID: 28691141
  365. Bereczki D, Fekete I. Vinpocetine for acute ischaemic stroke. Cochrane Database Syst Rev. 2008 Jan 23; 2008(1): CD000480. doi: 10.1002/14651858.CD000480.pub2. PMID: 18253980; PMCID: PMC7034523
  366. Belova LA, Mashin VV, Abramova VV, Slastyon EY, Belov DV. Éffektivnost' korteksina v ostrom periode polusharnogo ishemicheskogo insul'ta [Efficacy of Korteksin in acute period of hemispheric ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2018; 118(7): 30-34. Russian. doi: 10.17116/jnevro20181187130. PMID: 30132453.
  367. Mashin VV, Belova LA, Aizatullin IF, Pavlova VA, Slasten EV, Abramova VV, Belov DV. Otsenka éffek- tivnosti i bezopasnosti primeneniia lekarstvennogo preparata Korteksin v komplekse reabilitatsionnykh meropriiatiĭ po vertikalizatsii u patsientov s ishemicheskim insul'tom v ostrom periode [Evaluation of the efficacy and safety of application of the drug cortexin in the complex rehabilitation of verticalization in patients with ischemic stroke in the acute period]. Zh Nevrol Psikhiatr Im S S Korsakova. 2019; 119(9): 62-67. Russian. doi: 10.17116/jnevro201911909162. PMID: 31626220
  368. Gusev EI, Skvortsova VI, Dambinova SA, Raevskiy KS, Alekseev AA, Bashkatova VG, Kovalenko AV, Kudrin VS, Yakovleva EV. Neuroprotective effects of glycine for therapy of acute ischaemic stroke. Cerebrovasc Dis. 2000 Jan-Feb; 10(1): 49-60. doi: 10.1159/000016025. PMID: 10629347
  369. Gusev EI, Skvortsova VI, Dambinova SA, Raevskiy KS, Alekseev AA, Bashkatova VG, Kovalenko AV, Kudrin VS, Yakovleva EV. Neuroprotective effects of glycine for therapy of acute ischaemic stroke. Cerebrovasc Dis. 2000 Jan-Feb; 10(1): 49-60. doi: 10.1159/000016025. PMID: 10629347
  370. Агафьина А., Коваленко А., Румянцева С. и др. Эффективность нейрометаболического протектора Цитофлавина у больных, перенесших ишемический инсульт, в раннем восстановительном периоде (многоцентровое рандомизированное исследование). Врач. 2006; 1: 60-65.
  371. Sazonov IE, Kudinov AA, Fedotova EP. Izuchenie dozozavisimogo effekta tsitoflavina v terapii ostrogo perioda ishemicheskogo insul'ta [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017; 117(2): 64-67. Russian. doi: 10.17116/jnevro20171172164-67. PMID: 28374695.
  372. Muratov FK, Shermukhamedova FK, Batocyrenov BV, Haritonova TV. Mul'timodal'noe deistvie tsitofla- vina pri ostrom mozgovom insul'te, razvivshemsya na fone metabolicheskogo sindroma [Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova. 2016; 116(12): 44-47. Russian. doi: 10.17116/jnevro201611612144-47. PMID: 28139625.
  373. Odinak MM, Skvortsova VI, Vozniuk IA, Rumiantseva SA, Stakhovskaia LV, Klocheva EG, Novikova LB, Ianishevskiĭ SN, Golokhvastov SIu, Tsygan NV. [Efficacy of cytoflavin in patients in the acute ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2010; 110(12): 29-36. Russian. PMID: 21311484.
  374. Rumyantsevа SA, Kovalenko AL, Silinа EV, Stupin VA, Kabaeva EN, Chichanovskaya LV, Nazarov MV, Tsukurova LA, Burenichev DV, Golikov KV, Salnikov MV, Belova LA, Mashin VV, Mazina NK, Zhilina EA, Kolotik- Kameneva OY, Sherman MA. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115(8): 45-52. Russian. doi: 10.17116/jnevro20151158145-52. PMID: 26356615
  375. Федин А.И., Румянцева С.А., Пирадов М.А. и др. Эффективность нейрометаболического протектора Цитофлавина при инфаркте мозга (многоцентровое рандомизированное исследование) Новые технологии, методы диагностики, лечения и профилактики. 2005; 1(6): 13-19.
  376. Mazin PV, Sheshunov IV, Mazina NK. Metaanaliticheskaia otsenka klinicheskoĭ éffektivnosti tsitoflavina pri nevrologicheskikh zabolevaniiakh [Meta-analytic assessment of parenteral cytoflavin effectiveness in different neuro- logic disorders]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017; 117(3): 28-39. Russian. doi: 10.17116/jnevro20171173128- 39.
  377. Secades JJ, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Martínez-Vila E, Ríos J, Oudovenko N. Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo- Controlled Trials. J Stroke Cerebrovasc Dis. 2016 Aug; 25(8): 1984-96. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.010.
  378. Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Secades JJ; International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 2012 Jul 28; 380(9839): 349-57. doi: 10.1016/S0140-6736(12)60813-7.
  379. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a random- ized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999 Dec 1; 282(21): 2019-26. doi: 10.1001/jama.282.21.2019.
  380. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol. 2000 Nov; 48(5): 713-22.
  381. Одинак М.М, Вознюк И.А, Пирадов М.А., Румянцева С.А., Кузнецов А.Н., Янишевский С.Н., Голохвасгов С.Ю., Цыган Н.В.. Анналы НЕВРОЛОГИИ» 2010; 4(1).
  382. Muresanu DF, Heiss WD, Hoemberg V, Bajenaru O, Popescu CD, Vester JC, Rahlfs VW, Doppler E, Meier D, Moessler H, Guekht A. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double- Blind, Multicenter Trial. Stroke. 2016 Jan; 47(1): 151-9. doi: 10.1161/STROKEAHA.115.009416.
  383. Teasell R., Iruthayarajah J., Saikaley M, Longval M. Evidence based review of stroke rehabilitation (EBRSR) 19th Edition. 2019; 209, available at: http://www.ebrsr.com/sites/ default/files/EBRSR%20Handbook%20Chap- ter%204_Upper%20Extremity%20Post%20Stroke_ ML.pdf.
  384. Association of the Scienti.c Medical Societies in Germany. Rehabilitative Therapie bei Armparese nach Schlaganfall der DGNR. Langversion. 2020; 204, available at: https://www.awmf.org/uploads/tx_szleitlinien/080- 001l_S3_Rehabilitative_Therapie_bei_Armparese_nach_Schlaganfall_2020-07.pdf. EAN and EFNR guideline on phar- macological support in early motor rehabilitation after acute ischaemic stroke. Doi: 10.1111/ene.14936
  385. Bornstein NM, Guekht A, Vester J, Heiss WD, Gusev E, Hömberg V, Rahlfs VW, Bajenaru O, Popescu BO, Muresanu D. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurol Sci. 2018 Apr; 39(4): 629-640. doi: 10.1007/s10072-017-3214-0.
  386. Gusev EI, Skvortsova VI, Miasoedov NF, Nezavibat'ko VN, Zhuravleva EIu, Vanichkin AV. Effektivnost' semaksa v ostrom periode polusharnogo ishemicheskogo insul'ta (klinicheskoe i élektrofiziologicheskoe issledovanie) [Ef- fectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. Zh Nevrol Psikhiatr Im S S Korsakova. 1997; 97(6): 26-34. Russian. PMID: 11517472
  387. Stakhovskaya LV, Shamalov NA, Khasanova DR, Melnikova EV, Agafiina AS, Golikov KV, Bogdanov EI, Yakupova AA, Roshkovskaya LV, Lukinykh LV, Lokshtanova TM, Poverennova IE, Shepankevich LA. Rezul'taty randomizirovannogo dvoĭnogo slepogo mul'titsentrovogo platsebo-kontroliruemogo v parallel'nykh gruppakh issledo- vaniia éffektivnosti i bezopasnosti meksidola pri dlitel'noĭ posledovatel'noĭ terapii u patsientov v ostrom i rannem vossta- novitel'nom periodakh polusharnogo ishemicheskogo insul'ta (ÉPIKA) [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017; 117 (3. Vyp. 2): 55-65. Russian. doi: 10.17116/jnevro20171173255-65.
  388. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W; DECIMAL, DESTINY, and HAMLET Investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised con- trolled trials. Lancet Neurol. 2007; 6: 215-222.
  389. Yang MH, Lin HY, Fu J, Roodrajeetsing G, Shi SL, Xiao SW. Decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: a systematic review and meta-analysis. Surgeon. 2015; 13: 230-240.
  390. Alexander P, Heels-Ansdell D, Siemieniuk R, Bhatnagar N, Chang Y, Fei Y, Zhang Y, McLeod S, Prasad K, Guyatt G. Hemicraniectomy versus medical treatment with large MCA infarct: a review and meta-analysis. BMJ Open. 2016; 6: e014390.
  391. Крылов В.В., Древаль О.Н., Джинджихадзе Р.С., Лазарев В.А., Дашьян В.Г., Никитин А.С., Петриков С.С. Клинические рекомендации по диагностике и лечению злокачественных форм ишемического инсульта в бассейне средней мозговой артерии. URL: http://ruans.org/Text/Guidelines/ischemic_stroke_severe_form_mca.pdf.
  392. Alexander P, Heels-Ansdell D, Siemieniuk R, Bhatnagar N, Chang Y, Fei Y, Zhang Y, McLeod S, Prasad K, Guyatt G. Hemicraniectomy versus medical treatment with large MCA infarct: a review and meta-analysis. BMJ Open. 2016; 6: e014390.
  393. Agarwalla PK, Stapleton CJ, Ogilvy CS. Craniectomy in acute ischemic stroke. Neurosurgery. 2014; 74(suppl 1): S151–S162.
  394. Raco A, Caroli E, Isidori A, Salvati M. Management of acute cerebellar infarction: one institution’s experi- ence. Neurosurgery. 2003; 53: 1061–1065.
  395. Mostofi K. Neurosurgical management of massive cerebellar infarct outcome in 53 patients. Surg Neurol Int. 2013; 4: 28.
  396. Крылов В.В., Никитин А.С., Дашьян В.Г., Буров С.А., Петриков С.С., Асратян С.А. Хирургия массивного ишемического инсульта. М.: ГЭОТАР-Медиа 2016.
  397. Xu MY. Poststroke seizure: optimising its management. Stroke Vasc Neurol. 2018; 4(1): 48-56.
  398. Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, Tomson T, Hauser WA. Recom- mendation for a definition of acute symptomatic seizure. Epilepsia. 2010 Apr; 51(4): 671-5.
  399. Holtkamp M, Beghi E, Benninger F, Kälviäinen R, Rocamora R, Christensen H; European Stroke Organi- sation. European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy. Eur Stroke J. 2017 Jun; 2(2): 103-115.
  400. Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, Bare M, Bleck T, Dodson WE, Garrity L, Jagoda A, Lowenstein D, Pellock J, Riviello J, Sloan E, Treiman DM. Evidence-Based Guideline: Treatment of Con- vulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb; 16(1): 48-61.
  401. Brigo F, Nardone R, Tezzon F, Trinka E. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis. Epilepsy Behav. 2015 Aug; 49: 325- 36
  402. van Tuijl JH, van Raak EP, de Krom MC, Lodder J, Aldenkamp AP. Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis. Seizure. 2011 May; 20(4): 285-91.
  403. Sales F, Chaves J, McMurray R, Loureiro R, Fernandes H, Villanueva V. Eslicarbazepine acetate in post- stroke epilepsy: Clinical practice evidence from Euro-Esli. Acta Neurol Scand. 2020 Dec; 142 (6): 563-573.
  404. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, Mattson R, French JA, Perucca E, Tomson T; ILAE Subcommission on AED Guidelines. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013 Mar; 54(3): 551- 63.
  405. Werhahn KJ, Trinka E, Dobesberger J, Unterberger I, Baum P, Deckert-Schmitz M, Kniess T, Schmitz B, Bernedo V, Ruckes C, Ehrlich A, Krämer G. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia. 2015 Mar; 56(3): 450-9.
  406. Zelano J. Poststroke epilepsy: update and future directions. Ther Adv Neurol Disord. 2016 Sep; 9(5): 424- 35.
  407. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, Mattson R, French JA, Perucca E, Tomson T; ILAE Subcommission on AED Guidelines. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013 Mar; 54(3): 551- 63.
  408. Mitchell AJ, Sheth B, Gill J, Yadegarfar M, Stubbs B, Yadegarfar M, Meader N. Prevalence and predictors of post-stroke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder. Gen Hosp Psychiatry. 2017 Jul; 47: 48-60.
  409. Qin B, Chen H, Gao W, Zhao LB, Zhao MJ, Qin HX, Chen W, Chen L, Yang MX. Efficacy, acceptability, and tolerability of antidepressant treatments for patients with post-stroke depression: a network meta-analysis. Braz J Med Biol Res. 2018; 51(7): e7218.
  410. Gu J, Huang H, Chen K, Huang G, Huang Y, Xu H. Are they necessary? Preventive therapies for post-stroke depression: A meta-analysis of RCTs. Psychiatry Res. 2020 Feb; 284: 112670.
  411. FOCUS Trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet. 2019 Jan 19; 393(10168): 265-274.
  412. Stahl S.M. Prescriber's guide: Stahl's essential psychopharmacology. Cambridge University Press, 2020.
  413. Zhou S, Liu S, Liu X, Zhuang W. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis. Medicine (Baltimore). 2020 Feb; 99(6): e19062.
  414. Bai ZF, Wang LY. Efficacy of sertraline for post-stroke depression: A systematic review protocol of ran- domized controlled trial. Medicine (Baltimore). 2019 Apr; 98(16): e15299.
  415. Sun Y, Liang Y, Jiao Y, Lin J, Qu H, Xu J, Zhao C. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments metaanalysis. BMJ Open. 2017 Aug 3; 7(8): e016499.
  416. Sun Y, Liang Y, Jiao Y, Lin J, Qu H, Xu J, Zhao C. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments metaanalysis. BMJ Open. 2017 Aug 3; 7(8): e016499.
  417. Starkstein SE, Hayhow BD. Treatment of Post-Stroke Depression. Curr Treat Options Neurol. 2019 Jun 25; 21(7): 31.
  418. Lee EJ, Oh MS, Kim JS, Chang DI, Park JH, Cha JK, Heo JH, Sohn SI, Kim DE, Kim HY, Kim J, Seo WK, Lee J, Park SW, Kim YJ, Lee BC; EMOTION investigators. Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use. J Neurol Neurosurg Psychiatry. 2018 Mar; 89(3): 271-276.
  419. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry. 2010 Feb; 67(2): 187-96.
  420. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009 Feb 28; 373(9665): 746-58.
  421. Cui M, Huang CY, Wang F. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis. J Stroke Cerebrovasc Dis. 2018 Nov; 27(11): 2905-2918
  422. Deng L, Sun X, Qiu S, Xiong Y, Li Y, Wang L, Wei Q, Wang D, Liu M. Interventions for management of post-stroke depression: A Bayesian network meta-analysis of 23 randomized controlled trials. Sci Rep. 2017 Nov 28; 7(1): 16466.
  423. Van de Meent H, Geurts AC, Van Limbeek J. Pharmacologic treatment of poststroke depression: a system- atic review of the literature. Top Stroke Rehabil. 2003 Spring; 10(1): 79-92.
  424. Chun HY, Whiteley WN, Dennis MS, Mead GE, Carson AJ. Anxiety After Stroke: The Importance of Sub- typing. Stroke. 2018 Mar; 49(3): 556-564.
  425. Lerdal A, Kottorp A, Gay CL, Grov EK, Lee KA. Rasch analysis of the Beck Depression Inventory-II in stroke survivors: a cross-sectional study. J Affect Disord. 2014 Apr; 158: 48-52.
  426. Mitchell AJ, Sheth B, Gill J, Yadegarfar M, Stubbs B, Yadegarfar M, Meader N. Prevalence and predictors of post-stroke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder. Gen Hosp Psychiatry. 2017 Jul; 47: 48-60.
  427. Rafsten L, Danielsson A, Sunnerhagen KS. Anxiety after stroke: A systematic review and meta-analysis. J Rehabil Med. 2018 Sep 28; 50(9): 769-778
  428. . Wright F, Wu S, Chun HY, Mead G. Factors Associated with Poststroke Anxiety: A Systematic Review and Meta-Analysis. Stroke Res Treat. 2017; 2017: 2124743.
  429. Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012 Nov 14; 11(11): CD009286.
  430. Knapp P, Campbell Burton CA, Holmes J, Murray J, Gillespie D, Lightbody CE, Watkins CL, Chun HY, Lewis SR. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev. 2017 May 23; 5(5): CD008860.
  431. Cui M, Huang CY, Wang F. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis. J Stroke Cerebrovasc Dis. 2018 Nov; 27(11): 2905-2918.
  432. Wright F, Wu S, Chun HY, Mead G. Factors Associated with Poststroke Anxiety: A Systematic Review and Meta-Analysis. Stroke Res Treat. 2017; 2017: 2124743.
  433. Knapp P, Campbell Burton CA, Holmes J, Murray J, Gillespie D, Lightbody CE, Watkins CL, Chun HY, Lewis SR. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev. 2017 May 23; 5(5): CD008860
  434. Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011; 152(5): 1018-1023
  435. Campbell BCV, van Zwam WH, Goyal M, Menon BK, Dippel DWJ, Demchuk AM, Bracard S, White P, Dávalos A, Majoie CBLM, van der Lugt A, Ford GA, de la Ossa NP, Kelly M, Bourcier R, Donnan GA, Roos YBWEM, Bang OY, Nogueira RG, Devlin TG, van den Berg LA, Clarençon F, Burns P, Carpenter J, Berkhemer OA, Yavagal DR, Pereira VM, Ducrocq X, Dixit A, Quesada H, Epstein J, Davis SM, Jansen O, Rubiera M, Urra X, Micard E, Lingsma HF, Naggara O, Brown S, Guillemin F, Muir KW, van Oostenbrugge RJ, Saver JL, Jovin TG, Hill MD, Mitchell PJ; HERMES collaborators. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. Lancet Neurol. 2018 Jan; 17(1): 47-53. doi: 10.1016/S1474-4422(17)30407-6.
  436. Schonenberger, S., et al., Association of General Anesthesia vs Procedural Sedation With Functional Out- come Among Patients With Acute Ischemic Stroke Undergoing Thrombectomy: A Systematic Review and Meta-analysis. JAMA, 2019. 322(13): p. 1283-1293
  437. Küçükdeveci AA, Stibrant Sunnerhagen K, Golyk V, Delarque A, Ivanova G, Zampolini M, Kiekens C, Varela Donoso E, Christodoulou N. Evidence-based position paper on Physical and Rehabilitation Medicine professional practice for persons with stroke. The European PRM position (UEMS PRM Section). Eur J Phys Rehabil Med. 2018 Dec; 54(6): 957-970. doi: 10.23736/S1973-9087.18.05501-6
  438. Epub 2018 Aug 29. PMID: 30160440.Vasudevan JM, Browne BJ. Hemiplegic shoulder pain: an approach to diagnosis and management. Phys Med Rehabil Clin N Am. 2014 May; 25(2): 411-37. doi: 10.1016/j.pmr.2014.01.010. Epub 2014 Mar 14.
  439. Saunders DH, Sanderson M, Hayes S, Johnson L, Kramer S, Carter DD, Jarvis H, Brazzelli M, Mead GE. Physical fitness training for stroke patients. Cochrane Database Syst Rev. 2020 Mar 20; 3(3): CD003316. doi: 10.1002/14651858.CD003316.pub7.
  440. Langhorne P, Collier JM, Bate PJ, Thuy MN, Bernhardt J. Very early versus delayed mobilisation after stroke. Cochrane Database Syst Rev. 2018 Oct 16; 10(10): CD006187. doi: 10.1002/14651858.CD006187.pub3.
  441. Daniels SK, Anderson JA, Willson PC. Valid items for screening dysphagia risk in patients with stroke: a systematic review. Stroke. 2012 Mar; 43(3): 892-7. doi: 10.1161/STROKEAHA.111.640946.
  442. Burgos R, Bretón I, Cereda E, Desport JC, Dziewas R, Genton L, Gomes F, Jésus P, Leischker A, Muscari- toli M, Poulia KA, Preiser JC, Van der Marck M, Wirth R, Singer P, Bischoff SC. ESPEN guideline clinical nutrition in neurology. Clin Nutr. 2018 Feb; 37(1): 354-396. doi: 10.1016/j.clnu.2017.09.003.
  443. Geeganage C, Beavan J, Ellender S, Bath PM. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev. 2012 Oct 17; 10: CD000323. doi: 10.1002/14651858.CD000323.pub2.
  444. Иванова Г.Е., Мельникова Е.В., Шмонин А.А., Вербицкая Е.В., Белкин А.А., Бодрова Р.А., Лебедев П.В., Мальцева М.Н., Прокопенко С.В., Просвирнина М.С., Сарана А.М., Стаховская Л.В., Суворов А.Ю., Хасанова Д.Р., Шамалов Н.А. Оценка эффективности работы мультидисциплинарной бригады как новой модели оказания реабилитационной помощи пациентам с церебральным инсультом. Вестник РНИМУ 2019; 6: 5-15.
  445. Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Jun; 47(6): e98-e169. doi: 10.1161/STR.0000000000000098.
  446. Hebert D, Lindsay MP, McIntyre A, Kirton A, Rumney PG, Bagg S, Bayley M, Dowlatshahi D, Dukelow S, Garnhum M, Glasser E, Halabi ML, Kang E, MacKay-Lyons M, Martino R, Rochette A, Rowe S, Salbach N, Semenko B, Stack B, Swinton L, Weber V, Mayer M, Verrilli S, DeVeber G, Andersen J, Barlow K, Cassidy C, Dilenge ME, Fehlings D, Hung R, Iruthayarajah J, Lenz L, Majnemer A, Purtzki J, Rafay M, Sonnenberg LK, Townley A, Janzen S, Foley N, Teasell R. Canadian stroke best practice recommendations: Stroke rehabilitation practice guidelines, update 2015. Int J Stroke. 2016 Jun; 11(4): 459- 84. doi: 10.1177/1747493016643553.
  447. Legg LA, Lewis SR, Schofield-Robinson OJ, Drummond A, Langhorne P. Occupational therapy for adults with problems in activities of daily living after stroke. Cochrane Database Syst Rev. 2017 Jul 19; 7(7): CD003585. doi: 10.1002/14651858.CD003585.pub3.
  448. Zhang C, Li-Tsang CW, Au RK. Robotic approaches for the rehabilitation of upper limb recovery after stroke: a systematic review and meta-analysis. Int J Rehabil Res. 2017 Mar; 40(1): 19-28. doi: 10.1097/MRR.0000000000000204.
  449. Mitchell C, Bowen A, Tyson S, Butterfint Z, Conroy P. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury. Cochrane Database Syst Rev. 2017 Jan 25; 1(1): CD002088. doi: 10.1002/14651858.CD002088.pub3.
  450. Russo MJ, Prodan V, Meda NN, Carcavallo L, Muracioli A, Sabe L, Bonamico L, Allegri RF, Olmos L. High-technology augmentative communication for adults with post-stroke aphasia: a systematic review. Expert Rev Med Devices. 2017 May; 14(5): 355-370. doi: 10.1080/17434440.2017.1324291.
  451. Legg LA, Lewis SR, Schofield-Robinson OJ, Drummond A, Langhorne P. Occupational therapy for adults with problems in activities of daily living after stroke. Cochrane Database Syst Rev. 2017 Jul 19; 7(7): CD003585. doi: 10.1002/14651858.CD003585.pub3.
  452. Langhorne P, Collier JM, Bate PJ, Thuy MN, Bernhardt J. Very early versus delayed mobilisation after stroke. Cochrane Database Syst Rev. 2018 Oct 16; 10(10): CD006187. doi: 10.1002/14651858.CD006187.pub3.
  453. Белкин А.А. Синдром последствий интенсивной терапии (ПИТ-синдром). Вопросы интенсивной терапии имени А.И. Салтанова. 2018; 2: 12-23.
  454. Billinger SA, Arena R, Bernhardt J, Eng JJ, Franklin BA, Johnson CM, MacKay-Lyons M, Macko RF, Mead GE, Roth EJ, Shaughnessy M, Tang A; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Clinical Cardiology. Physical activity and exercise recommendations for stroke survivors: a statement for healthcare pro- fessionals from the American Heart Association/American Stroke Association. Stroke. 2014 Aug; 45(8): 2532-53. doi: 10.1161/STR.0000000000000022.
  455. Billinger SA, Arena R, Bernhardt J, Eng JJ, Franklin BA, Johnson CM, MacKay-Lyons M, Macko RF, Mead GE, Roth EJ, Shaughnessy M, Tang A; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Clinical Cardiology. Physical activity and exercise recommendations for stroke survivors: a statement for healthcare pro- fessionals from the American Heart Association/American Stroke Association. Stroke. 2014 Aug; 45(8): 2532-53. doi: 10.1161/STR.0000000000000022.
  456. Coleman ER, Moudgal R, Lang K, Hyacinth HI, Awosika OO, Kissela BM, Feng W. Early Rehabilitation After Stroke: a Narrative Review. Curr Atheroscler Rep. 2017 Nov 7; 19(12): 59. doi: 10.1007/s11883-017-0686-6.
  457. Daniels SK, Anderson JA, Willson PC. Valid items for screening dysphagia risk in patients with stroke: a systematic review. Stroke. 2012 Mar; 43(3): 892-7. doi: 10.1161/STROKEAHA.111.640946.
  458. Burgos R, Bretón I, Cereda E, Desport JC, Dziewas R, Genton L, Gomes F, Jésus P, Leischker A, Muscari- toli M, Poulia KA, Preiser JC, Van der Marck M, Wirth R, Singer P, Bischoff SC. ESPEN guideline clinical nutrition in neurology. Clin Nutr. 2018 Feb; 37(1): 354-396. doi: 10.1016/j.clnu.2017.09.003.
  459. Coleman ER, Moudgal R, Lang K, Hyacinth HI, Awosika OO, Kissela BM, Feng W. Early Rehabilitation After Stroke: a Narrative Review. Curr Atheroscler Rep. 2017 Nov 7; 19(12): 59. doi: 10.1007/s11883-017-0686-6.
  460. Hebert D, Lindsay MP, McIntyre A, Kirton A, Rumney PG, Bagg S, Bayley M, Dowlatshahi D, Dukelow S, Garnhum M, Glasser E, Halabi ML, Kang E, MacKay-Lyons M, Martino R, Rochette A, Rowe S, Salbach N, Semenko B, Stack B, Swinton L, Weber V, Mayer M, Verrilli S, DeVeber G, Andersen J, Barlow K, Cassidy C, Dilenge ME, Fehlings D, Hung R, Iruthayarajah J, Lenz L, Majnemer A, Purtzki J, Rafay M, Sonnenberg LK, Townley A, Janzen S, Foley N, Teasell R. Canadian stroke best practice recommendations: Stroke rehabilitation practice guidelines, update 2015. Int J Stroke. 2016 Jun; 11(4): 459-84. doi: 10.1177/1747493016643553.
  461. Coleman ER, Moudgal R, Lang K, Hyacinth HI, Awosika OO, Kissela BM, Feng W. Early Rehabilitation After Stroke: a Narrative Review. Curr Atheroscler Rep. 2017 Nov 7; 19(12): 59. doi: 10.1007/s11883-017-0686-6.
  462. Koog YH, Jin SS, Yoon K, Min BI. Interventions for hemiplegic shoulder pain: systematic review of ran- domised controlled trials. Disabil Rehabil. 2010; 32(4): 282-91. doi: 10.3109/09638280903127685.
  463. Ratnasabapathy Y, Broad J, Baskett J, Pledger M, Marshall J, Bonita R. Shoulder pain in people with a stroke: a population-based study. Clin Rehabil. 2003 May; 17(3): 304-11. doi: 10.1191/0269215503cr612oa.
  464. Хасанова Д.Р. Инсульт. Современные подходы диагностики, лечения и профилактики: методические рекомендации. Под ред. Д. Р. Хасановой, В. И. Данилова. М.: ГЭОТАР-Медиа, 2014; 248. URL: https://www.rosmedlib.ru/book/ISBN9785970428269.html.
  465. Инсульт у взрослых: центральный парез верхней конечности. Клинические рекомендации. М., 2017; 105/
  466. Vasudevan JM, Browne BJ. Hemiplegic shoulder pain: an approach to diagnosis and management. Phys Med Rehabil Clin N Am. 2014 May; 25(2): 411-37. doi: 10.1016/j.pmr.2014.01.010.
  467. Howlett OA, Lannin NA, Ada L, McKinstry C. Functional electrical stimulation improves activity after stroke: a systematic review with meta-analysis. Arch Phys Med Rehabil. 2015 May; 96(5): 934-43. doi: 10.1016/j.apmr.2015.01.013. Epub 2015 Jan 26.
  468. Prenton S, Hollands KL, Kenney LP. Functional electrical stimulation versus ankle foot orthoses for foot- drop: A meta-analysis of orthotic effects. J Rehabil Med. 2016 Oct 5; 48(8): 646-656. doi: 10.2340/16501977-2136.
  469. Veerbeek JM, van Wegen E, van Peppen R, van der Wees PJ, Hendriks E, Rietberg M, Kwakkel G. What is the evidence for physical therapy poststroke? A systematic review and meta-analysis. PLoS One. 2014 Feb 4; 9(2): e87987. doi: 10.1371/journal.pone.0087987.
  470. Norouzi-Gheidari N, Archambault PS, Fung J. Effects of robot-assisted therapy on stroke rehabilitation in upper limbs: systematic review and meta-analysis of the literature. J Rehabil Res Dev. 2012; 49(4): 479-96. doi: 10.1682/jrrd.2010.10.0210.
  471. Mehrholz J, Pohl M, Platz T, Kugler J, Elsner B. Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev. 2018 Sep 3; 9(9): CD006876. doi: 10.1002/14651858.CD006876.pub5.
  472. Mehrholz J, Pohl M, Platz T, Kugler J, Elsner B. Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev. 2018 Sep 3; 9(9): CD006876. doi: 10.1002/14651858.CD006876.pub5.
  473. Norouzi-Gheidari N, Archambault PS, Fung J. Effects of robot-assisted therapy on stroke rehabilitation in upper limbs: systematic review and meta-analysis of the literature. J Rehabil Res Dev. 2012; 49(4): 479-96. doi: 10.1682/jrrd.2010.10.0210.
  474. Küçükdeveci AA, Stibrant Sunnerhagen K, Golyk V, Delarque A, Ivanova G, Zampolini M, Kiekens C, Varela Donoso E, Christodoulou N. Evidence-based position paper on Physical and Rehabilitation Medicine professional practice for persons with stroke. The European PRM position (UEMS PRM Section). Eur J Phys Rehabil Med. 2018 Dec; 54(6): 957-970. doi: 10.23736/S1973-9087.18.05501-6.
  475. Vasudevan JM, Browne BJ. Hemiplegic shoulder pain: an approach to diagnosis and management. Phys Med Rehabil Clin N Am. 2014 May; 25(2): 411-37. doi: 10.1016/j.pmr.2014.01.010.
  476. 606. Saunders DH, Sanderson M, Hayes S, Johnson L, Kramer S, Carter DD, Jarvis H, Brazzelli M, Mead GE. Physical fitness training for stroke patients. Cochrane Database Syst Rev. 2020 Mar 20; 3(3): CD003316. doi: 10.1002/14651858.CD003316.pub7.
  477. Rosales RL, Efendy F, Teleg ES, Delos Santos MM, Rosales MC, Ostrea M, Tanglao MJ, Ng AR. Botuli- num toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. J Neurol Sci. 2016 Dec 15; 371: 6-14. doi: 10.1016/j.jns.2016.10.005.
  478. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014 Jan 18; 383(9913): 245-54. doi: 10.1016/s0140-6736(13)61953-4.
  479. Kinnear BZ, Lannin NA, Cusick A, Harvey LA, Rawicki B. Rehabilitation therapies after botulinum toxin- A injection to manage limb spasticity: a systematic review. Phys Ther. 2014 Nov; 94(11): 1569-81. doi: 10.2522/ptj.20130408.
  480. Esquenazi A, Bavikatte G, Bandari DS, Jost WH, Munin MC, Tang SFT, Largent J, Adams AM, Zuzek A, Francisco GE. Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity. PM R. 2021 Oct; 13(10): 1079-1093. doi: 10.1002/pmrj.12517.
  481. Rosales RL, Efendy F, Teleg ES, Delos Santos MM, Rosales MC, Ostrea M, Tanglao MJ, Ng AR. Botuli- num toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. J Neurol Sci. 2016 Dec 15; 371: 6-14. doi: 10.1016/j.jns.2016.10.005.
  482. Foley N, Murie-Fernandez M, Speechley M, Salter K, Sequeira K, Teasell R. Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-anal- ysis. Eur J Neurol. 2010 Dec; 17(12): 1419-27. doi: 10.1111/j.1468-1331.2010.03084.x.
  483. Esquenazi A, Bavikatte G, Bandari DS, Jost WH, Munin MC, Tang SFT, Largent J, Adams AM, Zuzek A, Francisco GE. Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity. PM R. 2021 Oct; 13(10): 1079-1093. doi: 10.1002/pmrj.12517.
  484. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014 Jan 18; 383(9913): 245-54. doi: 10.1016/s0140-6736(13)61953-4.
  485. Gadidi V, Katz-Leurer M, Carmeli E, Bornstein NM. Long-term outcome poststroke: predictors of activity limitation and participation restriction. Arch Phys Med Rehabil. 2011 Nov; 92(11): 1802-8. doi: 10.1016/j.apmr.2011.06.014.
  486. Küçükdeveci AA, Stibrant Sunnerhagen K, Golyk V, Delarque A, Ivanova G, Zampolini M, Kiekens C, Varela Donoso E, Christodoulou N. Evidence-based position paper on Physical and Rehabilitation Medicine professional practice for persons with stroke. The European PRM position (UEMS PRM Section). Eur J Phys Rehabil Med. 2018 Dec; 54(6): 957-970. doi: 10.23736/S1973-9087.18.05501-6.
  487. Francisco GE, McGuire JR. Poststroke spasticity management. Stroke. 2012 Nov; 43(11): 3132-6. doi: 10.1161/STROKEAHA.111.639831.
  488. Khan F, Amatya B, Bensmail D, Yelnik A. Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews. Ann Phys Rehabil Med. 2019 Jul; 62(4): 265-273. doi: 10.1016/j.rehab.2017.10.001. Epub 2017 Oct 16. PMID: 29042299.
  489. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014 Jan 18; 383(9913): 245-54. doi: 10.1016/s0140-6736(13)61953-4.
  490. Watson JC, Sandroni P. Central Neuropathic Pain Syndromes. Mayo Clin Proc. 2016 Mar; 91(3): 372-85. doi: 10.1016/j.mayocp.2016.01.017. PMID: 26944242
  491. Saunders DH, Sanderson M, Hayes S, Johnson L, Kramer S, Carter DD, Jarvis H, Brazzelli M, Mead GE. Physical fitness training for stroke patients. Cochrane Database Syst Rev. 2020 Mar 20; 3(3): CD003316. doi: 10.1002/14651858.CD003316.pub7.
  492. States RA, Pappas E, Salem Y. Overground physical therapy gait training for chronic stroke patients with mobility deficits. Cochrane Database Syst Rev. 2009 Jul 8; 2009(3): CD006075. doi: 10.1002/14651858.CD006075.pub2. 623. Billinger SA, Arena R, Bernhardt J, Eng JJ, Franklin BA, Johnson CM, MacKay-Lyons M, Macko RF, Mead GE, Roth EJ, Shaughnessy M, Tang A; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Clinical Cardiology. Physical activity and exercise recommendations for stroke survivors: a statement for healthcare pro- fessionals from the American Heart Association/American Stroke Association. Stroke. 2014 Aug; 45(8): 2532-53. doi: 10.1161/STR.0000000000000022.
  493. Legg LA, Lewis SR, Schofield-Robinson OJ, Drummond A, Langhorne P. Occupational therapy for adults with problems in activities of daily living after stroke. Cochrane Database Syst Rev. 2017 Jul 19; 7(7): CD003585. doi: 10.1002/14651858.CD003585.pub3.
  494. Geroin C, Mazzoleni S, Smania N, Gandolfi M, Bonaiuti D, Gasperini G, Sale P, Munari D, Waldner A, Spidalieri R, Bovolenta F, Picelli A, Posteraro F, Molteni F, Franceschini M; Italian Robotic Neurorehabilitation Research Group. Systematic review of outcome measures of walking training using electromechanical and robotic devices in patients with stroke. J Rehabil Med. 2013 Nov; 45(10): 987-96. doi: 10.2340/16501977-1234.
  495. van Heugten C, Gregório GW, Wade D. Evidence-based cognitive rehabilitation after acquired brain injury: a systematic review of content of treatment. Neuropsychol Rehabil. 2012; 22(5): 653-73. doi: 10.1080/09602011.2012.680891.
  496. Poulin V, Korner-Bitensky N, Dawson DR, Bherer L. Efficacy of executive function interventions after stroke: a systematic review. Top Stroke Rehabil. 2012 Mar-Apr; 19(2): 158-71. doi: 10.1310/tsr1902-158.
  497. Cicerone KD, Dahlberg C, Kalmar K, Langenbahn DM, Malec JF, Bergquist TF, Felicetti T, Giacino JT, Harley JP, Harrington DE, Herzog J, Kneipp S, Laatsch L, Morse PA. Evidence-based cognitive rehabilitation: recommen- dations for clinical practice. Arch Phys Med Rehabil. 2000 Dec; 81(12): 1596-615. doi: 10.1053/apmr.2000.19240.
  498. Ахутина Т.В., Микадзе Ю.В., Иванова М.В., Ларина О.Д., Норвилс С.Н., Царева И.В. Логопедическая диагностика и реабилитация пациентов с повреждениями головного мозга в остром периоде: клинические рекомендации. М., 2014; 46.
  499. Боголепова А.Н., Васенина Е.Е., Захаров В.В., Катунина Е.А., Левин О.С., Литвиненко И.В., Преображенская И.С., Фукалов Ю.A., Шкловский В.М., Цыган Н.В. Яхно Н.Н. Реабилитации высших психических функций у больных с очаговым поражением головного мозга: клинические рекомендации. М., 2018; 88.
  500. Bowen A, Hazelton C, Pollock A, Lincoln NB. Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database Syst Rev. 2013 Jul 1;2013(7):CD003586. doi: 10.1002/14651858.CD003586.pub3. Update in: Cochrane Database Syst Rev. 2021 Jul 1; 7: CD003586.
  501. Приказ Министерства здравоохранения РФ от 31 июля 2020 г. № 778н «О Порядке организации медицинской реабилитации взрослых» Зарегистрировано в Минюсте РФ 25 сентября 2020 г. Регистрационный № 60039.
  502. Hebert D, Lindsay MP, McIntyre A, Kirton A, Rumney PG, Bagg S, Bayley M, Dowlatshahi D, Dukelow S, Garnhum M, Glasser E, Halabi ML, Kang E, MacKay-Lyons M, Martino R, Rochette A, Rowe S, Salbach N, Semenko B, Stack B, Swinton L, Weber V, Mayer M, Verrilli S, DeVeber G, Andersen J, Barlow K, Cassidy C, Dilenge ME, Fehlings D, Hung R, Iruthayarajah J, Lenz L, Majnemer A, Purtzki J, Rafay M, Sonnenberg LK, Townley A, Janzen S, Foley N, Teasell R. Canadian stroke best practice recommendations: Stroke rehabilitation practice guidelines, update 2015. Int J Stroke. 2016 Jun;11(4):459-84. doi: 10.1177/1747493016643553.
  503. Иванова Г.Е., Кривобородов Г.Г., Салюков Р.В., Бушков Ф.А., Ефремов Н.С., Кадыров З.А. Коррекция функциональных нарушений опорожнения мочевого пузыря при неврологических заболеваниях методом периодической катетеризации: клинические рекомендации. М., 2016; 40.
  504. Thomas LH, Cross S, Barrett J, French B, Leathley M, Sutton CJ, Watkins C. Treatment of urinary incon- tinence after stroke in adults. Cochrane Database Syst Rev. 2008 Jan 23; 2008(1): CD004462. doi: 10.1002/14651858.CD004462.pub3.
  505. 635. Panfili Z, Metcalf M, Griebling TL. Contemporary Evaluation and Treatment of Poststroke Lower Uri- nary Tract Dysfunction. Urol Clin North Am. 2017 Aug; 44(3): 403-414. doi: 10.1016/j.ucl.2017.04.007. PMID: 28716321.
  506. Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, Billinger SA; American Heart Associa- tion Council on Cardiovascular Nursing and the Stroke Council. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke. 2010 Oct; 41(10): 2402-48. doi: 10.1161/STR.0b013e3181e7512b.
  507. B. Blok, J. Pannek, Castro-Diaz, G. del Popolo, J. Groen, R. Hamid, G. Karsenty, T.M. Kessler, R. Boissier, H. Ecclestone, B. Padilla Fernández, T. Gross, L. ‘t Hoen, S. Musco, V. Phé, M.P. Schneider. Рекомендации Европейской Ассоциации Урологов по нейроурологии. Пер. К.А. Ширанов. М. 2016.
  508. Thieme H, Morkisch N, Mehrholz J, Pohl M, Behrens J, Borgetto B, Dohle C. Mirror therapy for improving motor function after stroke. Cochrane Database Syst Rev. 2018 Jul 11;7(7):CD008449. doi: 10.1002/14651858.CD008449.pub3. PMID: 29993119; PMCID: PMC6513639
  509. Назарова, М.А., М.А. Пирадов, Л.А. Черникова, Зрительная обратная связь - зеркальная терапия в нейрореабилитации. Анналы клинической и экспериментальной неврологии 2012; 6: 36-41.
  510. Laver KE, Lange B, George S, Deutsch JE, Saposnik G, Crotty M. Virtual reality for stroke rehabilitation. Cochrane Database Syst Rev. 2017 Nov 20; 11(11): CD008349. doi: 10.1002/14651858.CD008349.pub4.
  511. Thieme H, Morkisch N, Mehrholz J, Pohl M, Behrens J, Borgetto B, Dohle C. Mirror therapy for improving motor function after stroke. Cochrane Database Syst Rev. 2018 Jul 11; 7(7): CD008449. doi: 10.1002/14651858.CD008449.pub3.
  512. Sorinola IO, Powis I, White CM. Does additional exercise improve trunk function recovery in stroke pa- tients? A meta-analysis. NeuroRehabilitation. 2014 Jan 1; 35(2): 205-13. doi: 10.3233/NRE-141123.
  513. Keller I, Lefin-Rank G. Improvement of visual search after audiovisual exploration training in hemianopic patients. Neurorehabil Neural Repair. 2010 Sep; 24(7): 666-73. doi: 10.1177/1545968310372774.
  514. Corbetta D, Sirtori V, Castellini G, Moja L, Gatti R. Constraint-induced movement therapy for upper ex- tremities in people with stroke. Cochrane Database Syst Rev. 2015 Oct 8; 2015(10): CD004433. doi: 10.1002/14651858.CD004433.pub3.
  515. Corbetta D, Sirtori V, Castellini G, Moja L, Gatti R. Constraint-induced movement therapy for upper ex- tremities in people with stroke. Cochrane Database Syst Rev. 2015 Oct 8; 2015(10): CD004433. doi: 10.1002/14651858.CD004433.pub3.
  516. Mehrholz J, Pohl M, Platz T, Kugler J, Elsner B. Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev. 2018 Sep 3; 9(9): CD006876. doi: 10.1002/14651858.CD006876.pub5.
  517. Mehrholz J, Pohl M, Platz T, Kugler J, Elsner B. Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev. 2018 Sep 3; 9(9): CD006876. doi: 10.1002/14651858.CD006876.pub5.
  518. Mehrholz J, Thomas S, Elsner B. Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev. 2017 Aug 17; 8(8): CD002840. doi: 10.1002/14651858.CD002840.pub4.
  519. Küçükdeveci AA, Stibrant Sunnerhagen K, Golyk V, Delarque A, Ivanova G, Zampolini M, Kiekens C, Varela Donoso E, Christodoulou N. Evidence-based position paper on Physical and Rehabilitation Medicine professional practice for persons with stroke. The European PRM position (UEMS PRM Section). Eur J Phys Rehabil Med. 2018 Dec; 54(6): 957-970. doi: 10.23736/S1973-9087.18.05501-6.
  520. Billinger SA, Arena R, Bernhardt J, Eng JJ, Franklin BA, Johnson CM, MacKay-Lyons M, Macko RF, Mead GE, Roth EJ, Shaughnessy M, Tang A; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Clinical Cardiology. Physical activity and exercise recommendations for stroke survivors: a statement for healthcare pro- fessionals from the American Heart Association/American Stroke Association. Stroke. 2014 Aug; 45(8): 2532-53. doi: 10.1161/STR.0000000000000022.
  521. Lee J, Stone AJ. Combined Aerobic and Resistance Training for Cardiorespiratory Fitness, Muscle Strength, and Walking Capacity after Stroke: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2020 Jan; 29(1): 104498. doi: 10.1016/j.jstrokecerebrovasdis.2019.104498.
  522. Nadler M, Pauls M. Shoulder orthoses for the prevention and reduction of hemiplegic shoulder pain and subluxation: systematic review. Clin Rehabil. 2017 Apr; 31(4): 444-453. doi: 10.1177/0269215516648753.
  523. . Küçükdeveci AA, Stibrant Sunnerhagen K, Golyk V, Delarque A, Ivanova G, Zampolini M, Kiekens C, Varela Donoso E, Christodoulou N. Evidence-based position paper on Physical and Rehabilitation Medicine professional practice for persons with stroke. The European PRM position (UEMS PRM Section). Eur J Phys Rehabil Med. 2018 Dec; 54(6): 957-970. doi: 10.23736/S1973-9087.18.05501-6.
  524. Francisco GE, McGuire JR. Poststroke spasticity management. Stroke. 2012 Nov; 43(11): 3132-6. doi: 10.1161/STROKEAHA.111.639831.
  525. Khan F, Amatya B, Bensmail D, Yelnik A. Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews. Ann Phys Rehabil Med. 2019 Jul; 62(4): 265-273. doi: 10.1016/j.rehab.2017.10.001.
  526. Medici M, Pebet M, Ciblis D. A double-blind, long-term study of tizanidine ('Sirdalud') in spasticity due to cerebrovascular lesions. Curr Med Res Opin. 1989; 11(6): 398-407. doi: 10.1185/03007998909110141.
  527. Stamenova P, Koytchev R, Kuhn K, Hansen C, Horvath F, Ramm S, Pongratz D. A randomized, double- blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke. Eur J Neu- rol. 2005 Jun; 12(6): 453-61. doi: 10.1111/j.1468-1331.2005.01006.x. PMID: 15885050.
  528. Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Jun; 47(6): e98-e169. doi: 10.1161/STR.0000000000000098.
  529. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014 Jan 18; 383(9913): 245-54. doi: 10.1016/s0140-6736(13)61953-4.
  530. Creamer M, Cloud G, Kossmehl P, Yochelson M, Francisco GE, Ward AB, Wissel J, Zampolini M, Abouihia A, Calabrese A, Saltuari L. Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity. Stroke. 2018 Sep; 49(9): 2129-2137. doi: 10.1161/STROKEAHA.118.022255.
  531. Vasudevan JM, Browne BJ. Hemiplegic shoulder pain: an approach to diagnosis and management. Phys Med Rehabil Clin N Am. 2014 May; 25(2): 411-37. doi: 10.1016/j.pmr.2014.01.010.
  532. Viana R, Pereira S, Mehta S, Miller T, Teasell R. Evidence for therapeutic interventions for hemiplegic shoulder pain during the chronic stage of stroke: a review. Top Stroke Rehabil. 2012 Nov-Dec; 19(6): 514-22. doi: 10.1310/tsr1906-514. PMID: 23192716.
  533. Corbetta D, Sirtori V, Castellini G, Moja L, Gatti R. Constraint-induced movement therapy for upper ex- tremities in people with stroke. Cochrane Database Syst Rev. 2015 Oct 8; 2015(10): CD004433. doi: 10.1002/14651858.CD004433.pub3.
  534. Vasudevan JM, Browne BJ. Hemiplegic shoulder pain: an approach to diagnosis and management. Phys Med Rehabil Clin N Am. 2014 May; 25(2): 411-37. doi: 10.1016/j.pmr.2014.01.010. Epub 2014 Mar 14. PMID: 24787341.
  535. Viana R, Pereira S, Mehta S, Miller T, Teasell R. Evidence for therapeutic interventions for hemiplegic shoulder pain during the chronic stage of stroke: a review. Top Stroke Rehabil. 2012 Nov-Dec; 19(6): 514-22. doi: 10.1310/tsr1906-514.
  536. Corbetta D, Sirtori V, Castellini G, Moja L, Gatti R. Constraint-induced movement therapy for upper ex- tremities in people with stroke. Cochrane Database Syst Rev. 2015 Oct 8;2015(10):CD004433. doi: 10.1002/14651858.CD004433.pub3.
  537. Thieme H, Morkisch N, Mehrholz J, Pohl M, Behrens J, Borgetto B, Dohle C. Mirror therapy for improving motor function after stroke. Cochrane Database Syst Rev. 2018 Jul 11; 7(7): CD008449. doi: 10.1002/14651858.CD008449.pub3.
  538. Barclay RE, Stevenson TJ, Poluha W, Semenko B, Schubert J. Mental practice for treating upper extremity deficits in individuals with hemiparesis after stroke. Cochrane Database Syst Rev. 2020 May 25; 5(5): CD005950. doi: 10.1002/14651858.CD005950.pub5.
  539. Thieme H, Morkisch N, Mehrholz J, Pohl M, Behrens J, Borgetto B, Dohle C. Mirror therapy for improving motor function after stroke. Cochrane Database Syst Rev. 2018 Jul 11; 7(7): CD008449. doi: 10.1002/14651858.CD008449.pub3.
  540. Ang KK, Chua KS, Phua KS, Wang C, Chin ZY, Kuah CW, Low W, Guan C. A Randomized Controlled Trial of EEG-Based Motor Imagery Brain-Computer Interface Robotic Rehabilitation for Stroke. Clin EEG Neurosci. 2015 Oct; 46(4): 310-20. doi: 10.1177/1550059414522229.
  541. Фролов А.А., Мокиенко О.А., Люкманов Р.Х., Черникова Л.А., Котов С.В., Турбина Л.Г., Бобров П.Д., Бирюкова Е.В., Кондур А.А., Иванова Г.Е., Старицын А.Н., Бушкова Ю.В., Джалагония И.З., Курганская М.Е., Павлова О.Г., Будилин С.Ю., Азиатская Г.А., Хижникова А.Е., Червяков А.В., Лукьянов А.Л. и др. Предварительные результаты контролируемого исследования эффективности технологии ИМК-экзоскелет при постинсультном парезе руки. Вестник Российского государственного медицинского университета. 2016; 2: 17-25.
  542. Carvalho R, Dias N, Cerqueira JJ. Brain-machine interface of upper limb recovery in stroke patients reha- bilitation: A systematic review. Physiother Res Int. 2019 Apr; 24(2): e1764. doi: 10.1002/pri.1764.
  543. Lee J, Stone AJ. Combined Aerobic and Resistance Training for Cardiorespiratory Fitness, Muscle Strength, and Walking Capacity after Stroke: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2020 Jan; 29(1): 104498. doi: 10.1016/j.jstrokecerebrovasdis.2019.104498.
  544. Инсульт. Руководство для врачей. Под ред. Л.В. Стаховской, С.В. Котова. Издательство МИА 2014; 400.
  545. Рекомендации по ведению больных с ишемическими инсультами и транзиторными ишемическими атаками Европейского общества по борьбе с инсультами (ESO), 2008 Cerebrovasc Dis 2008; 25: 457-507. URL: http//nsicu.ru/uploads/attachment/file/61/ StrokeGuidelinesRussian.pdf (рус. яз.) http://www.karger.com/Article/Pdf/131083.
  546. Рекомендации по ведению больных с острым нарушением мозгового кровообращения Американской ассоциации сердца (АНА) и Американской ассоциации по борьбе с инсультами (АSA) 2005 Stroke 2005; 36: 916-923. URL: http://stroke.ahajournals.ord/ content/36/4/916.e[tract].
  547. Неврология. Национальное руководство. Краткое издание. Под ред. Е.И. Гусева, А.Н. Коновалова, А. Б. Гехт. М.: ГЭОТАР-Медиа 2018; 688.
  548. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, et al; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018; 378: e34. doi: 10.1056/NEJMoa1800389.
  549. Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, Das A, Hartley L, Stranges S. Mediterranean- style diet for the primary and second- ary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2019; 3: CD009825. doi: 10.1002/14651858. CD009825.pub3
  550. Judd SE, Gutiérrez OM, Newby PK, Howard G, Howard VJ, Locher JL, Kissela BM, Shikany JM. Dietary patterns are associated with incident stroke and contribute to excess risk of stroke in Black Americans. Stroke. 2013; 44: 3305-3311. doi: 10.1161/STROKEAHA.113.002636
  551. He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 75: 632-647. doi: 10.1016/j.jacc.2019.11.055.
  552. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, et al; DASH- Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet: DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344: 3-10. doi: 10.1056/NEJM200101043440101
  553. Turan TN, Nizam A, Lynn MJ, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Harrell J, Derdeyn CP, Fiorella D, et al. Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017; 88: 379-385. doi: 10.1212/WNL.0000000000003534
  554. English C, Janssen H, Crowfoot G, Bourne J, Callister R, Dunn A, Oldmeadow C, Ong LK, Palazzi K, Patterson A, et al. Frequent, short bouts of light-intensity exercises while standing decreases systolic blood pressure: Break- ing Up Sitting Time After Stroke (BUST-Stroke) trial. Int J Stroke. 2018; 13: 932-940. doi: 10.1177/1747493018798535
  555. Biswas A, Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, Alter DA. Sedentary time and its asso- ciation with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med. 2015; 162: 123-132. doi: 10.7326/M14-1651
  556. Rigotti NA, Clair C, Munafò MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012; 5: CD001837. doi: 10.1002/14651858.CD001837.pub3
  557. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interven- tions for smoking cessation. Cochrane Database Syst Rev. 2016; 3: CD008286. doi: 10.1002/14651858.CD008286.pub3. 689. Evans-Hudnall GL, Stanley MA, Clark AN, Bush AL, Resnicow K, Liu Y, Kass JS, Sander AM. Improving secondary stroke self-care among underserved ethnic minority individuals: a randomized clinical trial of a pilot interven- tion. J Behav Med. 2014; 37: 196-204. doi: 10.1007/s10865-012-9469-2.
  558. 690. Ahmadi M, Laumeier I, Ihl T, Steinicke M, Ferse C, Endres M, Grau A, Hastrup S, Poppert H, Palm F, et al. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE- TMS): an open-label, randomised controlled trial. Lancet Neurol. 2020; 19: 49-60. doi: 10.1016/S1474-4422(19)30369-2 691. Pan B, Jin X, Jun L, Qiu S, Zheng Q, Pan M. The relationship between smoking and stroke: a meta-analysis. Medicine (Baltimore). 2019; 98: e14872. doi: 10.1097/MD.0000000000014872.
  559. Lin MP, Ovbiagele B, Markovic D, Towfighi A. Association of second- hand smoke with stroke outcomes. Stroke. 2016; 47: 2828-2835. doi: 10.1161/STROKEAHA.116.014099.
  560. Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R. Passive smok- ing as well as active smoking increases the risk of acute stroke. Tob Control. 1999; 8: 156-160. doi: 10.1136/tc.8.2.156.
  561. Lee PN, Thornton AJ, Forey BA, Hamling JS. Environmental tobacco smoke exposure and risk of stroke in never smokers: an updated review with meta-analysis. J Stroke Cerebrovasc Dis. 2017; 26: 204-216. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.011
  562. Evans-Hudnall GL, Stanley MA, Clark AN, Bush AL, Resnicow K, Liu Y, Kass JS, Sander AM. Improving secondary stroke self-care among underserved ethnic minority individuals: a randomized clinical trial of a pilot interven- tion. J Behav Med. 2014; 37: 196-204. doi: 10.1007/s10865-012-9469-2.
  563. Ois A, Gomis M, Rodríguez-Campello A, Cuadrado-Godia E, Jiménez-Conde J, Pont-Sunyer C, Cuccurella G, Roquer J. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke. 2008; 39: 1717-1721. doi: 10.1161/STROKEAHA.107.505438.
  564. Ricci C, Wood A, Muller D, Gunter MJ, Agudo A, Boeing H, van der Schouw YT, Warnakula S, Saieva C, Spijkerman A, et al. Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case- cohort study. BMJ. 2018; 361: k934. doi: 10.1136/bmj.k934.
  565. Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, Rehm J. Alcohol consumption and the risk of morbidity and mortality for different stroke types a systematic review and meta-analysis. BMC Public Health. 2010; 10: 258. doi: 10.1186/1471-2458-10-258
  566. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, et al; LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016; 375: 311-322. doi: 10.1056/NEJMoa1603827.
  567. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L; Look AHEAD Research Group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011; 34: 1481-1486. doi: 10.2337/dc10-2415
  568. Kernan WN, Inzucchi SE, Sawan C, Macko RF, Furie KL. Obesity: a stubbornly obvious target for stroke pre- vention. Stroke. 2013; 44: 278-286. doi: 10.1161/STROKEAHA.111.639922
  569. Kroll ME, Green J, Beral V, Sudlow CL, Brown A, Kirichek O, Price A, Yang TO, Reeves GK; Million Women Study Collaborators. Adiposity and ischemic and hemorrhagic stroke: prospective study in women and meta- analysis. Neurology. 2016; 87: 1473-1481. doi: 10.1212/WNL.0000000000003171
  570. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L; Look AHEAD Research Group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011; 34: 1481-1486. doi: 10.2337/dc10-2415
  571. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012; 307: 56-65. doi: 10.1001/jama.2011.1914
  572. Fisher DP, Johnson E, Haneuse S, Arterburn D, Coleman KJ, O’Connor PJ, O’Brien R, Bogart A, Theis MK, Anau J, et al. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. JAMA. 2018; 320: 1570-1582. doi: 10.1001/jama.2018.14619
  573. LeBlanc ES, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. Behavioral and pharma- cotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018; 320: 1172-1191. doi: 10.1001/jama.2018.7777
  574. Zonneveld TP, Richard E, Vergouwen MD, Nederkoorn PJ, de Haan R, Roos YB, Kruyt ND. Blood pres- sure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev.2018; 7: CD007858. doi: 10.1002/14651858.CD007858.pub2.
  575. PROGRESS Collaborative Group. Randomised trial of perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358: 1033-1041. doi: 10.1016/S0140-6736(01)06178-5.
  576. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003; 34: 2741-2748. doi: 10.1161/01.STR.0000092488.40085.15
  577. Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, Eguchi K, Kamiyama K, Minematsu K, Ueda S, et al; Recurrent Stroke Prevention Clinical Outcome Study Group. Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 2019; 76: 1309-1318. doi: 10.1001/jamaneurol.2019.2167.
  578. Mant J, McManus RJ, Roalfe A, Fletcher K, Taylor CJ, Martin U, Virdee S, Greenfield S, Hobbs FD. Dif- ferent systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke–Blood Pressure) randomised controlled trial. BMJ.2016; 352: i708. doi: 10.1136/bmj.i708.
  579. Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, et al; PODCAST Trial Investigators. Intensive versus guideline blood pressure and lipid lowering in patients with pre- vious stroke: main results from the pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) randomised controlled trial. PLoS One. 2017; 12: e0164608. doi: 10.1371/journal.pone.0164608
  580. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(3): 3786. doi: 10.15829/1560-4071-2020-3-3786
  581. Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, Eguchi K, Kamiyama K, Minematsu K, Ueda S, et al; Recurrent Stroke Prevention Clinical Outcome Study Group. Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 2019; 76: 1309-1318. doi: 10.1001/jamaneurol.2019.2167.
  582. Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, et al; PODCAST Trial Investigators. Intensive versus guideline blood pressure and lipid lowering in patients with pre- vious stroke: main results from the pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) randomised controlled trial. PLoS One. 2017; 12: e0164608. doi: 10.1371/journal.pone.0164608.
  583. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, et al; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008; 359: 1225-1237. doi: 10.1056/NEJMoa0804593.
  584. Mant J, McManus RJ, Roalfe A, Fletcher K, Taylor CJ, Martin U, Virdee S, Greenfield S, Hobbs FD. Dif- ferent systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke–Blood Pressure) randomised controlled trial. BMJ. 2016; 352: i708. doi: 10.1136/bmj.i708
  585. Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, Eguchi K, Kamiyama K, Minematsu K, Ueda S, et al; Recurrent Stroke Prevention Clinical Outcome Study Group. Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 2019; 76: 1309-1318. doi: 10.1001/jamaneurol.2019.2167.
  586. Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, et al; PODCAST Trial Investigators. Intensive versus guideline blood pressure and lipid lowering in patients with pre- vious stroke: main results from the pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) randomised controlled trial. PLoS One. 2017; 12:e0164608. doi: 10.1371/journal.pone.0164608
  587. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, et al; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008; 359: 1225-1237. doi: 10.1056/NEJMoa0804593
  588. Mant J, McManus RJ, Roalfe A, Fletcher K, Taylor CJ, Martin U, Virdee S, Greenfield S, Hobbs FD. Dif- ferent systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke–Blood Pressure) randomised controlled trial. BMJ. 2016; 352: i708. doi: 10.1136/bmj.i708
  589. Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020; 382(1): 9. doi: 10.1056/ NEJMoa1910355.
  590. Cholesterol Treatment Trialists Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Efficacy and safety of more intensive lowering of LDL choles- terol: a metaanalysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 16701681.
  591. Cholesterol Treatment Trialists Collaboration, Fulcher J, O’Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, Colhoun H, Braunwald E, La Rosa J, Pedersen TR, Tonkin A, Davis B, Sleight P, Franzosi MG, Baigent C, Keech A. Efficacy and safety of LDL-lowering therapy among men and women: meta- analysis of individual data from 174,000 participants in 27 randomised trials. Lancet2 015; 385: 13971405.
  592. Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020; 382(1): 9. doi: 10.1056/ NEJMoa1910355
  593. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015; 372: 23872397.
  594. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, et al; FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017; 376: 1713–1722. doi: 10.1056/NEJMoa1615664.
  595. Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, et al; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018; 379: 2097.2107. doi: 10.1056/NEJMoa1801174.
  596. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, et al; IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015; 372: 2387.2397. doi: 10.1056/NEJMoa1410489
  597. Cholesterol Treatment Trialists Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Efficacy and safety of more intensive lowering of LDL choles- terol: a metaanalysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 16701681.
  598. Weng TC, Yang YH, Lin SJ, Tai SH. A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther. 2010 Apr; 35(2): 139-51. doi: 10.1111/j.1365-2710.2009.01085.x. PMID: 20456733.
  599. Vallejo-Vaz AJ, Fayyad R, Boekholdt SM, Hovingh GK, Kastelein JJ, Melamed S, Barter P, Waters DD, Ray KK. Triglyceride-rich lipoprotein cholesterol and risk of cardiovascular events among patients receiving statin therapy in the TNT trial.Circulation 2018; 138: 770781
  600. Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016; 388: 2532-61.
  601. Group HPSC. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascu- lar and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007; 45: 645-54; discussion 53-4.
  602. Weng TC, Yang YH, Lin SJ, Tai SH. A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther. 2010 Apr; 35(2): 139-51. doi: 10.1111/j.1365-2710.2009.01085.x. PMID: 20456733
  603. Yang Z, Edwards D, Massou E, Saunders CL, Brayne C, Mant J. Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study. Clin Epidemiol. 2019 Jun 28; 11: 495-508. doi: 10.2147/CLEP.S201983.
  604. Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. J Am Heart Assoc. 2018 May 8; 7(10): e008546. doi: 10.1161/JAHA.118.008546.
  605. Statins After Ischemic Stroke in the Oldest. A Cohort Study Using the Clinical Practice Research Datalink Database. Geert J. Lefeber, Wilma Knol, Patrick C. Souverein, Marcel L. Bouvy, Anthonius de Boer and Huiberdina L. Koek Stroke. 2021; 52: 1244–1252 10.1161/STROKEAHA.120.030755
  606. Bohula EA, Wiviott SD, Giugliano RP, Blazing MA, Park JG, Murphy SA, White JA, Mach F, Van de Werf F, Dalby AJ, et al. Prevention of stroke with the addition of ezetimibe to statin therapy in patients with acute coronary syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation.2017; 136: 2440-2450. doi: 10.1161/CIRCULATIONAHA.117.029095.
  607. Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020; 382(1): 9. doi: 10.1056/ NEJMoa1910355
  608. Nissen SE, Stroes E, Dent-Acosta RE, Rosenson RS, Lehman SJ, Sattar N, Preiss D, Bruckert E, Ceska R, Lepor N, Ballantyne CM, Gouni-Berthold I, Elliott M, Brennan DM, Wasserman SM, Somaratne R, Scott R, Stein EA; Gauss-3 Investigators. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intoler- ance: the GAUSS-3 randomized clinical trial. JAMA 2016; 315: 15801590.
  609. Schreml J, Gouni-Berthold I. Role of anti-PCSK9 antibodies in the treatment of patients with statin intoler- ance.Curr Med Chem 2018; 25: 15381548.
  610. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, et al; FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017; 376: 1713-1722. doi: 10.1056/NEJMoa1615664
  611. Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, et al; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018; 379: 2097-2107. doi: 10.1056/NEJMoa1801174].
  612. Toth PP, Worthy G, Gandra SR, Sattar N, Bray S, Cheng LI, Bridges I, Worth GM, Dent R, Forbes CA, Deshpande S, Ross J, Kleijnen J, Stroes ESG. Systematic Review and Network Meta-Analysis on the Efficacy of Evo- locumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia. J Am Heart Assoc. 2017 Oct 2; 6(10): e005367.
  613. Benner JS, Tierce JC, Ballantyne CM, Prasad C, Bullano MF, Willey VJ, Erbey J, Sugano DS. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoeconomics. 2004; 22(suppl 3): 13-23. doi: 10.2165/00019053-200422003-00003
  614. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, d’Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investi- gators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 18491861.
  615. Aim-High Investigators, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.N Engl J Med 2011; 365: 22552267.
  616. Group HTC, Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014; 371: 203212.
  617. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12; 317(20): 1237-45. doi: 10.1056/NEJM198711123172001. PMID: 3313041
  618. Lipids and lipoproteins in symptomatic coronary heart disease. Distribution, intercorrelations, and signifi- cance for risk classification in 6,700 men and 1,500 women. The Bezafibrate Infarction Prevention (BIP) Study Group, Israel. Circulation1992; 86: 839848.
  619. De Schryver, EL, Algra, A, Kappelle, LJ, van Gijn, J, Koudstaal, PJ. Vitamin K antagonists versus antiplate- let therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin. Cochrane Database Syst Rev. 2012; 2012: CD001342. doi: 10.1002/14651858.CD001342.pub3;
  620. Mohr, JP, Thompson, JL, Lazar, RM, Levin, B, Sacco, RL, Furie, KL, Kistler, JP, Albers, GW, Pettigrew, LC, Adams, HP, Jr. et al; Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001; 345: 1444–1451. doi: 10.1056/NEJMoa011258
  621. Diener, HC, Cunha, L, Forbes, C, Sivenius, J, Smets, P, Lowenthal, A. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996; 143: 1–13. doi: 10.1016/s0022-510x(96)00308-5;
  622. ESPRIT Study Group; Halkes, PH, van Gijn, J, Kappelle, LJ, Koudstaal, PJ, Algra, A. Aspirin plus dipyr- idamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006; 367: 1665-1673. doi: 10.1016/S0140-6736(06)68734-5;
  623. Kwok, CS, Shoamanesh, A, Copley, HC, Myint, PK, Loke, YK, Benavente, OR. Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials. Stroke. 2015; 46: 1014- 1023. doi: 10.1161/STROKEAHA.114.008422;
  624. Sacco, RL, Diener, HC, Yusuf, S, Cotton, D, Ounpuu, S, Lawton, WA, Palesch, Y, Martin, RH, Albers, GW, Bath, P, et al; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008; 359: 1238-1251. doi: 10.1056/NEJMoa0805002
  625. SPS3 Investigators; Benavente, OR, Hart, RG, McClure, LA, Szychowski, JM, Coffey, CS, Pearce, LA. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012; 367: 817-825. doi: 10.1056/NEJMoa1204133.
  626. Johnston, SC, Easton, JD, Farrant, M, Barsan, W, Conwit, RA, Elm, JJ, Kim, AS, Lindblad, AS, Palesch, YY; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018; 379: 215-225. doi: 10.1056/NEJMoa1800410.
  627. Wang, Y, Wang, Y, Zhao, X, Liu, L, Wang, D, Wang, C, Wang, C, Li, H, Meng, X, Cui, L, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013; 369: 11-19. doi: 10.1056/NEJMoa1215340.
  628. Naqvi, IA, Kamal, AK, Rehman, H. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2020; 8: CD009716. doi: 10.1002/14651858.CD009716.pub2
  629. Diener, HC, Bogousslavsky, J, Brass, LM, Cimminiello, C, Csiba, L, Kaste, M, Leys, D, Matias-Guiu, J, Rupprecht, HJ; MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004; 364: 331-337. doi: 10.1016/S0140-6736(04)16721-4
  630. SPS3 Investigators; Benavente, OR, Hart, RG, McClure, LA, Szychowski, JM, Coffey, CS, Pearce, LA. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012; 367: 817-825. doi: 10.1056/NEJMoa1204133
  631. Bath, PM, Woodhouse, LJ, Appleton, JP, Beridze, M, Christensen, H, Dineen, RA, Duley, L, England, TJ, Flaherty, K, Havard, D, et al; TARDIS Investigators. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole ver- sus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open- label, phase 3 superiority trial. Lancet. 2018; 391: 850-859. doi: 10.1016/S0140-6736(17)32849-0
  632. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, et al; Warfarin- Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005; 352: 1305-1316. doi: 10.1056/NEJMoa043033
  633. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial steno- sis. N Engl J Med. 2011; 365: 993-1003. doi: 10.1056/NEJMoa1105335
  634. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial steno- sis. N Engl J Med. 2011; 365: 993-1003. doi: 10.1056/NEJMoa1105335
  635. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, Frankel M, Chimowitz MI; WASID Study Group. Risk factor status and vas- cular events in patients with symptomatic intracranial stenosis. Neurology. 2007; 69: 2063-2068. doi: 10.1212/01.wnl.0000279338.18776.26.
  636. Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, Zou X, Pan Y, Wang A, Meng X, et al; CHANCE Inves- tigators. Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology. 2015; 85: 1154–1162. doi: 10.1212/WNL.0000000000001972.
  637. Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, Han Z, Tan KS, Ratanakorn D, Chollate P, et al; CLAIR Study Investigators. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a ran- domised, open-label, blinded-endpoint trial. Lancet Neurol. 2010; 9: 489-497. doi: 10.1016/S1474-4422(10)70060-0.
  638. Turan TN, Nizam A, Lynn MJ, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Harrell J, Derdeyn CP, Fiorella D, et al. Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017; 88: 379-385. doi: 10.1212/WNL.0000000000003534.
  639. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M; Warfarin- Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patients with intracra- nial arterial stenosis. Circulation. 2007; 115: 2969-2975. doi: 10.1161/CIRCULATIONAHA.106.622464.
  640. Yu DD, Pu YH, Pan YS, Zou XY, Soo Y, Leung T, Liu LP, Wang DZ, Wong KS, Wang YL, et al; Chinese Intracranial Atherosclerosis (CICAS) Study Group. High blood pressure increases the risk of poor outcome at dis- charge and 12-month follow-up in patients with symptomatic intracranial large artery stenosis and occlusions: subgroup analysis of the CICAS Study. CNS Neurosci Ther. 2015; 21: 530-535. doi: 10.1111/cns.12400.
  641. Park JM, Kim BJ, Kwon SU, Hwang YH, Heo SH, Rha JH, Lee J, Park MS, Kim JT, Song HJ, et al. Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis: a result of randomized trial. J Hypertens. 2018; 36: 1936-1941. doi: 10.1097/HJH.0000000000001784
  642. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, et al; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014; 383: 333-341. doi: 10.1016/S0140- 6736(13)62038-3.
  643. Lutsep HL, Lynn MJ, Cotsonis GA, Derdeyn CP, Turan TN, Fiorella D, Janis LS, Lane BF, Montgomery J, Chimowitz MI; SAMMPRIS Investigators. Does the stenting versus aggressive medical therapy trial support stenting for subgroups with intracranial stenosis? Stroke. 2015; 46: 3282-3284. doi: 10.1161/STROKEAHA.115.009846.
  644. Wabnitz AM, Derdeyn CP, Fiorella DJ, Lynn MJ, Cotsonis GA, Liebeskind DS, Waters MF, Lutsep H, Lopez-Cancio E, Turan TN, et al; SAMMPRIS Investigators. Hemodynamic markers in the anterior circulation as predic- tors of recurrent stroke in patients with intracranial stenosis [published online December 11, 2018]. Stroke. doi: 10.1161/STROKEAHA.118.020840. https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.020840? url_ver=Z39.88-2003&rfr_id=ori:rid: cross- ref.org&rfr_dat=cr_pub%20%200pubmed.
  645. EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. results of an international randomized trial. N Engl J Med. 1985;313:1191–1200. doi: 10.1056/ NEJM198511073131904
  646. Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, et al; Treat Stroke to Target Investigators. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020;382:9. doi: 10.1056/NEJMoa1910355.
  647. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists Collab- oration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915–924. doi: 10.1016/S0140-6736(04)15785-1
  648. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ; Ca- rotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised controlled trials of endarter- ectomy for symptomatic carotid stenosis. Lancet. 2003;361:107–116. doi: 10.1016/s0140-6736(03)12228-3
  649. Powers WJ, Clarke WR, Grubb RL Jr, Videen TO, Adams HP Jr, Derdeyn CP; COSS Investigators. Extra- cranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA. 2011;306:1983–1992. doi: 10.1001/jama.2011.1610.
  650. Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, et al; Treat Stroke to Target Investigators. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020;382:9. doi: 10.1056/NEJMoa1910355.
  651. Markus HS, Harshfield EL, Compter A, Kuker W, Kappelle LJ, Clifton A, van der Worp HB, Rothwell P, Algra A; Vertebral Stenosis Trialists' Collaboration. Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. Lancet Neurol. 2019 Jul;18(7):666-673.
  652. Eikelboom J. W., Connolly S. J., Bosch J. et al.; COMPASS Investigators. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017;377 (14):1319–1330.
  653. Eikelboom J. W., Connolly S. J., Bosch J. et al.; COMPASS Investigators. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017;377 (14):1319–1330.
  654. Sharma M, Hart RG, Connolly SJ, Bosch J, Shestakovska O, Ng KKH, Catanese L, Keltai K, Aboyans V, Alings M, Ha JW, Varigos J, Tonkin A, O'Donnell M, Bhatt DL, Fox K, Maggioni A, Berkowitz SD, Bruns NC, Yusuf S, Eikelboom JW. Stroke Outcomes in the COMPASS Trial. Circulation. 2019 Feb 26;139(9):1134-1145.
  655. Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease. Heart 2021;107:1130–1137
  656. Aboyans V, Bauersachs R, Mazzolai L, Brodmann M, Palomares JFR, Debus S, Collet JP, Drexel H, Espi- nola-Klein C, Lewis BS, Roffi M, Sibbing D, Sillesen H, Stabile E, Schlager O, De Carlo M. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. Eur Heart J. 2021 Oct 14;42(39):4013-4024. doi: 10.1093/eurheartj/ehab390
  657. Eikelboom J. W., Connolly S. J., Bosch J. et al.; COMPASS Investigators. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017;377 (14):1319–1330
  658. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010; 137: 263-272. doi: 10.1378/chest.09-1584.
  659. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P. Selecting patients with atrial fibrillation for antico- agulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110:2287–2292. doi: 10.1161/01.CIR.0000145172.55640.93.
  660. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classifi- cation schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864– 2870. doi: 10.1001/jama.285.22.2864
  661. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation study: final results. Circulation. 1991;84:527–39.
  662. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137:263–272. doi: 10.1378/chest.09-1584.
  663. Mason PK, Lake DE, DiMarco JP, Ferguson JD, Mangrum JM, Bilchick K, Moorman LP, Moorman JR. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrilla- tion. Am J Med. 2012; 125: 603.e1–603.e6. doi: 10.1016/j.amjmed.2011.09.030.
  664. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost. 2012;107:1172–1179. doi: 10.1160/TH12-03-0175.
  665. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrilla- tion. N Engl J Med. 2009;361:1139–1151. doi: 10.1056/NEJMoa0905561.
  666. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–891. doi: 10.1056/NEJMoa1009638.
  667. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrilla- tion. N Engl J Med. 2011;365:981–992. doi: 10.1056/NEJMoa1107039.
  668. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093–2104. doi: 10.1056/NEJMoa1310907
  669. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, et al; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120–129. doi: 10.1056/NEJMoa1105575
  670. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrilla- tion. N Engl J Med. 2009;361:1139–1151. doi: 10.1056/NEJMoa0905561.
  671. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–891. doi: 10.1056/NEJMoa1009638.
  672. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrilla- tion. N Engl J Med. 2011;365:981–992. doi: 10.1056/NEJMoa1107039.
  673. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093–2104. doi: 10.1056/NEJMoa1310907
  674. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, et al; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120–129. doi: 10.1056/NEJMoa1105575
  675. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955–962. doi: 10.1016/S0140- 6736(13)62343-0
  676. Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST, Fischer U, Norrving B. Timing of anticoagulation after re- cent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol. 2019;18:117– 126. doi: 10.1016/S1474-4422(18)30356-9.
  677. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V, Micheli S, Bertolani L, Venti M, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke. 2008;39:2249–2256. doi: 10.1161/STROKEAHA.107.510321.
  678. Ahmed N, Steiner T, Caso V, Wahlgren N; ESO-KSU Session Participants. Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13-15 November 2016. Eur Stroke J. 2017;2:95–102. doi: 10.1177/2396987317699144.
  679. Калинин МН, Хасанова ДР, Ибатуллин ММ. Возможные сроки начала антикоагулянтной терапии у больных с ишемическим инсультом и фибрилляцией предсердий: последующий анализ индекса геморрагической трансформации (Hemorrhagic Transformation Index). Неврология, нейропсихиатрия, психосоматика. 2019;11(2):12- 21.
  680. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V, Micheli S, Bertolani L, Venti M, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke. 2008;39:2249–2256. doi: 10.1161/STROKEAHA.107.510321
  681. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Georg Haeusler K, Oldgren J, Reinecke H, Roldan-Schilling V, et al; ESC Scientific Document Group. The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral an- ticoagulants in patients with atrial fibrillation: executive summary. Europace. 2018; 20: 1231–1242. doi: 10.1093/europace/euy054
  682. Ahmed N, Steiner T, Caso V, Wahlgren N; ESO-KSU Session Participants. Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13-15 November 2016. Eur Stroke J. 2017;2:95–102. doi: 10.1177/2396987317699144
  683. Muscari A, Faccioli L, Lega MV, Lorusso A, Masetti M, Pastore Trossello M, Puddu GM, Spinardi L, Zoli M. Predicting hemorrhagic transformation and its timing from maximum cerebral lesion diameter in nonlacunar ischemic strokes. Brain Behav. 2020;10:e01497. doi: 10.1002/brb3.1497
  684. Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST, Fischer U, Norrving B. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol. 2019 Jan;18(1):117- 126. Doi: 10.1016/S1474-4422(18)30356-9.
  685. Hans-Christoph Diener, James Aisenberg, Jack Ansell, Dan Atar, Günter Breithardt, John Eikelboom, Mi- chael D. Ezekowitz, Christopher B. Granger, Jonathan L. Halperin, Stefan H. Hohnloser, Elaine M. Hylek, Paulus Kirch- hof, Deirdre A. Lane, Freek W.A. Verheugt, Roland Veltkamp, Gregory Y.H. Lip, Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2, European Heart Journal, Volume 38, Issue 12, 21 March 2017, Pages 860–868
  686. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997 Jun 7;349(9066):1641-9.
  687. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997 May 31;349(9065):1569-81.
  688. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, et al.. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial.On behalf of the CAST and IST collaborative groups. Stroke. 2000; 31:1240–1249.
  689. Dans AL, Connolly SJ, Wallentin L et al. Concomitant use of antiplatelet therapy with dabigatran or warfa- rin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation. 2013;127:634–640. 823. Flaker GC, Gruber M, Connolly SJ et al. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Am Heart J. 2006; 152: 967–973.
  690. SPAF I-III = Hart RG, Pearce LA, McBride R, et al “Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators” Stroke 1999 Jun; 30(6): 1223-9.
  691. AFASAK 2 = A.L.Gullov, MD, B.G.Koefoed,MD, P.Petersen, DMSc et al “Fixed minidose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation” Arch Intern Med 1998;158:1513-1521 RE-LY (sub-analysis) DOI: 10.1161/CIRCULATIONAHA.112.115386;
  692. Olesen JB, Lip GY, Lindhardsen J, et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.Thromb Haemost. 2011; 106(4): 739–749. doi:10.1160/TH11-05-0364
  693. Kleindorfer et al 2021 Guideline for the Secondary Prevention of Ischemic Stroke. Stroke. 2021;52:00–00. DOI: 10.1161/STR.0000000000000375
  694. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long- term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12. doi: 10.1016/j.jacc.2014.04.029.
  695. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–542. doi: 10.1016/S0140-6736(09)61343- X.
  696. Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, Horton RP, Buchbinder M, Neuzil P, Gordon NT, et al; PREVAIL and PROTECT AF Investigators. 5-Year outcomes after left atrial appendage closure: from the PRE- VAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70:2964– 2975. doi: 10.1016/j.jacc.2017.10.021.
  697. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, et al; PROTECT AF Steering Committee and Investigators. Percutaneous left atrial appendage closure vs war- farin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312:1988– 1998. doi: 10.1001/jama.2014.15192
  698. Hart RG, Coull BM, Hart D. Early recurrent embolism associated with non- valvular atrial fibrillation: a retrospective study. Stroke. 1983;14:688–693. doi: 10.1161/01.str.14.5.688.
  699. Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST, Fischer U, Norrving B. Timing of anticoagulation after re- cent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol. 2019;18:117– 126. doi: 10.1016/S1474-4422(18)30356-9.
  700. Hans-Christoph Diener, James Aisenberg, Jack Ansell, Dan Atar, Günter Breithardt, John Eikelboom, Mi- chael D. Ezekowitz, Christopher B. Granger, Jonathan L. Halperin, Stefan H. Hohnloser, Elaine M. Hylek, Paulus Kirch- hof, Deirdre A. Lane, Freek W.A. Verheugt, Roland Veltkamp, Gregory Y.H. Lip, Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2, European Heart Journal 2017; 38(12): 860-868.
  701. Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, et al. Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States. Circulation. 2018;138:1519–1529. doi: 10.1161/CIRCULATIONAHA.118.035418
  702. Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M. Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a system- atic review and meta- analysis. J Am Heart Assoc. 2017;6:e005835. doi: 10.1161/JAHA.117.005835.
  703. Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M, Pais P, Erol C, Diaz R, Bahit MC, et al. Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Circula- tion. 2015;132:624–632. doi: 10.1161/CIRCULATIONAHA.114.014807.
  704. Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, et al; ROCKET AF Steering Committee & Investigators. Clinical characteristics and out- comes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. Eur Heart J. 2014; 35: 3377–3385. doi: 10.1093/eurheartj/ehu305.
  705. Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Zumalde J, Salvador A, Mataix L; NASPEAF Investigators. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonval- vular atrial fibrillation: a randomized multicenter study. J Am Coll Cardiol. 2004;44:1557–1566. doi: 10.1016/j.jacc.2004.05.084.
  706. Ezekowitz MD, Nagarakanti R, Noack H, Brueckmann M, Litherland C, Jacobs M, Clemens A, Reilly PA, Connolly SJ, Yusuf S, et al. Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long- Term Anticoagulant Therapy). Circulation. 2016; 134: 589– 598. doi: 10.1161/CIRCULATIONAHA.115.020950.
  707. Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, et al; RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206–1214. doi: 10.1056/NEJMoa1300615
  708. Hering D, Piper C, Bergemann R, Hillenbach C, Dahm M, Huth C, Horstkotte D. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Inten- sity Anticoagulation study. Chest. 2005; 127: 53–59. doi: 10.1378/chest.127.1.53
  709. Massel DR, Little SH. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev. 2013: CD003464. doi: 10.1002/14651858.CD003464.pub2
  710. Rodriguez CJ, Bartz TM, Longstreth WT Jr, Kizer JR, Barasch E, Lloyd-Jones DM, Gottdiener JS. Associ- ation of annular calcification and aortic valve sclerosis with brain findings on magnetic resonance imaging in community dwelling older adults: the Cardiovascular Health Study. J Am Coll Cardiol. 2011;57:2172–2180. doi: 10.1016/j.jacc.2011.01.034.
  711. Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, Best LG, Resnick HE, Roman MJ, Devereux RB. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascu- lar disease: the Strong Heart Study. Stroke. 2005;36:2533–2537. doi: 10.1161/01.STR.0000190005.09442.ad.
  712. Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ. Echocardiographically docu- mented mitral-valve prolapse: long-term follow-up of 237 patients. N Engl J Med. 1985;313:1305–1309. doi: 10.1056/NEJM198511213132101.
  713. Hayek E, Griffin B. Mitral valve prolapse: old beliefs yield to new knowledge. Cleve Clin J Med. 2002;69:889–896. doi: 10.3949/ccjm.69.11.889 483.
  714. Zuppiroli A, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitral valve prolapse. Am J Cardiol. 1995;75:1028–1032. doi: 10.1016/s0002-9149(99)80718-8
  715. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2021;143:e229]. Circulation. 2021; 143: e72–e227. doi: 10.1161/CIR.0000000000000923.
  716. Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015; 373: 2015– 2024. doi: 10.1056/NEJMoa1509233.
  717. Sundt TM, Zehr KJ, Dearani JA, Daly RC, Mullany CJ, McGregor CG, Puga FJ, Orszulak TA, Schaff HV. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg. 2005; 129: 1024–1031. doi: 10.1016/j.jtcvs.2004.11.028
  718. Russo A, Grigioni F, Avierinos JF, Freeman WK, Suri R, Michelena H, Brown R, Sundt TM, Enriquez- Sarano M. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clin- ical implications. J Am Coll Cardiol. 2008;51:1203–1211. doi: 10.1016/j.jacc.2007.10.058.
  719. Colli A, Mestres CA, Castella M, Gherli T. Comparing warfarin to aspirin (WoA) after aortic valve replace- ment with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial. J Heart Valve Dis. 2007;16:667–671.
  720. Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25:1111– 1119. doi: 10.1016/0735-1097(94)00563-6.
  721. Nuñez L, Gil Aguado M, Larrea JL, Celemín D, Oliver J. Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis. Ann Thorac Surg. 1984;37:84–87. doi: 10.1016/s0003- 4975(10)60717-5
  722. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2021;143:e229]. Circulation. 2021; 143: e72–e227. doi: 10.1161/CIR.0000000000000923
  723. Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015; 373: 2015– 2024. doi: 10.1056/NEJMoa1509233.
  724. Sundt TM, Zehr KJ, Dearani JA, Daly RC, Mullany CJ, McGregor CG, Puga FJ, Orszulak TA, Schaff HV. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg. 2005; 129: 1024–1031. doi: 10.1016/j.jtcvs.2004.11.028.
  725. Russo A, Grigioni F, Avierinos JF, Freeman WK, Suri R, Michelena H, Brown R, Sundt TM, Enriquez- Sarano M. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clin- ical implications. J Am Coll Cardiol. 2008; 51: 1203–1211. doi: 10.1016/j.jacc.2007.10.058
  726. Colli A, Mestres CA, Castella M, Gherli T. Comparing warfarin to aspirin (WoA) after aortic valve replace- ment with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial. J Heart Valve Dis. 2007; 16: 667–671.
  727. Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25:1111– 1119. doi: 10.1016/0735-1097(94)00563-6.
  728. Nuñez L, Gil Aguado M, Larrea JL, Celemín D, Oliver J. Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis. Ann Thorac Surg. 1984;37:84–87. doi: 10.1016/s0003- 4975(10)60717-5
  729. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745–1755. doi: 10.1016/S0022-5223(95)70038-2.
  730. Barsic B, Dickerman S, Krajinovic V, Pappas P, Altclas J, Carosi G, Casabé JH, Chu VH, Delahaye F, Edathodu J, et al; International Collaboration on Endocarditis–Prospective Cohort Study Investigators. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis. 2013;56:209–217. doi: 10.1093/cid/cis878
  731. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2021;143:e229]. Circulation. 2021; 143: e72–e227. doi: 10.1161/CIR.0000000000000923
  732. García-Cabrera E, Fernández-Hidalgo N, Almirante B, Ivanova-Georgieva R, Noureddine M, Plata A, Lo- mas JM, Gálvez-Acebal J, Hidalgo-Tenorio C, Ruíz-Morales J, et al; Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases; Spanish Network for Research in Infectious Diseases. Neurological complications of infective endo- carditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013; 127: 2272–2284. doi: 10.1161/CIRCULATIONAHA.112.000813
  733. Pöss, J, Desch, S, Eitel, C, de Waha, S, Thiele, H, Eitel, I. Left ventricular thrombus formation after ST- segment-elevation myocardial infarction: insights from a cardiac magnetic resonance multicenter study. Circ Cardiovasc Imaging. 2015; 8: e003417. doi: 10.1161/CIRCIMAGING.115.003417;
  734. Vaitkus, PT, Barnathan, ES. Embolic potential, prevention and management of mural thrombus complicat- ing anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol. 1993;22:1004–1009. doi: 10.1016/0735- 1097(93)90409-t;
  735. Velangi, PS, Choo, C, Chen, KA, Kazmirczak, F, Nijjar, PS, Farzaneh-Far, A, Okasha, O, Akçakaya, M, Weinsaft, JW, Shenoy, C. Long-term embolic outcomes after detection of left ventricular thrombus by late gadolinium enhancement cardiovascular magnetic resonance imaging: a matched cohort study. Circ Cardiovasc Imaging. 2019;12:e009723. doi: 10.1161/CIRCIMAGING.119.009723
  736. Fleddermann, AM, Hayes, CH, Magalski, A, Main, ML. Efficacy of direct acting oral anticoagulants in treatment of left ventricular thrombus. Am J Cardiol. 2019;124:367–372. doi: 10.1016/j.amjcard.2019.05.009.
  737. Al-Abcha A, Herzallah K, Saleh Y, Mujer M, Abdelkarim O, Abdelnabi M, Almaghraby A, Abela GS. The Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi: A Meta- Analysis and Systematic Review. Am J Cardiovasc Drugs. 2021 Jul;21(4):435-441.
  738. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24. Erratum in: Stroke. 2021 Jul;52(7):e483-e484. PMID: 34024117.
  739. Lee JM, Park JJ, Jung HW, Cho YS, Oh IY, Yoon CH, Suh JW, Chun EJ, Choi SI, Youn TJ, et al. Left ventricular thrombus and subsequent thromboembolism, comparison of anticoagulation, surgical removal, and antiplatelet agents. J Atheroscler Thromb. 2013;20:73–93. doi: 10.5551/jat.13540.
  740. Johannessen KA, Nordrehaug JE, von der Lippe G. Left ventricular thrombi after short-term high-dose an- ticoagulants in acute myocardial infarction. Eur Heart J. 1987;8:975–980. doi: 10.1093/oxfordjournals.eurheartj.a062374
  741. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24. Erratum in: Stroke. 2021 Jul;52(7):e483-e484. PMID: 34024117.
  742. Amarenco P, Davis S, Jones EF, Cohen AA, Heiss WD, Kaste M, Laouénan C, Young D, Macleod M, Donnan GA; Aortic Arch Related Cerebral Hazard Trial Investigators. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke. 2014;45:1248–1257. doi: 10.1161/STROKEAHA.113.004251.
  743. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rup- precht HJ; MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–337. doi: 10.1016/S0140-6736(04)16721-4.
  744. Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379:215–225. doi: 10.1056/NEJMoa1800410
  745. Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, et al; Treat Stroke to Target Investigators. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020;382:9. doi: 10.1056/NEJMoa1910355
  746. Deng X, Gao F, Zhang D, Zhang Y, Wang R, Wang S, Cao Y, Zhao Y, Pan Y, Liu X, et al. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis. J Neurosurg. 2018;128:1785–1791. doi: 10.3171/2017.2.JNS162405.
  747. Deng X, Gao F, Zhang D, Zhang Y, Wang R, Wang S, Cao Y, Zhao Y, Pan Y, Ye X, et al. Effects of different surgical modalities on the clinical outome of patients with moyamoya disease: a prospective cohort study. J Neu- rosurg. 2018; 128: 1327–1337. doi: 10.3171/2016.12.JNS162626.
  748. Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW. Meta-analysis of the surgical outcomes of sympto- matic moyamoya disease in adults. J Neurosurg. 2018;128:793–799. doi: 10.3171/2016.11.JNS161688.
  749. Li Q, Gao Y, Xin W, Zhou Z, Rong H, Qin Y, Li K, Zhou Y, Wang J, Xiong J, et al. Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease. World Neurosurg. 2019;127:354–361. doi: 10.1016/j.wneu.2019.04.062.
  750. Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P, Wanebo JE, Spetzler RF. Perioperative complications and long-term outcomes after bypasses in adults with moyamoya disease: a systematic review and meta- analysis. World Neurosurg. 2016;92:179–188. doi: 10.1016/j.wneu.2016.04.083.
  751. Kim H, Jang DK, Han YM, Sung JH, Park IS, Lee KS, Yang JH, Huh PW, Park YS, Kim DS, et al. Direct bypass versus indirect bypass in adult moy- amoya angiopathy with symptoms or hemodynamic instability: a meta- analysis of comparative studies. World Neurosurg. 2016;94:273–284. doi: 10.1016/j.wneu.2016.07.009.
  752. Jang DK, Lee KS, Rha HK, Huh PW, Yang JH, Park IS, Ahn JG, Sung JH, Han YM. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. J Neurosurg. 2017;127:492–502. doi: 10.3171/2016.8.JNS152875
  753. Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW. Meta-analysis of the surgical outcomes of sympto- matic moyamoya disease in adults. J Neurosurg. 2018;128:793–799. doi: 10.3171/2016.11.JNS161688.
  754. Li Q, Gao Y, Xin W, Zhou Z, Rong H, Qin Y, Li K, Zhou Y, Wang J, Xiong J, et al. Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease. World Neurosurg. 2019;127:354–361. doi: 10.1016/j.wneu.2019.04.062
  755. Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, Jüni P, Mattle HP, et al. Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J Am Coll Cardiol. 2016;67:907–917. doi: 10.1016/j. jacc.2015.12.023.
  756. Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, Song JM, Kang DH, Kwon SU, Kang DW, et al. Cryp- togenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol. 2018;71:2335–2342. doi: 10.1016/j.jacc.2018.02.046.
  757. Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, et al; CLOSE Investigators. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377:1011–1021. doi: 10.1056/NEJMoa1705915.
  758. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017; 377: 1022–1032. doi: 10.1056/NEJMoa1610057.
  759. Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, et al; Gore REDUCE Clinical Study Investigators. Patent foramen ovale closure or an- tiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377:1033–1042. doi: 10.1056/NEJMoa1707404.
  760. Turc G, Lee JY, Brochet E, Kim JS, Song JK, Mas JL; CLOSE and DEFENSE-PFO Trial Investigators. Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale. J Am Coll Cardiol. 2020;75:2312–2320. doi: 10.1016/j.jacc.2020.02.068
  761. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81:619–625
  762. Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, et al; CLOSE Investigators. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377:1011–1021. doi: 10.1056/NEJMoa1705915.
  763. Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS Investigators. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16. PMID: 29766772.
  764. Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev. 2002;(4):CD002005.
  765. Miranda B, Ferro JM, Canhгo P, Stam J, Bousser MG, Barinagarrementeria F, Scoditti U; ISCVT Investi- gators. Venous thromboembolic events after cerebral vein thrombosis. Stroke. 2010;41:1901–1906.
  766. Ferro JM. et al. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA Neurol. Published online September 03, 2019. doi:10.1001/jamaneurol.2019.2764.
  767. Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, di Minno M, Maino A, Martinelli I, Masuhr F, de Sousa DA, Stam J; European Stroke Organization. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J. 2017 Sep;2(3):195-221. doi: 10.1177/2396987317719364. Epub 2017 Jul 21. PMID: 31008314; PMCID: PMC6454824.
  768. Ferro JM. et al. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA Neurol. Published online September 03, 2019. doi:10.1001/jamaneurol.2019.2764
  769. Markus HS, Hayter E, Levi C, Feldman A, Venables G, Norris J. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14:361–367. doi: 10.1016/S1474-4422(15)70018-9.
  770. Markus HS, Levi C, King A, Madigan J, Norris J; Cervical Artery Dissection in Stroke Study (CADISS) Investigators. Antiplatelet therapy vs anticoagulation therapy in cervical artery dissection: the Cervical Artery Dissection in Stroke Study (CADISS) randomized clinical trial final results. JAMA Neurol. 2019;76:657–664. doi: 10.1001/jamaneurol.2019.0072
  771. Redekop GJ. Extracranial carotid and vertebral artery dissection: a review. Can J Neurol Sci. 2008;35:146– 152. doi:10.1017/s0317167100008556.
  772. Moon K, Albuquerque FC, Cole T, Gross BA, McDougall CG. Stroke prevention by endovascular treatment of carotid and vertebral artery dissections. J Neurointerv Surg. 2017;9:952–957. doi: 10.1136/neurintsurg-2016-012565.
  773. Spanos K, Karathanos C, Stamoulis K, Giannoukas AD. Endovascular treatment of traumatic internal carotid artery pseudoaneurysm. Injury. 2016; 47: 307–312. doi: 10.1016/j.injury.2015.09.015
  774. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375.
  775. VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol. 2010; 9: 855–865. doi: 10.1016/S1474-4422(10)70187-3.
  776. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565–575. doi: 10.1001/jama.291.5.565
  777. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24. Erratum in: Stroke. 2021 Jul;52(7):e483-e484. PMID: 34024117.
  778. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004; 291: 565–575. doi: 10.1001/jama.291.5.565.
  779. Yap S, Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years’ experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis. 1998; 21: 738–747. doi: 10.1023/a:1005445132327.
  780. Yap S, Naughten ER, Wilcken B, Wilcken DE, Boers GH. Vascular complications of severe hyperhomo- cysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-low- ering therapy. Semin Thromb Hemost. 2000;26:335–340. doi:10.1055/s-2000-8100
  781. Chevalet P, Barrier JH, Pottier P, Magadur-Joly G, Pottier MA, Hamidou M, Planchon B, El Kouri D, Con- nan L, Dupond JL, et al. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol. 2000;27:1484–1491.
  782. Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G. The fasttrack ultrasound clinic for early di- agnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to im- prove clinical outcome in giant cell arteritis? Rheumatology (Oxford). 2016;55:66–70. doi: 10.1093/rheumatology/kev289. 917. Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 2006;54:3310–3318. doi: 10.1002/art.22163
  783. . Saraya T, Shimura C, Wada H, Aoshima M, Goto H. Evidence for vascular spread of varicella zoster- associated vasculopathy. Ann Intern Med. 2006; 144:535–537. doi: 10.7326/0003-4819-144-7-200604040-00022.
  784. Carod-Artal FJ, Gascon J. Chagas disease and stroke. Lancet Neurol. 2010;9:533–542. doi: 10.1016/S1474- 4422(10)70042-9.
  785. Lima-Costa MF, Matos DL, Ribeiro AL. Chagas disease predicts 10-year stroke mortality in community- dwelling elderly: the Bambui Cohort Study of Aging. Stroke. 2010;41:2477–2482. doi: 10.1161/ STROKEAHA.110.588061.
  786. de Sousa AS, Xavier SS, Rodriguez de Freitas GR, Hasslocher-Moreno A. Prevention strategies of cardio- embolic ischemic stroke in Chagas’ disease. Arq Bras Cardiol. 2008;91:306–310. doi: 10.1590/s0066- 782x2008001700004.
  787. Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J Neurol Sci. 2011;303:22–30. doi: 10.1016/j.jns.2010.12.015.
  788. Anderson NE, Somaratne J, Mason DF, Holland D, Thomas MG. Neurological and systemic complications of tuberculous meningitis and its treatment at Auckland City Hospital, New Zealand. J Clin Neurosci. 2010;17:1114–1118. doi: 10.1016/j.jocn.2010.01.006.
  789. Cordato DJ, Djekic S, Taneja SR, Maley M, Beran RG, Cappelen-Smith C, Griffith NC, Hanna IY, Hodgkinson SJ, Worthington JM, et al. Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005-09). J Clin Neurosci. 2013; 20: 943–947. doi: 10.1016/j.jocn.2012. 08.011.
  790. Mishra AK, Arvind VH, Muliyil D, Kuriakose CK, George AA, Karuppusami R, Benton Carey RA, Mani S, Hansdak SG. Cerebrovascular injury in cryptococcal meningitis. Int J Stroke. 2018;13:57–65. doi: 10.1177/1747493017706240
  791. Genthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, et al; International Antiviral Society-USA Panel. Antiretroviral treatment of adult HIV infection: 2014 recommenda- tions of the International Antiviral Society-USA Panel. JAMA. 2014;312:410–425. doi: 10.1001/jama.2014.8722.
  792. Connor M. Human immunodeficiency virus (HIV) and stroke: targets for intervention. Infect Disord Drug Targets. 2010;10:76–83. doi:10.2174/187152610790963483.
  793. Cutfield NJ, Steele H, Wilhelm T, Weatherall MW. Successful treatment of HIV associated cerebral vascu- lopathy with HAART. J Neurol NeurosurgPsychiatry. 2009;80:936–937. doi: 10.1136/jnnp.2008.165852.
  794. Benjamin LA, Allain TJ, Mzinganjira H, Connor MD, Smith C, Lucas S, Joekes E, Kampondeni S, Chetcuti K, Turnbull I, et al. The role of human immunodeficiency virus-associated vasculopathy in the etiology of stroke. J Infect Dis. 2017;216:545–553. doi: 10.1093/infdis/jix340
  795. Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, Wong ET, Huang JH. Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurol. 2016;16:9. doi:10.1186/s12883-015-0509-8.
  796. Patil A, Shree R, Naheed D, Goyal MK, Mehta S, Ahuja CK, Radotra BD, Lal V. Pearls & oysters: paraneoplastic cerebral vasculitis: rare cause of spontaneous convexity subarachnoid hemorrhage. Neurology. 2018; 90: e815–e817. doi: 10.1212/WNL.0000000000005025.
  797. Quinones E, Potes LI, Silva N, Lobato-Polo J. Lymphomatoid granulomatosis of the brain: a case report. Surg Neurol Int. 2016;7(suppl 23):S612–S616. doi: 10.4103/2152-7806.189732
  798. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, et al. International consensus statement on an update of the classification criteria for definite antiphospho- lipid syndrome (APS). J Thromb Haemost. 2006;4:295–306. doi: 10.1111/j.1538-7836.2006.01753.x.
  799. Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein throm- bosis: a critical review of the literature. Arthritis Care Res (Hoboken). 2013;65:1869–1873. doi: 10.1002/acr.22066
  800. Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018;132:1365–1371. doi: 10.1182/blood-2018-04-848333.
  801. . Ordi-Ros J, Sбez-Comet L, Pйrez-Conesa M, Vidal X, Riera-Mestre A, Castro-Salomу A, Cuquet-Pedrag- osa J, Ortiz-Santamaria V, Mauri-Plana M, Sola C, et al. Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial. Ann Intern Med. 2019; 171:685–694. doi: 10.7326/M19-0291.
  802. Dufrost V, Risse J, Reshetnyak T, Satybaldyeva M, Du Y, Yan XX, Salta S, Gerotziafas G, Jing ZC, Elalamy I, et al. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants: results from an international patient-level data meta-analysis. Autoimmun Rev. 2018;17:1011–1021. doi: 10.1016/j.au- trev.2018.04.009
  803. Lamy C, Hamon JB, Coste J and Mas JL. Ischemic stroke in young women: Risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy.Neurology2000; 55: 269–274.
  804. Coppage KH, Hinton AC, Moldenhauer J, Kovilam O, Barton JR and Sibai BM. Maternal and perinatal outcome in women with a history of stroke. Am J Obstet Gynecol2004; 190: 1331–1334.
  805. Crovetto F, Ossola MW, Spadaccini G, Duiella SF, Somigliana E and Fedele L. Ischemic stroke recurrence during pregnancy: A case series and a review of the literature.Arch Gynecol Obstet2012; 286: 599–604
  806. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replace- ment therapy after ischemic stroke. N Engl J Med. 2001;345:1243–1249.
  807. Caso V, Falorni A, Bushnell CD, Acciarresi M, Remohí J, Sprigg N, Gerli S. Pregnancy, Hormonal Treat- ments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke: A Consensus Document. Stroke. 2017 Feb; 48(2): 501-506. doi: 10.1161/STROKEAHA.116.013964.
  808. Cherry N, Gilmour K, Hannaford P, Heagerty A, Khan MA, Kitchener H, et al. Oestrogen therapy for pre- vention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet. 2002; 360: 2001–2008.
  809. Caso V, Falorni A, Bushnell CD, Acciarresi M, Remohí J, Sprigg N, Gerli S. Pregnancy, Hormonal Treat- ments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke: A Consensus Document. Stroke. 2017 Feb;48(2):501-506. doi: 10.1161/STROKEAHA.116.013964.
  810. Swartz RH, Ladhani NNN, Foley N, Nerenberg K, Bal S, Barrett J, Bushnell C, Chan WS, Chari R, Dow- latshahi D, Amrani ME, Gandhi S, Gubitz G, Hill MD, James A, Jeerakathil T, Jin A, Kirton A, Lanthier S, Lausman A, Leffert LR, Mandzia J, Menon B, Pikula A, Poppe A, Potts J, Ray J, Saposnik G, Sharma M, Smith EE, Bhogal S, Smitko E, Lindsay MP; Heart and Stroke Foundation Canadian Stroke Best Practice Advisory Committees. Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy. Int J Stroke. 2018 Jun;13(4):406-419. doi: 10.1177/1747493017743801.
  811. Caso V, Falorni A, Bushnell CD, Acciarresi M, Remohí J, Sprigg N, Gerli S. Pregnancy, Hormonal Treat- ments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke: A Consensus Document. Stroke. 2017 Feb;48(2):501-506. doi: 10.1161/STROKEAHA.116.013964.
  812. Caso V, Falorni A, Bushnell CD, Acciarresi M, Remohí J, Sprigg N, Gerli S. Pregnancy, Hormonal Treat- ments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke: A Consensus Document. Stroke. 2017 Feb;48(2):501-506. doi: 10.1161/STROKEAHA.116.013964. Epub 2017 Jan 9. PMID: 28070003.
  813. Swartz RH, Ladhani NNN, Foley N, Nerenberg K, Bal S, Barrett J, Bushnell C, Chan WS, Chari R, Dow- latshahi D, Amrani ME, Gandhi S, Gubitz G, Hill MD, James A, Jeerakathil T, Jin A, Kirton A, Lanthier S, Lausman A, Leffert LR, Mandzia J, Menon B, Pikula A, Poppe A, Potts J, Ray J, Saposnik G, Sharma M, Smith EE, Bhogal S, Smitko E, Lindsay MP; Heart and Stroke Foundation Canadian Stroke Best Practice Advisory Committees. Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy. Int J Stroke. 2018 Jun;13(4):406-419. doi: 10.1177/1747493017743801.
  814. Shanmugalingam R, Reza Pour N, Chuah SC, et al. Vertebral artery dissection in hypertensive disorders of pregnancy: A case series and literature review. BMC Preg Childbirth2016; 16: 164
  815. Caso V, Falorni A, Bushnell CD, Acciarresi M, Remohí J, Sprigg N, Gerli S. Pregnancy, Hormonal Treat- ments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke: A Consensus Document. Stroke. 2017 Feb;48(2):501-506. doi: 10.1161/STROKEAHA.116.013964.
  816. Swartz RH, Ladhani NNN, Foley N, Nerenberg K, Bal S, Barrett J, Bushnell C, Chan WS, Chari R, Dowlatshahi D, Amrani ME, Gandhi S, Gubitz G, Hill MD, James A, Jeerakathil T, Jin A, Kirton A, Lanthier S, Lausman A, Leffert LR, Mandzia J, Menon B, Pikula A, Poppe A, Potts J, Ray J, Saposnik G, Sharma M, Smith EE, Bhogal S, Smitko E, Lindsay MP; Heart and Stroke Foundation Canadian Stroke Best Practice Advisory Committees. Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy. Int J Stroke. 2018 Jun;13(4):406-419. doi: 10.1177/1747493017743801. Epub 2017 Nov 24. PMID: 29171360
  817. Schisterman EF, Silver RM, Lesher LL, et al. Preconception low-dose aspirin and pregnancy outcomes: Results from the EAGeR randomised trial.Lancet2014; 384: 29–36
  818. Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH and Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force.Ann Intern Med2014; 160: 695–703.
  819. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I and Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: A meta-analysis. Am J Obstet Gynecol2002; 187: 1623–1630.
  820. Norgard B, Puho E, Czeizel AE, Skriver MV and Sorensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: A populationbased case-control study. Am J Obstet Gynecol2005; 192: 922–923
  821. Visser J, Ulander VM, Helmerhorst FM, et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: A randomised multicentre trial.Thromb Haemost2011; 105: 295–301
  822. Xu Z, Fan J, Luo X, et al. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: A systematic review and meta-analysis. Can J Cardiol2016; 32: 1248.e1–e9
  823. Rodger MA, Hague WM, Kingdom J, et al. Antepartum dalteparin versus no antepartum dalteparin for the pre- vention of pregnancy complications in pregnant women with thrombophilia (TIPPS): A multinational open-label randomised trial.Lancet2014; 384: 1673–1683.
  824. Visser J, Ulander VM, Helmerhorst FM, et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: A randomised multicentre trial.Thromb Haemost2011; 105: 295–301
  825. Swartz RH, Ladhani NNN, Foley N, Nerenberg K, Bal S, Barrett J, Bushnell C, Chan WS, Chari R, Dow- latshahi D, Amrani ME, Gandhi S, Gubitz G, Hill MD, James A, Jeerakathil T, Jin A, Kirton A, Lanthier S, Lausman A, Leffert LR, Mandzia J, Menon B, Pikula A, Poppe A, Potts J, Ray J, Saposnik G, Sharma M, Smith EE, Bhogal S, Smitko E, Lindsay MP; Heart and Stroke Foundation Canadian Stroke Best Practice Advisory Committees. Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy. Int J Stroke. 2018 Jun;13(4):406-419. doi: 10.1177/1747493017743801.
  826. Chan WS, Rey E, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can2014; 36: 527–553
  827. Swartz RH, Ladhani NNN, Foley N, Nerenberg K, Bal S, Barrett J, Bushnell C, Chan WS, Chari R, Dow- latshahi D, Amrani ME, Gandhi S, Gubitz G, Hill MD, James A, Jeerakathil T, Jin A, Kirton A, Lanthier S, Lausman A, Leffert LR, Mandzia J, Menon B, Pikula A, Poppe A, Potts J, Ray J, Saposnik G, Sharma M, Smith EE, Bhogal S, Smitko E, Lindsay MP; Heart and Stroke Foundation Canadian Stroke Best Practice Advisory Committees. Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy. Int J Stroke. 2018 Jun;13(4):406-419. doi: 10.1177/1747493017743801.
  828. Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.Can J Cardiol2011; 27: S1–59.
  829. Datta P, Rewers-Felkins K, Kallem RR, Baker T and Hale TW. Transfer of low dose aspirin into human milk. J Hum Lact2017; 33: 296–299
  830. Артериальная гипертензия у взрослых: клинические рекомендации. Российский кардиологический журнал. 2020; 25(3): 3786. doi: 10.15829/1560-4071-2020-3-3786
  831. Easterling T. et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for man- agement of severe hypertension in pregnancy: an open-label, randomised controlled trial. The Lancet 2019; 394 (10203): 1011-1021.
  832. Weitz C. et al. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. International Journal of Gynecology & Obstetrics. 1987; 25 (1): 35-40.
  833. Williams B et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood pressure 2018; 27(6): 314-340.
  834. Bateman BT, Hernandez-Diaz S, Fischer MA, et al. Statins and congenital malformations: Cohort study. BMJ2015; 350: h1035.
  835. Zarek J and Koren G. The fetal safety of statins: A systematic review and meta-analysis. J Obstet Gynaecol Can 2014; 36: 506–509.
  836. Winterfeld U, Allignol A, Panchaud A, et al. Pregnancy outcome following maternal exposure to statins: A multicentre prospective study.BJOG2013; 120: 463–471
  837. Scott CA, Bewley S, Rudd A, et al. Incidence, risk factors, management, and outcomes of stroke in preg- nancy. Obstet Gynecol2012; 120: 318–324
  838. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ; Ca- rotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised controlled trials of endarter- ectomy for symptomatic carotid stenosis. Lancet. 2003;361:107–116. doi: 10.1016/s0140-6736(03)12228-3
  839. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ; Ca- rotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised controlled trials of endarter- ectomy for symptomatic carotid stenosis. Lancet. 2003;361:107–116. doi: 10.1016/s0140-6736(03)12228-3
  840. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 Jul 1;363(1):11-23. doi: 10.1056/NEJMoa0912321
  841. Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, Ferguson GG, Fox AJ, Rankin RN, Ha- chinski VC, Wiebers DO. et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453
  842. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ; Ca- rotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised controlled trials of endarter- ectomy for symptomatic carotid stenosis. Lancet. 2003;361:107–116. doi: 10.1016/s0140-6736(03)12228-3
  843. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ; Ca- rotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised controlled trials of endarter- ectomy for symptomatic carotid stenosis. Lancet. 2003;361:107–116. doi: 10.1016/s0140-6736(03)12228-3
  844. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists Collab- oration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915–924. doi: 10.1016/S0140-6736(04)15785-1
  845. De Rango P, Brown MM, Chaturvedi S, Howard VJ, Jovin T, Mazya MV, Paciaroni M, Manzone A, Far- chioni L, Caso V. Summary of Evidence on Early Carotid Intervention for Recently Symptomatic Stenosis Based on Meta- Analysis of Current Risks. Stroke. 2015 Dec;46(12):3423-36. doi: 10.1161/STROKEAHA.115.010764
  846. Rantner B, Eckstein HH, Ringleb P, Woelfle KD, Bruijnen H, Schmidauer C, Fraedrich G. American Soci- ety of Anesthesiology and Rankin as predictive parameters for the outcome of carotid endarterectomy within 28 days after an ischemic stroke. J Stroke Cerebrovasc Dis. 2006 May-Jun;15(3):114-20. doi: 10.1016/j.jstrokecerebro- vasdis.2006.03.004.
  847. Wölfle KD, Pfadenhauer K, Bruijnen H, Becker T, Engelhardt M, Wachenfeld-Wahl C, Schulze-Hamma E, Loeprecht H, Wohlgemuth WA. Early carotid endarterectomy in patients with a nondisabling ischemic stroke: results of a retrospective analysis. Vasa. 2004 Feb;33(1):30-5. doi: 10.1024/0301-1526.33.1.30
  848. Karkos CD, McMahon G, McCarthy MJ, Dennis MJ, Sayers RD, London NJ, Naylor AR. The value of urgent carotid surgery for crescendo transient ischemic attacks. J Vasc Surg. 2007 Jun;45(6):1148-54. doi: 10.1016/j.jvs.2007.02.005.
  849. Dorigo W, Pulli R, Nesi M, Alessi Innocenti A, Pratesi G, Inzitari D, Pratesi C. Urgent carotid endarterec- tomy in patients with recent/crescendo transient ischaemic attacks or acute stroke. Eur J Vasc Endovasc Surg. 2011 Mar;41(3):351-7. doi: 10.1016/j.ejvs.2010.11.026
  850. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, et al; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Pro- tected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–1501. doi: 10.1056/NEJMoa040127.
  851. Brott TG, Hobson RW, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, et al; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11–23. doi: 10.1056/NEJMoa0912321
  852. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 Oct 7;351(15):1493-501. doi: 10.1056/NEJMoa040127
  853. Massop D, Dave R, Metzger C, Bachinsky W, Solis M, Shah R, Schultz G, Schreiber T, Ashchi M, Hibbard R; SAPPHIRE Worldwide Investigators. Stenting and angioplasty with protection in patients at high-risk for endarterec- tomy: SAPPHIRE Worldwide Registry first 2,001 patients. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):129-36. doi: 10.1002/ccd.21844.
  854. Kang JL, Chung TK, Lancaster RT, Lamuraglia GM, Conrad MF, Cambria RP. Outcomes after carotid endarterectomy: is there a high-risk population? A National Surgical Quality Improvement Program report. J Vasc Surg. 2009 Feb;49(2):331-8, 339.e1; discussion 338-9. doi: 10.1016/j.jvs.2008.09.018.
  855. Bangalore S, Kumar S, Wetterslev J, Bavry AA, Gluud C, Cutlip DE, Bhatt DL. Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol. 2011 Feb;68(2):172-84. doi: 10.1001/archneurol.2010.262
  856. Langhorne P, Ramachandra S. Organised inpatient (stroke unit) care for stroke: network meta-analysis. Cochrane Database of Systematic Reviews 2020, Issue 4. Art. No.: CD000197. DOI: 10.1002/14651858.CD000197.pub4. 992. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, Starke RD, Todd HW, Viste KM, Girgus M, Shephard T, Emr M, Shwayder P, Walker MD. Recommendations for the establishment of primary stroke centers: Brain Attack Coalition. JAMA.2000; 283: 3102–3109.
  857. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, Koroshetz W, Marler JR, Booss J, Zorowitz RD, Croft JB, Magnis E, Mulligan D, Jagoda A, O’Connor R, Cawley CM, Connors JJ, Rose-DeRenzy JA, Emr M, Warren M, Walker MD; Brain Attack Coalition. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke.2005;36:1597–1616.
  858. Effectiveness of Primary and Comprehensive Stroke Centers. PERFECT Stroke: A Nationwide Observa- tional Study From Finland. Atte Meretoja, Risto O. Roine, Markku Kaste, Miika Linna, Susanna Roine, Merja Juntunen, Terttu Erilä, Matti Hillbom, Reijo Marttila, Aimo Rissanen, Juhani Sivenius, and Unto Häkkinen. Stroke. 2010;41:1102– 1107
  859. Zhai YK, Zhu WJ, Hou HL, Sun DX, Zhao J. Efficacy of telemedicine for thrombolytic therapy in acute ischemic stroke: a meta-analysis. J Telemed Telecare. 2015;21(3):123–30.
  860. Kepplinger J, Barlinn K, Deckert S, Scheibe M, Bodechtel U, Schmitt J. Safety and efficacy of thrombolysis in telestroke: A systematic review and meta-analysis. Neurology. 2016;87(13):1344–51.
  861. Baratloo A, Rahimpour L, Abushouk AI, Safari S, Lee CW, Abdalvand A. Effects of Telestroke on Throm- bolysis Times and Outcomes: A Meta-analysis. Prehospital Emerg Care. 2018;22(4):472–84.
  862. Boden-Albala B, Stillman J, Roberts ET, Quarles LW, Glymour MM, Chong J, Moats H, Torrico V, Parides MC. Comparison of acute stroke preparedness strategies to decrease emergency department arrival time in a multiethnic cohort: the Stroke Warning Information and Faster Treatment Study. Stroke. 2015;46:1806–1812. doi: 10.1161/STROKEAHA.114.008502
  863. Rudd M. et al. A systematic review of stroke recognition instruments in hospital and prehospital settings //Emergency Medicine Journal. – 2016. – Т. 33. – №. 11. – С. 818-822

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*